data_1rji_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1rji _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo . . . . . 0 N--CA 1.454 -0.822 0 N-CA-C 113.312 0.466 . . . . 0.29999999999999999 113.312 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 0.2 OUTLIER -94.59 103.3 14.54 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 CA-C-O 121.159 0.504 . . . . 1.05 110.609 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.599 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 5.9 p30 -90.21 161.36 15.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.665 -0.698 . . . . 1.8700000000000001 111.245 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.449 ' HB2' ' CB ' ' A' ' 12' ' ' ASP . 17.7 p -175.39 172.61 2.65 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.443 0.639 . . . . 0.11 112.071 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.7 mttt -118.8 -46.68 2.54 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 114.913 -1.04 . . . . 3.4199999999999999 108.935 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.6 p -110.46 -178.43 3.5 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.582 -0.735 . . . . 1.47 110.17 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -62.28 -57.97 9.43 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 111.818 0.303 . . . . 1.9099999999999999 111.818 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 30.8 mtt180 -72.17 2.34 6.06 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.696 0.628 . . . . 5.0700000000000003 112.696 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.449 ' CB ' ' HB2' ' A' ' 7' ' ' CYS . 3.7 m-20 -75.75 -25.06 56.19 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.714 -0.476 . . . . 1.1499999999999999 109.714 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.48 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -94.25 25.15 3.96 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.583 -0.735 . . . . 0.070000000000000007 110.337 178.515 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -50.22 -30.61 7.16 Favored 'Isoleucine or valine' 0 C--N 1.345 0.397 0 N-CA-C 111.689 0.255 . . . . 1.0600000000000001 111.689 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 61.6 mtt -57.27 -29.01 63.48 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.62 -0.264 . . . . 2.6200000000000001 110.83 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.497 ' HB2' HG11 ' A' ' 5' ' ' VAL . 2.0 t -83.44 -47.57 11.25 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.396 -0.365 . . . . 0.39000000000000001 110.616 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.545 ' CA ' HD13 ' A' ' 20' ' ' ILE . . . -168.08 -169.49 31.62 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 120.738 -0.744 . . . . 0.20999999999999999 113.145 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 17.8 mt -92.02 81.21 5.1 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.143 0.497 . . . . 2.2999999999999998 111.019 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.15 82.17 1.65 Allowed Glycine 0 N--CA 1.455 -0.064 0 CA-C-N 115.523 -0.762 . . . . 0.13 111.489 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.545 HD13 ' CA ' ' A' ' 17' ' ' GLY . 1.1 mm -109.18 133.17 55.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 112.376 0.51 . . . . 1.02 112.376 -178.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 57.1 m -67.35 127.06 31.28 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.88 -0.785 . . . . 1.0800000000000001 108.88 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.432 ' SG ' ' C ' ' A' ' 7' ' ' CYS . 4.4 t -96.98 126.64 42.26 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.11 0.481 . . . . 0.14999999999999999 112.093 -178.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.578 ' HB3' ' HG3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -94.62 -158.35 0.63 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.427 -0.806 . . . . 3.29 109.007 178.689 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -56.42 65.72 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.343 0.657 . . . . 2.1899999999999999 111.892 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 79.1 20.18 70.64 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.169 -0.923 . . . . 0.14000000000000001 113.031 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.599 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 45.0 m-85 -145.33 -175.16 4.6 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.86 0.689 . . . . 2.1499999999999999 112.86 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.523 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -92.44 138.92 31.1 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.611 -0.722 . . . . 0.13 111.826 -178.864 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.578 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 5.7 mt-30 -91.44 -51.82 5.09 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.829 -0.623 . . . . 0.48999999999999999 111.09 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.59 0 CA-C-N 116.06 -0.518 . . . . 0.45000000000000001 111.923 -179.676 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo . . . . . 0 N--CA 1.454 -0.822 0 N-CA-C 113.219 0.43 . . . . 0.0 113.219 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.461 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -96.04 100.02 10.17 Favored 'Isoleucine or valine' 0 C--N 1.342 0.24 0 CA-C-O 120.986 0.422 . . . . 0.0 110.616 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.537 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 26.3 p30 -90.27 166.71 13.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.986 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.1 p -179.73 174.22 0.96 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.385 0.612 . . . . 0.0 112.188 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -120.71 -46.2 2.37 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.344 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.5 p -113.42 -176.89 3.0 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.404 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.82 -63.22 1.38 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.49 4.2 2.52 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -76.86 -29.35 55.81 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.499 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -92.2 23.03 4.04 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.139 178.209 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.1 p -51.21 -27.39 6.16 Favored 'Isoleucine or valine' 0 C--N 1.345 0.378 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.481 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -56.48 -25.8 52.18 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.445 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.5 t -84.08 -44.42 14.08 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.676 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.506 ' CA ' HD13 ' A' ' 20' ' ' ILE . . . -172.09 -169.2 34.57 Favored Glycine 0 C--N 1.337 0.608 0 C-N-CA 120.497 -0.858 . . . . 0.0 113.273 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.9 mt -91.09 82.39 5.56 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.194 0.521 . . . . 0.0 111.007 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.29 82.43 1.66 Allowed Glycine 0 C--N 1.324 -0.118 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.721 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.506 HD13 ' CA ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -111.66 142.37 24.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -177.863 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 1.9 p -83.49 130.36 35.01 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.1 t -98.56 127.16 44.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.005 0.431 . . . . 0.0 111.891 -178.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.598 ' O ' ' N ' ' A' ' 25' ' ' GLY . 1.3 pttt -95.11 -155.73 0.48 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -53.64 64.08 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 O-C-N 123.956 0.785 . . . . 0.0 112.343 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 79.32 16.11 78.86 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.541 -0.754 . . . . 0.0 113.195 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 50.7 m-85 -143.64 -177.6 5.49 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 117.574 0.687 . . . . 0.0 112.403 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.461 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -83.66 140.1 32.38 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.543 -179.323 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' A' ' 21' ' ' SER . 14.5 mt-30 -90.55 -46.61 8.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.453 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.495 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.557 -179.693 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo . . . . . 0 N--CA 1.454 -0.844 0 N-CA-C 113.091 0.381 . . . . 0.0 113.091 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.513 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -95.15 103.3 14.54 Favored 'Isoleucine or valine' 0 C--N 1.34 0.171 0 CA-C-O 121.066 0.46 . . . . 0.0 110.674 -179.849 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.559 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 1.6 p-10 -90.14 163.51 14.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.949 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.4 p -178.5 172.78 1.42 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.37 0.605 . . . . 0.0 112.201 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.0 mttm -118.39 -46.88 2.57 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.237 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 p -112.27 -177.73 3.24 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.33 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -61.39 -58.23 9.05 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.5 mmt85 -72.78 2.45 6.66 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.2 -27.64 53.61 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.47 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.94 23.73 3.56 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.141 178.123 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.3 p -50.8 -28.77 6.47 Favored 'Isoleucine or valine' 0 C--N 1.346 0.446 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.363 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -55.35 -26.59 41.94 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.733 0.302 . . . . 0.0 110.592 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.2 t -84.07 -44.64 13.88 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.696 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.526 ' CA ' HD11 ' A' ' 20' ' ' ILE . . . -173.33 -170.01 36.4 Favored Glycine 0 C--N 1.337 0.619 0 C-N-CA 120.453 -0.879 . . . . 0.0 113.419 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.3 mt -91.13 81.49 5.57 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.162 0.506 . . . . 0.0 110.878 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.76 82.26 1.6 Allowed Glycine 0 N--CA 1.457 0.07 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.361 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.526 HD11 ' CA ' ' A' ' 17' ' ' GLY . 1.2 mm -111.26 147.1 15.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -177.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 28.7 m -87.58 129.41 35.11 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.9 t -98.46 129.47 45.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.065 0.46 . . . . 0.0 111.89 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.577 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.1 OUTLIER -94.9 -156.92 0.53 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.024 178.385 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -57.01 66.02 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.402 0.62 . . . . 0.0 111.678 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 79.83 18.53 72.54 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 115.322 -0.854 . . . . 0.0 113.066 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 54.0 m-85 -145.2 -175.28 4.64 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 117.516 0.658 . . . . 0.0 112.705 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.513 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -88.39 137.54 32.23 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.021 -179.008 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.419 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 9.8 mt-30 -90.17 -45.38 9.14 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.689 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.537 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.749 -179.545 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo . . . . . 0 N--CA 1.455 -0.767 0 N-CA-C 113.255 0.444 . . . . 0.0 113.255 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.521 HG21 ' SG ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -99.58 96.56 5.04 Favored 'Isoleucine or valine' 0 C--N 1.342 0.259 0 CA-C-O 121.082 0.467 . . . . 0.0 110.382 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.601 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 8.0 p-10 -90.32 166.77 13.12 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.339 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.6 p -176.19 166.2 2.87 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.246 0.546 . . . . 0.0 112.27 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -109.71 -40.23 4.88 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.241 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.7 p -123.02 -177.39 3.66 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.037 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -60.76 -59.46 5.36 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -0.25 7.11 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -76.77 -30.1 56.37 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.579 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -89.63 21.85 3.29 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.972 178.042 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.2 p -49.48 -25.14 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.462 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.553 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 20.9 mmt -52.46 -28.64 20.99 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.521 ' SG ' HG21 ' A' ' 5' ' ' VAL . 0.7 OUTLIER -83.83 -45.05 13.7 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.974 179.337 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.492 ' N ' HD11 ' A' ' 20' ' ' ILE . . . -173.12 -166.2 31.19 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.383 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.7 mt -91.48 81.24 5.39 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.078 0.466 . . . . 0.0 110.969 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.26 81.35 1.46 Allowed Glycine 0 N--CA 1.457 0.082 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.613 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.579 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 1.0 OUTLIER -112.13 122.9 67.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.0 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 45.8 m -61.24 134.8 57.37 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.9 t -103.32 126.44 50.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.925 0.393 . . . . 0.0 111.559 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.579 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.1 OUTLIER -95.38 -157.5 0.58 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.225 178.735 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -55.08 64.87 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.404 0.682 . . . . 0.0 112.121 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 78.48 18.68 75.4 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.816 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 38.0 m-85 -144.14 179.62 7.1 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 117.354 0.577 . . . . 0.0 112.5 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.44 144.85 35.44 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.194 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' A' ' 21' ' ' SER . 10.7 mt-30 -90.34 -40.14 12.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.378 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.606 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.949 -179.472 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo . . . . . 0 N--CA 1.454 -0.819 0 N-CA-C 113.314 0.467 . . . . 0.0 113.314 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.439 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -94.9 101.99 13.1 Favored 'Isoleucine or valine' 0 C--N 1.341 0.223 0 CA-C-O 121.078 0.466 . . . . 0.0 110.579 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.526 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 6.4 p30 -90.15 165.15 14.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.837 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.9 p -176.73 175.64 1.63 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.306 0.574 . . . . 0.0 112.261 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.7 mttm -121.26 -49.11 2.18 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.448 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.88 -176.69 2.99 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.269 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.88 -64.26 1.0 Allowed 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.25 5.37 1.73 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.31 -31.28 58.09 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.514 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.38 22.02 4.16 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.376 178.622 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.7 p -51.61 -27.12 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.434 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 65.5 mtm -57.56 -25.04 59.37 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.646 0.26 . . . . 0.0 110.38 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.4 t -84.09 -44.05 14.44 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.523 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.502 ' CA ' HD13 ' A' ' 20' ' ' ILE . . . -171.04 -168.38 32.68 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.431 -0.89 . . . . 0.0 113.402 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.02 82.39 5.59 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.186 0.517 . . . . 0.0 111.029 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.05 82.79 1.69 Allowed Glycine 0 N--CA 1.457 0.061 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.843 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.514 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 0.9 OUTLIER -111.13 139.11 36.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -177.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.4 m -82.32 128.65 34.42 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.9 t -94.91 128.3 41.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.938 0.399 . . . . 0.0 111.325 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.615 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -99.46 -154.71 0.48 Allowed 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.319 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -50.14 63.83 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.096 0.959 . . . . 0.0 113.031 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 76.63 14.4 82.52 Favored Glycine 0 CA--C 1.522 0.508 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.387 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 47.0 m-85 -142.71 -177.34 5.26 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 117.533 0.667 . . . . 0.0 112.645 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.439 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -82.85 141.05 32.56 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.467 -179.401 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.443 ' CG ' ' HB3' ' A' ' 23' ' ' LYS . 34.7 mt-30 -90.63 -51.24 5.49 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.569 179.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.489 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.784 -179.623 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo . . . . . 0 N--CA 1.455 -0.784 0 N-CA-C 113.233 0.436 . . . . 0.0 113.233 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.483 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -94.76 102.06 13.19 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 CA-C-O 121.125 0.488 . . . . 0.0 110.508 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.539 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 4.3 p-10 -90.1 164.08 14.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.055 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.2 p -176.83 174.45 1.77 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.391 0.615 . . . . 0.0 112.127 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -119.71 -46.56 2.45 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.213 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.0 p -114.26 -177.16 3.06 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.243 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.94 -61.0 2.94 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.83 1.73 5.12 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -76.74 -28.45 55.77 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.478 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -92.62 22.92 4.34 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.153 178.104 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.1 p -51.14 -28.68 7.32 Favored 'Isoleucine or valine' 0 C--N 1.345 0.401 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.377 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 23.0 mtt -55.29 -25.98 37.46 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.489 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.5 t -84.1 -45.09 13.38 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.452 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.522 ' CA ' HD12 ' A' ' 20' ' ' ILE . . . -171.35 -169.7 34.58 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.402 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.7 mp -91.28 82.26 5.46 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.219 0.533 . . . . 0.0 110.835 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.61 82.41 1.65 Allowed Glycine 0 C--N 1.324 -0.097 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.514 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.522 HD12 ' CA ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -111.23 146.63 15.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -177.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 67.0 m -87.8 129.63 35.12 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.5 t -96.53 127.71 42.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.074 0.464 . . . . 0.0 111.886 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.583 ' O ' ' N ' ' A' ' 25' ' ' GLY . 1.0 OUTLIER -95.05 -155.73 0.48 Allowed 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.364 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -54.97 65.21 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.375 0.67 . . . . 0.0 112.045 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 77.8 17.2 79.04 Favored Glycine 0 CA--C 1.521 0.444 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.95 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 41.1 m-85 -142.99 -176.67 5.0 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 117.392 0.596 . . . . 0.0 112.517 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.483 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -86.02 138.74 31.74 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.738 -179.284 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.43 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 16.2 mt-30 -89.94 -46.65 8.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.694 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.543 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 -179.672 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo . . . . . 0 N--CA 1.454 -0.814 0 N-CA-C 113.319 0.469 . . . . 0.0 113.319 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.48 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -97.13 100.91 11.55 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 CA-C-O 120.994 0.426 . . . . 0.0 110.735 -179.903 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.548 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 1.0 OUTLIER -90.37 165.25 13.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.789 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.9 p -178.79 173.86 1.2 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.363 0.602 . . . . 0.0 112.222 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.73 -48.59 2.37 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.152 178.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -112.62 -178.36 3.38 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.899 178.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -58.92 -60.88 3.16 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.3 0.57 4.79 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.38 -30.52 60.18 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.459 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.21 23.29 3.38 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.536 178.563 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.6 p -51.3 -27.63 6.79 Favored 'Isoleucine or valine' 0 C--N 1.345 0.384 0 CA-C-N 116.68 -0.237 . . . . 0.0 111.384 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 10.3 mmt -56.06 -25.73 46.36 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.404 178.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.4 t -84.09 -44.91 13.58 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.624 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.515 ' CA ' HD11 ' A' ' 20' ' ' ILE . . . -172.73 -169.12 34.96 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.434 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 mt -91.23 82.98 5.47 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.192 0.52 . . . . 0.0 110.84 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.27 82.68 1.68 Allowed Glycine 0 C--N 1.325 -0.061 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.41 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.515 HD11 ' CA ' ' A' ' 17' ' ' GLY . 1.1 mm -111.18 148.0 14.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -177.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.419 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 18.3 m -89.61 129.93 35.99 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.8 t -97.33 129.75 44.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.076 0.465 . . . . 0.0 111.987 -178.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.575 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -95.18 -157.41 0.57 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.994 178.352 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -56.69 65.62 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.233 0.613 . . . . 0.0 111.83 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 80.99 16.73 74.11 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-N 115.325 -0.852 . . . . 0.0 113.123 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 62.5 m-85 -144.99 -174.1 4.27 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 117.487 0.644 . . . . 0.0 112.57 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.48 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -86.86 139.05 31.05 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.79 -179.178 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.427 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 8.6 mt-30 -90.56 -44.15 9.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.479 178.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.581 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.565 -179.544 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo . . . . . 0 N--CA 1.454 -0.796 0 N-CA-C 113.249 0.442 . . . . 0.0 113.249 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.474 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -95.24 101.24 12.24 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 CA-C-O 120.964 0.411 . . . . 0.0 110.482 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.522 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 27.5 p-10 -90.1 165.66 13.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.13 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.4 p -177.53 174.61 1.52 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.382 0.61 . . . . 0.0 112.324 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.04 -48.28 2.35 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.367 178.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.6 p -113.47 -175.66 2.72 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.176 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.27 -62.43 1.88 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.14 4.57 2.65 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.02 -29.61 55.43 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.476 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.41 22.91 3.66 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.102 178.305 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.0 p -51.64 -26.52 6.75 Favored 'Isoleucine or valine' 0 C--N 1.345 0.391 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.313 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -25.93 60.48 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.777 0.322 . . . . 0.0 110.277 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.5 t -84.18 -44.91 13.49 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.557 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.526 ' CA ' HD13 ' A' ' 20' ' ' ILE . . . -170.58 -169.69 33.96 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.182 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 35.1 mt -91.02 81.89 5.61 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.111 0.482 . . . . 0.0 110.976 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.24 82.11 1.64 Allowed Glycine 0 N--CA 1.458 0.12 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.655 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.526 HD13 ' CA ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -110.71 145.93 16.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -178.126 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.418 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 19.9 m -87.06 129.07 35.06 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.8 t -95.32 127.76 41.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.072 0.463 . . . . 0.0 111.99 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.62 ' O ' ' N ' ' A' ' 25' ' ' GLY . 2.6 ptmt -95.1 -155.42 0.47 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -54.28 65.02 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.286 0.634 . . . . 0.0 111.928 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.62 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 76.88 18.24 79.03 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.842 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 54.1 m-85 -143.93 -176.58 5.05 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 117.277 0.538 . . . . 0.0 112.357 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.474 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -85.11 140.34 31.03 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.74 -179.272 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' A' ' 21' ' ' SER . 15.7 mt-30 -90.53 -47.9 7.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.489 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.523 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.417 -179.591 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo . . . . . 0 N--CA 1.455 -0.75 0 N-CA-C 113.231 0.435 . . . . 0.0 113.231 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.433 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -97.97 98.74 7.67 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 CA-C-O 121.057 0.456 . . . . 0.0 110.667 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.514 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 12.0 p-10 -90.33 165.31 13.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.691 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.2 p -177.48 174.58 1.54 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.432 0.634 . . . . 0.0 112.559 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.7 mtpm? -119.71 -47.86 2.4 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.257 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.75 -177.53 3.15 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.01 178.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.84 -58.15 9.65 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.83 0.52 7.02 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.13 -32.35 59.09 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.5 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -90.92 20.35 4.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.384 178.397 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.403 HG12 ' N ' ' A' ' 15' ' ' MET . 13.3 p -51.3 -27.69 6.83 Favored 'Isoleucine or valine' 0 C--N 1.344 0.356 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.101 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.403 ' N ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -55.06 -25.79 33.19 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.317 178.304 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.1 t -83.99 -43.75 14.86 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.57 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.529 ' CA ' HD12 ' A' ' 20' ' ' ILE . . . -171.24 -169.88 34.72 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.212 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -91.13 82.26 5.54 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.121 0.486 . . . . 0.0 110.658 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.76 82.12 1.63 Allowed Glycine 0 C--N 1.323 -0.178 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.554 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.529 HD12 ' CA ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -110.83 146.54 15.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.075 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.1 m -88.6 129.45 35.49 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.3 t -97.45 126.93 43.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.916 0.389 . . . . 0.0 111.589 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.624 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -99.15 -154.49 0.47 Allowed 'General case' 0 C--O 1.225 -0.209 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.434 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -50.82 64.27 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.729 0.812 . . . . 0.0 112.776 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 76.64 15.15 81.8 Favored Glycine 0 CA--C 1.522 0.511 0 CA-C-N 115.714 -0.675 . . . . 0.0 113.397 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 54.8 m-85 -142.97 -176.18 4.8 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 117.486 0.643 . . . . 0.0 112.403 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.433 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -83.64 140.55 32.12 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.639 -179.35 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.481 ' CG ' ' HB3' ' A' ' 23' ' ' LYS . 16.3 mt-30 -90.81 -44.73 9.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.456 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.528 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.522 -179.598 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 N--CA 1.453 -0.881 0 N-CA-C 113.13 0.396 . . . . 0.0 113.13 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.493 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -94.88 102.84 14.03 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 CA-C-O 121.12 0.486 . . . . 0.0 110.548 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.558 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 7.6 p30 -90.17 164.77 14.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.012 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.0 p -178.07 174.69 1.34 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.467 0.651 . . . . 0.0 112.156 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -120.75 -44.73 2.42 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.669 178.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.17 -177.65 3.22 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.026 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.59 -63.94 1.1 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.1 1.96 3.15 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.12 -29.54 60.59 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.496 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -92.17 23.71 3.68 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.397 178.636 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.7 p -50.87 -27.44 5.19 Favored 'Isoleucine or valine' 0 C--N 1.343 0.323 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.552 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.51 -25.81 52.62 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.393 178.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.6 t -84.26 -43.88 14.42 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.726 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.515 ' CA ' HD12 ' A' ' 20' ' ' ILE . . . -173.25 -169.3 35.54 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.324 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.12 81.78 5.56 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.221 0.534 . . . . 0.0 110.934 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.69 82.87 1.68 Allowed Glycine 0 N--CA 1.458 0.161 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.43 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.515 HD12 ' CA ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -112.47 141.88 26.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -177.793 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.47 131.79 34.99 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 177.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.0 t -99.08 129.37 45.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.163 0.506 . . . . 0.0 112.021 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.608 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -94.94 -156.05 0.49 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.189 178.484 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -55.41 65.23 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 O-C-N 123.674 0.609 . . . . 0.0 111.807 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.608 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 78.76 18.24 75.72 Favored Glycine 0 CA--C 1.52 0.363 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.984 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.558 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 57.9 m-85 -144.74 -175.53 4.7 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 117.383 0.591 . . . . 0.0 112.43 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.493 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -85.72 138.32 32.2 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.755 -179.164 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.404 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 10.3 mt-30 -90.27 -45.48 9.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.536 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.484 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.544 -179.559 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo . . . . . 0 N--CA 1.454 -0.796 0 N-CA-C 113.165 0.41 . . . . 0.0 113.165 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.487 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -98.7 101.36 12.03 Favored 'Isoleucine or valine' 0 C--N 1.34 0.152 0 CA-C-O 121.049 0.452 . . . . 0.0 110.724 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.532 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 5.3 p30 -90.55 164.51 14.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.008 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.9 p -176.89 164.31 2.33 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.389 0.614 . . . . 0.0 112.233 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -111.33 -31.27 7.11 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.572 178.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.66 -179.17 5.22 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.349 178.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.95 -62.03 2.19 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.8 -1.46 7.18 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -74.99 -31.7 61.49 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.101 0.477 . . . . 0.0 109.849 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.471 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -88.09 23.46 2.1 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.379 178.306 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.3 p -51.31 -28.0 7.24 Favored 'Isoleucine or valine' 0 C--N 1.345 0.397 0 CA-C-N 116.752 -0.204 . . . . 0.0 111.292 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 27.2 mmm -55.23 -26.01 36.88 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.714 0.293 . . . . 0.0 110.311 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.4 t -83.95 -45.14 13.48 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.642 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.522 ' CA ' HD13 ' A' ' 20' ' ' ILE . . . -172.86 -169.15 35.09 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.436 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.7 mt -91.12 83.36 5.56 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.059 0.457 . . . . 0.0 110.816 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.19 82.62 1.68 Allowed Glycine 0 C--N 1.322 -0.202 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.365 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.522 HD13 ' CA ' ' A' ' 17' ' ' GLY . 1.2 mm -110.96 148.13 14.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -177.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.25 133.24 34.09 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.0 t -103.34 127.68 50.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.036 0.445 . . . . 0.0 112.045 -178.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.587 ' O ' ' N ' ' A' ' 25' ' ' GLY . 8.4 pttt -94.81 -156.07 0.49 Allowed 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.56 64.71 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.299 0.64 . . . . 0.0 112.259 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 80.2 17.43 74.18 Favored Glycine 0 CA--C 1.522 0.49 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.951 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 50.0 m-85 -143.74 -176.9 5.16 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 117.39 0.595 . . . . 0.0 112.476 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.487 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -85.03 138.37 32.49 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.69 -179.286 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.423 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 8.7 mt-30 -90.65 -40.21 12.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.528 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.523 0 N-CA-C 111.562 -0.615 . . . . 0.0 111.562 -179.516 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo . . . . . 0 N--CA 1.454 -0.814 0 N-CA-C 113.296 0.46 . . . . 0.0 113.296 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.476 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -94.9 102.76 13.94 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 CA-C-O 121.052 0.453 . . . . 0.0 110.529 -179.89 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 26.6 p30 -90.01 164.99 14.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.076 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.3 p -178.02 174.59 1.37 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.333 0.587 . . . . 0.0 111.927 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.4 mmtt -118.95 -48.64 2.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.217 178.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.0 p -112.68 -175.87 2.78 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.217 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.05 -61.94 2.24 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.5 mtt85 -71.48 3.73 3.61 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -179.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.46 -29.37 56.89 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.456 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.19 23.15 3.42 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.332 178.475 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 p -50.91 -27.62 5.46 Favored 'Isoleucine or valine' 0 C--N 1.344 0.335 0 CA-C-N 116.737 -0.211 . . . . 0.0 111.209 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 41.2 mtt -56.72 -25.52 54.67 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.755 0.312 . . . . 0.0 110.483 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.6 t -84.08 -44.66 13.85 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.481 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.516 ' CA ' HD12 ' A' ' 20' ' ' ILE . . . -171.39 -169.3 34.15 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.415 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.13 82.08 5.55 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.246 0.546 . . . . 0.0 110.999 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.03 82.29 1.65 Allowed Glycine 0 C--O 1.23 -0.095 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.627 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.516 HD12 ' CA ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -110.68 149.53 13.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -178.066 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.425 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 42.0 m -90.7 129.86 36.76 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.9 t -97.31 128.61 44.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.091 0.472 . . . . 0.0 112.156 -178.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.59 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -94.93 -155.48 0.47 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.484 -0.78 . . . . 0.0 108.963 178.374 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -55.3 65.13 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.243 0.617 . . . . 0.0 111.913 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 78.18 18.51 76.31 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.932 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 58.9 m-85 -144.37 -175.93 4.83 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 117.382 0.591 . . . . 0.0 112.427 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.476 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -86.14 139.3 31.22 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.76 -179.191 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.425 ' HB2' ' O ' ' A' ' 21' ' ' SER . 11.0 mt-30 -90.58 -45.58 8.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.538 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.549 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.611 -179.541 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo . . . . . 0 N--CA 1.455 -0.749 0 N-CA-C 113.338 0.476 . . . . 0.0 113.338 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.419 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -95.54 101.76 12.79 Favored 'Isoleucine or valine' 0 C--N 1.342 0.271 0 CA-C-O 120.99 0.424 . . . . 0.0 110.526 179.876 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.547 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 18.8 p30 -90.0 165.14 14.22 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.161 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.4 p -178.28 170.65 1.73 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.298 0.57 . . . . 0.0 112.193 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -115.85 -42.88 3.04 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.386 178.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.06 -178.18 3.44 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.163 178.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.7 -58.59 7.82 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.07 0.01 6.86 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -77.09 -30.35 55.33 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.49 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -89.79 21.21 3.66 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.246 178.079 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.9 p -51.56 -28.42 8.65 Favored 'Isoleucine or valine' 0 C--N 1.346 0.456 0 CA-C-N 116.758 -0.201 . . . . 0.0 111.247 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.6 mtp -56.96 -25.4 57.91 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.406 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.5 t -84.0 -44.8 13.79 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.587 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.537 ' CA ' HD13 ' A' ' 20' ' ' ILE . . . -169.46 -169.31 32.6 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.583 -0.818 . . . . 0.0 113.37 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.5 mt -91.27 82.06 5.48 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.105 0.478 . . . . 0.0 110.867 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.9 82.43 1.66 Allowed Glycine 0 CA--C 1.515 0.051 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.656 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.537 HD13 ' CA ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -109.82 145.45 16.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -177.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 14.9 m -85.53 129.14 34.89 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.0 t -95.74 128.96 43.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.049 0.452 . . . . 0.0 111.931 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.588 ' O ' ' N ' ' A' ' 25' ' ' GLY . 3.9 ptmt -95.29 -157.01 0.54 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.471 -0.786 . . . . 0.0 108.98 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.0 65.76 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 O-C-N 123.696 0.623 . . . . 0.0 111.785 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 78.74 18.12 75.99 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.313 -0.858 . . . . 0.0 113.016 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 51.2 m-85 -144.52 -176.26 4.97 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 117.451 0.625 . . . . 0.0 112.667 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.419 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -86.74 140.94 29.26 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.784 -179.173 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.428 ' HB2' ' O ' ' A' ' 21' ' ' SER . 14.5 mt-30 -90.5 -50.15 6.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.537 179.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.489 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.694 -179.715 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo . . . . . 0 N--CA 1.451 -0.994 0 N-CA-C 112.998 0.346 . . . . 0.0 112.998 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.404 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -94.64 98.02 7.57 Favored 'Isoleucine or valine' 0 C--N 1.345 0.37 0 CA-C-O 120.931 0.396 . . . . 0.0 110.348 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.56 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 5.0 p30 -90.19 164.37 14.45 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.296 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.0 p -176.72 174.72 1.78 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.261 0.553 . . . . 0.0 111.896 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -119.97 -47.04 2.41 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.377 178.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.73 -177.72 3.21 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.138 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -60.63 -61.06 2.87 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.67 4.77 2.91 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -77.69 -28.29 50.97 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.471 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.9 22.24 4.38 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.041 178.092 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.6 p -51.12 -29.31 8.05 Favored 'Isoleucine or valine' 0 C--N 1.347 0.474 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.328 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 19.0 mtm -55.98 -25.88 45.92 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.721 0.296 . . . . 0.0 110.471 178.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.0 t -83.87 -45.35 13.33 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.541 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.538 ' CA ' HD13 ' A' ' 20' ' ' ILE . . . -170.23 -170.23 34.33 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.303 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.7 mp -91.11 82.17 5.55 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.234 0.54 . . . . 0.0 110.924 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.58 82.22 1.65 Allowed Glycine 0 C--N 1.325 -0.08 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.645 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.538 HD13 ' CA ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -110.75 145.12 17.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.27 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.418 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 70.4 m -86.33 129.38 34.87 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.9 t -96.73 126.68 42.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.063 0.459 . . . . 0.0 112.035 -178.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.597 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.1 OUTLIER -94.7 -154.91 0.44 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.329 -0.85 . . . . 0.0 108.768 178.285 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -54.95 65.17 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.453 0.701 . . . . 0.0 112.095 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 75.8 19.89 78.53 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.574 -179.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 39.5 m-85 -143.77 179.79 6.94 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -179.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.404 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -84.34 143.36 29.54 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.813 -179.131 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' A' ' 21' ' ' SER . 16.6 mt-30 -90.87 -56.0 3.34 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.752 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.45 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.207 -179.572 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo . . . . . 0 N--CA 1.456 -0.717 0 N-CA-C 113.052 0.366 . . . . 0.0 113.052 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.442 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -96.74 99.0 8.22 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 CA-C-O 121.074 0.464 . . . . 0.0 110.446 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.549 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 1.0 OUTLIER -90.21 166.35 13.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.95 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.5 p -177.85 174.41 1.45 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.275 0.559 . . . . 0.0 112.092 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.7 mmtm -119.99 -47.14 2.4 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.197 178.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.9 p -113.11 -176.89 3.0 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.253 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.14 -62.64 1.72 Allowed 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.92 4.26 2.73 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -179.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -77.26 -28.89 53.67 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.497 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.48 23.25 3.54 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.088 178.053 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.9 p -51.62 -28.2 8.62 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.417 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -26.09 45.17 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.743 0.306 . . . . 0.0 110.453 178.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.3 t -84.03 -45.25 13.28 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.663 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.528 ' CA ' HD12 ' A' ' 20' ' ' ILE . . . -170.77 -169.62 34.04 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.333 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.0 mt -91.16 82.72 5.51 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.167 0.508 . . . . 0.0 110.903 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.45 82.27 1.65 Allowed Glycine 0 C--N 1.324 -0.116 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.634 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.528 HD12 ' CA ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -111.25 141.97 25.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -178.175 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.415 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 11.4 m -83.77 129.01 34.94 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.0 t -95.13 127.43 41.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.128 0.49 . . . . 0.0 112.09 -178.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.596 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -95.48 -156.74 0.53 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.039 178.37 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -54.07 64.69 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 O-C-N 123.916 0.76 . . . . 0.0 112.336 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 78.39 15.55 80.77 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.922 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 44.7 m-85 -143.16 -177.99 5.63 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.442 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -84.17 142.9 29.99 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.905 -179.236 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' A' ' 21' ' ' SER . 6.3 mt-30 -90.86 -52.91 4.63 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.445 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.494 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.216 -179.61 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo . . . . . 0 N--CA 1.453 -0.854 0 N-CA-C 113.192 0.42 . . . . 0.0 113.192 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.0 98.35 7.01 Favored 'Isoleucine or valine' 0 C--N 1.341 0.232 0 CA-C-O 121.026 0.441 . . . . 0.0 110.665 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.54 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 5.0 p30 -90.45 166.21 13.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.691 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.5 p -176.36 174.28 1.98 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.436 0.636 . . . . 0.0 112.397 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -120.65 -45.6 2.4 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.339 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.61 -177.82 3.22 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.977 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -62.46 -58.18 8.54 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.8 3.9 3.76 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.9 -30.18 56.07 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.472 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.33 21.52 4.42 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.332 178.416 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.1 p -51.44 -28.27 8.01 Favored 'Isoleucine or valine' 0 C--N 1.345 0.392 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.388 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.78 -25.18 60.17 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.718 0.294 . . . . 0.0 110.356 178.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.2 t -84.05 -45.48 13.03 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.558 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.532 ' CA ' HD12 ' A' ' 20' ' ' ILE . . . -169.07 -169.3 32.27 Favored Glycine 0 C--N 1.335 0.524 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.298 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.8 mp -91.17 81.75 5.54 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.121 0.486 . . . . 0.0 111.002 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.28 81.77 1.62 Allowed Glycine 0 C--N 1.323 -0.16 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.862 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.532 HD12 ' CA ' ' A' ' 17' ' ' GLY . 0.9 OUTLIER -109.51 144.99 16.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 112.143 0.424 . . . . 0.0 112.143 -178.17 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -86.46 129.91 34.69 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.6 t -95.0 126.35 40.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.196 0.522 . . . . 0.0 111.851 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.614 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -96.58 -155.49 0.49 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.964 178.422 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -52.77 65.43 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.647 0.779 . . . . 0.0 112.16 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.614 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 74.49 16.28 80.09 Favored Glycine 0 CA--C 1.519 0.326 0 CA-C-N 115.386 -0.825 . . . . 0.0 113.073 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 44.7 m-85 -143.34 179.47 7.07 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 117.346 0.573 . . . . 0.0 112.317 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.55 143.42 33.25 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.799 -179.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -90.83 -55.06 3.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.402 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.373 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.286 -179.674 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo . . . . . 0 N--CA 1.453 -0.872 0 N-CA-C 113.038 0.361 . . . . 0.0 113.038 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.481 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -96.95 102.42 13.46 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-O 121.189 0.518 . . . . 0.0 110.683 -179.888 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -89.8 162.66 15.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.564 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.3 p -177.99 174.45 1.4 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.399 0.619 . . . . 0.0 112.342 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.2 -47.29 2.15 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.295 178.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.9 p -112.12 -176.81 3.01 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.219 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.09 -62.76 1.63 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.7 mtt85 -71.09 4.13 2.95 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.91 -27.38 54.91 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.445 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -92.84 23.75 4.0 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.256 178.272 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.3 p -50.88 -27.81 5.62 Favored 'Isoleucine or valine' 0 C--N 1.346 0.456 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.433 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 5.8 mtt -57.05 -25.72 59.12 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.672 0.273 . . . . 0.0 110.487 178.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.6 t -84.06 -45.19 13.32 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.564 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.528 ' CA ' HD11 ' A' ' 20' ' ' ILE . . . -171.26 -168.89 33.55 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 120.485 -0.864 . . . . 0.0 113.588 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.12 82.25 5.55 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.212 0.529 . . . . 0.0 111.075 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.03 82.22 1.65 Allowed Glycine 0 C--N 1.325 -0.073 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.514 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.528 HD11 ' CA ' ' A' ' 17' ' ' GLY . 1.1 mm -109.93 150.12 12.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 0.9 OUTLIER -91.81 129.77 37.71 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.057 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.6 t -96.92 127.65 43.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.996 0.426 . . . . 0.0 111.772 -178.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.6 ' O ' ' N ' ' A' ' 25' ' ' GLY . 38.1 pttt -95.04 -155.5 0.47 Allowed 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -54.05 64.95 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 O-C-N 123.915 0.759 . . . . 0.0 112.216 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 79.1 14.67 81.58 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.31 -0.859 . . . . 0.0 113.149 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -142.37 -176.52 4.87 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 117.607 0.704 . . . . 0.0 112.568 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.481 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -83.51 139.42 32.92 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.707 -179.362 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.42 ' HB2' ' O ' ' A' ' 21' ' ' SER . 12.8 mt-30 -90.36 -47.5 7.71 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.54 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.533 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.667 -179.718 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo . . . . . 0 N--CA 1.452 -0.923 0 N-CA-C 113.085 0.379 . . . . 0.0 113.085 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.445 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -100.06 98.7 7.3 Favored 'Isoleucine or valine' 0 C--N 1.34 0.17 0 CA-C-O 121.092 0.472 . . . . 0.0 110.823 -179.853 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.529 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 2.3 p-10 -90.37 166.91 13.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.654 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.8 p -179.1 173.17 1.18 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.445 0.641 . . . . 0.0 112.443 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.52 -47.68 2.53 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.035 178.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.9 p -113.08 -177.16 3.07 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.191 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -61.63 -56.97 14.05 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.63 -0.22 10.25 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.56 -28.71 59.12 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.453 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.7 23.61 3.5 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.414 178.546 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.6 p -51.62 -28.24 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.282 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -57.11 -26.04 59.8 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.397 178.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.5 t -83.85 -46.17 12.45 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.621 179.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.509 ' CA ' HD12 ' A' ' 20' ' ' ILE . . . -170.93 -169.09 33.56 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.454 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.3 82.56 5.44 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.276 0.56 . . . . 0.0 110.874 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.43 82.36 1.66 Allowed Glycine 0 N--CA 1.458 0.134 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.618 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.509 HD12 ' CA ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -110.16 150.12 12.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.167 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.403 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 6.0 m -91.74 129.15 37.76 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.0 t -96.5 125.86 41.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.961 0.41 . . . . 0.0 111.558 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.62 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -96.32 -152.66 0.38 Allowed 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.166 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -51.97 64.62 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.46 0.704 . . . . 0.0 112.721 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.62 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 74.48 19.62 79.81 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.8 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 89.1 m-85 -145.36 -175.44 4.71 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.445 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -84.15 140.31 31.84 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.803 -179.135 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.41 ' CG ' ' HB3' ' A' ' 23' ' ' LYS . 13.0 mt-30 -90.85 -45.66 8.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.285 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.577 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.25 -179.514 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo . . . . . 0 N--CA 1.455 -0.761 0 N-CA-C 113.308 0.465 . . . . 0.0 113.308 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.487 HG22 ' SG ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -99.82 95.87 4.49 Favored 'Isoleucine or valine' 0 C--N 1.343 0.295 0 CA-C-O 120.966 0.413 . . . . 0.0 110.097 179.675 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.527 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -90.19 165.14 14.13 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.144 -179.099 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.8 p -179.06 169.7 1.51 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.282 0.563 . . . . 0.0 112.151 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.0 mmtt -114.25 -45.06 3.07 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.059 177.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.6 p -115.92 -177.65 3.21 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.683 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -58.37 -62.46 1.83 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -69.47 -0.28 6.29 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -75.59 -28.42 58.91 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.0 110.258 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.594 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -90.8 24.49 2.71 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.069 178.28 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.4 p -49.46 -26.2 2.17 Favored 'Isoleucine or valine' 0 C--N 1.345 0.398 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.589 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 9.8 mtm -52.46 -29.16 23.27 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.606 0.241 . . . . 0.0 110.444 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.487 ' SG ' HG22 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -83.86 -46.96 11.58 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.914 179.377 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.489 ' N ' HD13 ' A' ' 20' ' ' ILE . . . -172.76 -166.03 30.67 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.458 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.29 81.45 5.49 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.244 0.545 . . . . 0.0 111.136 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.34 81.53 1.47 Allowed Glycine 0 N--CA 1.457 0.056 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.713 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.594 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 1.0 OUTLIER -113.07 123.27 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -178.12 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 0.2 OUTLIER -61.44 138.19 58.26 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 178.088 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.6 t -109.77 130.06 55.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.989 0.423 . . . . 0.0 111.946 -178.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.571 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.1 OUTLIER -95.1 -156.72 0.53 Allowed 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.31 178.596 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 -56.67 65.9 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.753 0.658 . . . . 0.0 111.733 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 79.1 21.02 68.71 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.954 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.527 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 58.4 m-85 -145.33 179.14 7.59 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 117.445 0.622 . . . . 0.0 112.429 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.81 143.6 35.88 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.192 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 21' ' ' SER . 7.3 mt-30 -90.51 -40.61 11.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.028 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.695 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.268 -179.501 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo . . . . . 0 N--CA 1.454 -0.811 0 N-CA-C 113.27 0.45 . . . . 0.0 113.27 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.422 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -95.88 102.11 13.16 Favored 'Isoleucine or valine' 0 C--N 1.342 0.254 0 CA-C-O 121.013 0.435 . . . . 0.0 110.265 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.542 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 26.1 p30 -88.9 164.94 14.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.303 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.9 p -177.19 167.86 2.37 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.29 0.567 . . . . 0.0 112.041 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.77 -46.92 3.09 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.898 178.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.6 p -114.89 -176.73 2.96 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.193 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -60.26 -61.77 2.36 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -71.4 3.86 3.44 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -178.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.96 -28.6 55.24 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.465 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -90.21 22.66 3.2 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.229 178.274 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.6 p -50.79 -28.17 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.307 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 10.8 mtt -55.76 -26.31 45.18 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.418 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.5 t -84.04 -44.89 13.66 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.538 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.541 ' CA ' HD13 ' A' ' 20' ' ' ILE . . . -170.69 -170.04 34.47 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.276 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.7 mp -91.1 81.52 5.59 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.129 0.49 . . . . 0.0 110.903 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.54 81.84 1.61 Allowed Glycine 0 C--N 1.325 -0.075 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.598 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.541 HD13 ' CA ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -110.49 147.74 14.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -178.053 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.2 m -86.49 136.93 32.9 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.2 t -104.97 130.85 53.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.272 0.558 . . . . 0.0 112.479 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.581 ' O ' ' N ' ' A' ' 25' ' ' GLY . 1.4 mtpp -94.03 -159.25 0.68 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.197 -0.911 . . . . 0.0 108.718 178.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -58.01 66.67 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.41 0.624 . . . . 0.0 111.025 179.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 80.53 19.27 68.98 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.969 -179.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 44.7 m-85 -143.45 -177.8 5.57 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 117.541 0.67 . . . . 0.0 112.601 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.422 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -86.62 142.52 28.19 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.2 -178.923 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.406 ' HG2' ' HD2' ' A' ' 23' ' ' LYS . 7.1 mt-30 -90.89 -50.19 6.02 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.499 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.535 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.534 -179.406 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo . . . . . 0 N--CA 1.454 -0.798 0 N-CA-C 113.144 0.402 . . . . 0.0 113.144 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.42 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -104.83 92.28 2.1 Favored 'Isoleucine or valine' 0 C--N 1.344 0.344 0 CA-C-O 121.201 0.524 . . . . 0.0 110.512 -179.965 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.492 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 1.0 OUTLIER -90.58 164.91 14.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.621 -179.695 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.401 ' C ' ' SG ' ' A' ' 22' ' ' CYS . 10.3 p -179.25 175.28 0.95 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.353 0.597 . . . . 0.0 112.387 179.439 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -122.12 -46.67 2.18 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.28 178.264 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.91 -177.95 3.26 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.323 178.74 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -58.39 -64.32 0.96 Allowed 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.526 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.27 3.18 2.35 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -179.102 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -76.59 -30.0 56.8 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.459 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.54 22.02 4.27 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.243 178.138 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.6 p -50.4 -29.55 6.47 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 CA-C-O 120.592 0.234 . . . . 0.0 111.195 179.724 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 7.1 ptp -54.71 -25.46 27.54 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.61 178.373 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.7 t -83.98 -43.97 14.66 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.646 179.396 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.539 ' CA ' HD13 ' A' ' 20' ' ' ILE . . . -171.11 -169.67 34.37 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.37 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -91.18 82.19 5.52 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.161 0.505 . . . . 0.0 110.776 179.744 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.66 82.15 1.64 Allowed Glycine 0 N--CA 1.457 0.062 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.523 -179.354 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.539 HD13 ' CA ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -110.73 150.31 13.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -177.939 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 p -91.18 138.46 31.57 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 177.7 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.401 ' SG ' ' C ' ' A' ' 7' ' ' CYS . 3.6 t -103.92 129.51 51.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.102 0.477 . . . . 0.0 111.957 -178.659 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.57 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -95.3 -157.35 0.57 Allowed 'General case' 0 C--O 1.227 -0.131 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.018 178.327 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -56.12 65.54 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.254 0.622 . . . . 0.0 112.024 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 81.21 15.25 77.27 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.16 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 65.5 m-85 -143.51 -174.87 4.35 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 117.455 0.627 . . . . 0.0 112.412 -179.55 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.42 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -81.61 140.0 34.68 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.687 -179.469 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -90.67 -36.22 14.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.467 178.647 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.646 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.635 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 34.0 p . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 120.576 0.226 . . . . 2.5499999999999998 111.302 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.675 ' CB ' ' HB3' ' A' ' 27' ' ' CYS . 69.7 Cg_endo -84.46 40.64 0.88 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.237 2.624 . . . . 0.65000000000000002 113.13 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.572 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -90.41 -60.62 0.22 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 2.7000000000000002 110.147 179.048 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.572 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 65.6 Cg_endo -94.69 13.05 1.47 Allowed 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.079 2.52 . . . . 0.29999999999999999 113.312 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 0.2 OUTLIER -94.59 103.3 14.54 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 CA-C-O 121.159 0.504 . . . . 1.05 110.609 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.599 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 5.9 p30 -90.21 161.36 15.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.665 -0.698 . . . . 1.8700000000000001 111.245 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.449 ' HB2' ' CB ' ' A' ' 12' ' ' ASP . 17.7 p -175.39 172.61 2.65 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.443 0.639 . . . . 0.11 112.071 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.7 mttt -118.8 -46.68 2.54 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 114.913 -1.04 . . . . 3.4199999999999999 108.935 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.6 p -110.46 -178.43 3.5 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.582 -0.735 . . . . 1.47 110.17 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -62.28 -57.97 9.43 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 111.818 0.303 . . . . 1.9099999999999999 111.818 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 30.8 mtt180 -72.17 2.34 6.06 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.696 0.628 . . . . 5.0700000000000003 112.696 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.449 ' CB ' ' HB2' ' A' ' 7' ' ' CYS . 3.7 m-20 -75.75 -25.06 56.19 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.714 -0.476 . . . . 1.1499999999999999 109.714 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.48 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -94.25 25.15 3.96 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.583 -0.735 . . . . 0.070000000000000007 110.337 178.515 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -50.22 -30.61 7.16 Favored 'Isoleucine or valine' 0 C--N 1.345 0.397 0 N-CA-C 111.689 0.255 . . . . 1.0600000000000001 111.689 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 61.6 mtt -57.27 -29.01 63.48 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.62 -0.264 . . . . 2.6200000000000001 110.83 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.497 ' HB2' HG11 ' A' ' 5' ' ' VAL . 2.0 t -83.44 -47.57 11.25 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.396 -0.365 . . . . 0.39000000000000001 110.616 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.545 ' CA ' HD13 ' A' ' 20' ' ' ILE . . . -168.08 -169.49 31.62 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 120.738 -0.744 . . . . 0.20999999999999999 113.145 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 17.8 mt -92.02 81.21 5.1 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.143 0.497 . . . . 2.2999999999999998 111.019 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.15 82.17 1.65 Allowed Glycine 0 N--CA 1.455 -0.064 0 CA-C-N 115.523 -0.762 . . . . 0.13 111.489 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.569 HG22 ' HB3' ' A' ' 30' ' ' CYS . 1.1 mm -109.18 133.17 55.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 112.376 0.51 . . . . 1.02 112.376 -178.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 57.1 m -67.35 127.06 31.28 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.88 -0.785 . . . . 1.0800000000000001 108.88 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.432 ' SG ' ' C ' ' A' ' 7' ' ' CYS . 4.4 t -96.98 126.64 42.26 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.11 0.481 . . . . 0.14999999999999999 112.093 -178.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.578 ' HB3' ' HG3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -94.62 -158.35 0.63 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.427 -0.806 . . . . 3.29 109.007 178.689 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -56.42 65.72 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.343 0.657 . . . . 2.1899999999999999 111.892 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 79.1 20.18 70.64 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.169 -0.923 . . . . 0.14000000000000001 113.031 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.599 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 45.0 m-85 -145.33 -175.16 4.6 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.86 0.689 . . . . 2.1499999999999999 112.86 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.675 ' HB3' ' CB ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -92.44 138.92 31.1 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.611 -0.722 . . . . 0.13 111.826 -178.864 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.578 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 5.7 mt-30 -91.44 -51.82 5.09 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.829 -0.623 . . . . 0.48999999999999999 111.09 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.48 ' HA2' ' HG3' ' A' ' 2' ' ' PRO . . . 179.9 100.09 0.13 Allowed Glycine 0 C--N 1.337 0.59 0 CA-C-N 116.06 -0.518 . . . . 0.45000000000000001 111.923 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.569 ' HB3' HG22 ' A' ' 20' ' ' ILE . 15.6 p -78.98 -128.79 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 111.446 0.165 . . . . 1.53 111.446 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 46.1 p . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.497 -0.763 . . . . 2.1200000000000001 111.191 -179.537 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 120.484 0.183 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.53 ' HA ' HG23 ' A' ' 5' ' ' VAL . 87.7 Cg_endo -81.39 43.73 1.59 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.909 2.406 . . . . 0.0 113.17 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.547 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.2 OUTLIER -96.49 -59.65 0.17 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.795 178.797 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.547 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 63.4 Cg_endo -93.84 10.37 2.03 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.997 2.465 . . . . 0.0 113.219 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.53 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -96.04 100.02 10.17 Favored 'Isoleucine or valine' 0 C--N 1.342 0.24 0 CA-C-O 120.986 0.422 . . . . 0.0 110.616 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.537 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 26.3 p30 -90.27 166.71 13.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.986 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.1 p -179.73 174.22 0.96 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.385 0.612 . . . . 0.0 112.188 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -120.71 -46.2 2.37 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.344 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.5 p -113.42 -176.89 3.0 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.404 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.82 -63.22 1.38 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.49 4.2 2.52 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -76.86 -29.35 55.81 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.499 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -92.2 23.03 4.04 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.139 178.209 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.1 p -51.21 -27.39 6.16 Favored 'Isoleucine or valine' 0 C--N 1.345 0.378 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.481 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -56.48 -25.8 52.18 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.445 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.5 t -84.08 -44.42 14.08 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.676 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.506 ' CA ' HD13 ' A' ' 20' ' ' ILE . . . -172.09 -169.2 34.57 Favored Glycine 0 C--N 1.337 0.608 0 C-N-CA 120.497 -0.858 . . . . 0.0 113.273 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.9 mt -91.09 82.39 5.56 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.194 0.521 . . . . 0.0 111.007 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.29 82.43 1.66 Allowed Glycine 0 C--N 1.324 -0.118 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.721 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.506 HD13 ' CA ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -111.66 142.37 24.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -177.863 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 1.9 p -83.49 130.36 35.01 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.1 t -98.56 127.16 44.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.005 0.431 . . . . 0.0 111.891 -178.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.598 ' O ' ' N ' ' A' ' 25' ' ' GLY . 1.3 pttt -95.11 -155.73 0.48 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -53.64 64.08 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 O-C-N 123.956 0.785 . . . . 0.0 112.343 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 79.32 16.11 78.86 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.541 -0.754 . . . . 0.0 113.195 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 50.7 m-85 -143.64 -177.6 5.49 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 117.574 0.687 . . . . 0.0 112.403 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.516 ' HB3' ' CB ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -83.66 140.1 32.38 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.543 -179.323 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' A' ' 21' ' ' SER . 14.5 mt-30 -90.55 -46.61 8.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.453 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 167.48 104.52 0.18 Allowed Glycine 0 C--N 1.335 0.495 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.557 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.442 ' HB2' HD13 ' A' ' 20' ' ' ILE . 14.9 p -80.71 -128.2 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 111.415 0.154 . . . . 0.0 111.415 -179.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.9 p . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.167 -0.92 . . . . 0.0 111.353 -179.575 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 120.539 0.209 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.593 ' CB ' ' HB3' ' A' ' 27' ' ' CYS . 97.9 Cg_endo -82.62 42.27 1.27 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.938 2.426 . . . . 0.0 113.027 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.76 ' HB2' ' HD3' ' A' ' 4' ' ' PRO . 34.6 m-85 -96.03 -57.47 0.2 Allowed Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.896 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.76 ' HD3' ' HB2' ' A' ' 3' ' ' TYR . 63.7 Cg_endo -96.95 13.21 0.96 Allowed 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.021 2.481 . . . . 0.0 113.091 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.513 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -95.15 103.3 14.54 Favored 'Isoleucine or valine' 0 C--N 1.34 0.171 0 CA-C-O 121.066 0.46 . . . . 0.0 110.674 -179.849 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.559 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 1.6 p-10 -90.14 163.51 14.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.949 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.4 p -178.5 172.78 1.42 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.37 0.605 . . . . 0.0 112.201 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.0 mttm -118.39 -46.88 2.57 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.237 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 p -112.27 -177.73 3.24 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.33 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -61.39 -58.23 9.05 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.5 mmt85 -72.78 2.45 6.66 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.2 -27.64 53.61 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.47 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.94 23.73 3.56 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.141 178.123 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.3 p -50.8 -28.77 6.47 Favored 'Isoleucine or valine' 0 C--N 1.346 0.446 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.363 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -55.35 -26.59 41.94 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.733 0.302 . . . . 0.0 110.592 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 4.2 t -84.07 -44.64 13.88 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.696 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.526 ' CA ' HD11 ' A' ' 20' ' ' ILE . . . -173.33 -170.01 36.4 Favored Glycine 0 C--N 1.337 0.619 0 C-N-CA 120.453 -0.879 . . . . 0.0 113.419 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.3 mt -91.13 81.49 5.57 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.162 0.506 . . . . 0.0 110.878 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.76 82.26 1.6 Allowed Glycine 0 N--CA 1.457 0.07 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.361 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.526 HD11 ' CA ' ' A' ' 17' ' ' GLY . 1.2 mm -111.26 147.1 15.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -177.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 28.7 m -87.58 129.41 35.11 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.9 t -98.46 129.47 45.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.065 0.46 . . . . 0.0 111.89 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.577 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.1 OUTLIER -94.9 -156.92 0.53 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.024 178.385 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -57.01 66.02 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.402 0.62 . . . . 0.0 111.678 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 79.83 18.53 72.54 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 115.322 -0.854 . . . . 0.0 113.066 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 54.0 m-85 -145.2 -175.28 4.64 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 117.516 0.658 . . . . 0.0 112.705 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.593 ' HB3' ' CB ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -88.39 137.54 32.23 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.021 -179.008 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.419 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 9.8 mt-30 -90.17 -45.38 9.14 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.689 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.403 ' HA2' ' HG3' ' A' ' 2' ' ' PRO . . . 167.13 105.22 0.18 Allowed Glycine 0 C--N 1.336 0.537 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.749 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 10.1 p -79.63 -126.45 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.4 p . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.213 -0.898 . . . . 0.0 111.224 -179.57 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 12.2 t . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 120.425 0.155 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.567 ' HA ' HG22 ' A' ' 5' ' ' VAL . 85.1 Cg_endo -81.4 41.62 1.18 Allowed 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.967 2.445 . . . . 0.0 113.372 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.521 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.9 OUTLIER -95.71 -59.23 0.19 Allowed Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.876 178.851 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.521 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 69.7 Cg_endo -92.44 8.08 2.91 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.908 2.405 . . . . 0.0 113.255 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.567 HG22 ' HA ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -99.58 96.56 5.04 Favored 'Isoleucine or valine' 0 C--N 1.342 0.259 0 CA-C-O 121.082 0.467 . . . . 0.0 110.382 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.601 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 8.0 p-10 -90.32 166.77 13.12 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.339 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.6 p -176.19 166.2 2.87 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.246 0.546 . . . . 0.0 112.27 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -109.71 -40.23 4.88 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.241 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.7 p -123.02 -177.39 3.66 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.037 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -60.76 -59.46 5.36 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -0.25 7.11 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -76.77 -30.1 56.37 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.579 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -89.63 21.85 3.29 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.972 178.042 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.2 p -49.48 -25.14 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.462 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.553 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 20.9 mmt -52.46 -28.64 20.99 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.521 ' SG ' HG21 ' A' ' 5' ' ' VAL . 0.7 OUTLIER -83.83 -45.05 13.7 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.974 179.337 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.492 ' N ' HD11 ' A' ' 20' ' ' ILE . . . -173.12 -166.2 31.19 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.383 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.7 mt -91.48 81.24 5.39 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.078 0.466 . . . . 0.0 110.969 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.26 81.35 1.46 Allowed Glycine 0 N--CA 1.457 0.082 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.613 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.579 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 1.0 OUTLIER -112.13 122.9 67.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.0 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 45.8 m -61.24 134.8 57.37 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.9 t -103.32 126.44 50.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.925 0.393 . . . . 0.0 111.559 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.579 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.1 OUTLIER -95.38 -157.5 0.58 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.225 178.735 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -55.08 64.87 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.404 0.682 . . . . 0.0 112.121 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 78.48 18.68 75.4 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.816 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 38.0 m-85 -144.14 179.62 7.1 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 117.354 0.577 . . . . 0.0 112.5 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.516 ' HB3' ' HB3' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -78.44 144.85 35.44 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.194 -179.729 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' A' ' 21' ' ' SER . 10.7 mt-30 -90.34 -40.14 12.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.378 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -170.27 96.72 0.12 Allowed Glycine 0 C--N 1.337 0.606 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.949 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -40.24 90.31 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 123.809 0.844 . . . . 0.0 111.889 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.432 ' CG2' HD13 ' A' ' 20' ' ' ILE . 2.6 t . . . . . 0 C--O 1.25 1.089 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.129 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.403 ' HB ' ' HD3' ' A' ' 2' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.77 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.6 ' CB ' ' HB3' ' A' ' 27' ' ' CYS . 96.5 Cg_endo -82.83 43.33 1.46 Allowed 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 122.66 2.24 . . . . 0.0 113.166 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.527 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 2.1 m-85 -96.31 -59.38 0.17 Allowed Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.84 178.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.527 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 58.0 Cg_endo -94.36 11.06 1.78 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.062 2.508 . . . . 0.0 113.314 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.527 HG22 ' HA ' ' A' ' 2' ' ' PRO . 0.1 OUTLIER -94.9 101.99 13.1 Favored 'Isoleucine or valine' 0 C--N 1.341 0.223 0 CA-C-O 121.078 0.466 . . . . 0.0 110.579 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.526 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 6.4 p30 -90.15 165.15 14.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.837 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.9 p -176.73 175.64 1.63 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.306 0.574 . . . . 0.0 112.261 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.7 mttm -121.26 -49.11 2.18 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.448 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.88 -176.69 2.99 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.269 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.88 -64.26 1.0 Allowed 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.25 5.37 1.73 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.31 -31.28 58.09 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.514 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.38 22.02 4.16 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.376 178.622 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.7 p -51.61 -27.12 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.434 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 65.5 mtm -57.56 -25.04 59.37 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.646 0.26 . . . . 0.0 110.38 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.401 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 4.4 t -84.09 -44.05 14.44 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.523 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.502 ' CA ' HD13 ' A' ' 20' ' ' ILE . . . -171.04 -168.38 32.68 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.431 -0.89 . . . . 0.0 113.402 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.02 82.39 5.59 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.186 0.517 . . . . 0.0 111.029 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.05 82.79 1.69 Allowed Glycine 0 N--CA 1.457 0.061 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.843 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.514 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 0.9 OUTLIER -111.13 139.11 36.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -177.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.4 m -82.32 128.65 34.42 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.9 t -94.91 128.3 41.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.938 0.399 . . . . 0.0 111.325 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.615 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -99.46 -154.71 0.48 Allowed 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.319 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -50.14 63.83 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.096 0.959 . . . . 0.0 113.031 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 76.63 14.4 82.52 Favored Glycine 0 CA--C 1.522 0.508 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.387 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 47.0 m-85 -142.71 -177.34 5.26 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 117.533 0.667 . . . . 0.0 112.645 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.6 ' HB3' ' CB ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -82.85 141.05 32.56 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.467 -179.401 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.443 ' CG ' ' HB3' ' A' ' 23' ' ' LYS . 34.7 mt-30 -90.63 -51.24 5.49 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.569 179.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.446 ' HA2' ' HG3' ' A' ' 2' ' ' PRO . . . 173.48 102.41 0.16 Allowed Glycine 0 C--N 1.335 0.489 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.784 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.411 ' HB2' HD13 ' A' ' 20' ' ' ILE . 15.5 p -80.93 -127.66 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 111.402 0.149 . . . . 0.0 111.402 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.1 p . . . . . 0 C--O 1.253 1.254 0 CA-C-O 118.548 -0.739 . . . . 0.0 110.994 -179.56 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 120.564 0.221 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.58 ' CB ' ' HB3' ' A' ' 27' ' ' CYS . 94.7 Cg_endo -83.1 42.48 1.29 Allowed 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.922 2.415 . . . . 0.0 113.359 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.524 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.2 OUTLIER -96.66 -59.37 0.17 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.761 178.775 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.524 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 62.0 Cg_endo -93.48 10.67 2.09 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.975 2.45 . . . . 0.0 113.233 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.511 HG21 ' HA ' ' A' ' 2' ' ' PRO . 0.1 OUTLIER -94.76 102.06 13.19 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 CA-C-O 121.125 0.488 . . . . 0.0 110.508 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.539 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 4.3 p-10 -90.1 164.08 14.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.055 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.2 p -176.83 174.45 1.77 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.391 0.615 . . . . 0.0 112.127 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -119.71 -46.56 2.45 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.213 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.0 p -114.26 -177.16 3.06 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.243 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.94 -61.0 2.94 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.83 1.73 5.12 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -76.74 -28.45 55.77 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.478 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -92.62 22.92 4.34 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.153 178.104 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.1 p -51.14 -28.68 7.32 Favored 'Isoleucine or valine' 0 C--N 1.345 0.401 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.377 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 23.0 mtt -55.29 -25.98 37.46 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.489 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.401 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 4.5 t -84.1 -45.09 13.38 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.452 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.522 ' CA ' HD12 ' A' ' 20' ' ' ILE . . . -171.35 -169.7 34.58 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.402 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.7 mp -91.28 82.26 5.46 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.219 0.533 . . . . 0.0 110.835 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.61 82.41 1.65 Allowed Glycine 0 C--N 1.324 -0.097 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.514 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.522 HD12 ' CA ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -111.23 146.63 15.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -177.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 67.0 m -87.8 129.63 35.12 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.5 t -96.53 127.71 42.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.074 0.464 . . . . 0.0 111.886 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.583 ' O ' ' N ' ' A' ' 25' ' ' GLY . 1.0 OUTLIER -95.05 -155.73 0.48 Allowed 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.364 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -54.97 65.21 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.375 0.67 . . . . 0.0 112.045 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 77.8 17.2 79.04 Favored Glycine 0 CA--C 1.521 0.444 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.95 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 41.1 m-85 -142.99 -176.67 5.0 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 117.392 0.596 . . . . 0.0 112.517 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.58 ' HB3' ' CB ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -86.02 138.74 31.74 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.738 -179.284 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.43 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 16.2 mt-30 -89.94 -46.65 8.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.694 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 167.97 104.44 0.18 Allowed Glycine 0 C--N 1.336 0.543 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.451 ' HB2' HD12 ' A' ' 20' ' ' ILE . 13.9 p -81.15 -127.96 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 121.971 0.108 . . . . 0.0 111.252 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.567 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 120.543 0.211 . . . . 0.0 111.283 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.541 ' CB ' ' HB3' ' A' ' 27' ' ' CYS . 96.7 Cg_endo -82.65 41.12 1.05 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.008 2.472 . . . . 0.0 113.36 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.55 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.2 OUTLIER -93.73 -59.72 0.2 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.854 178.811 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.55 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 64.9 Cg_endo -94.69 12.05 1.59 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.057 2.504 . . . . 0.0 113.319 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.535 HG22 ' HA ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -97.13 100.91 11.55 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 CA-C-O 120.994 0.426 . . . . 0.0 110.735 -179.903 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.548 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 1.0 OUTLIER -90.37 165.25 13.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.789 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.9 p -178.79 173.86 1.2 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.363 0.602 . . . . 0.0 112.222 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.73 -48.59 2.37 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.152 178.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -112.62 -178.36 3.38 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.899 178.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -58.92 -60.88 3.16 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.3 0.57 4.79 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.38 -30.52 60.18 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.459 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.21 23.29 3.38 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.536 178.563 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.6 p -51.3 -27.63 6.79 Favored 'Isoleucine or valine' 0 C--N 1.345 0.384 0 CA-C-N 116.68 -0.237 . . . . 0.0 111.384 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 10.3 mmt -56.06 -25.73 46.36 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.404 178.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.42 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 4.4 t -84.09 -44.91 13.58 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.624 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.515 ' CA ' HD11 ' A' ' 20' ' ' ILE . . . -172.73 -169.12 34.96 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.434 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 mt -91.23 82.98 5.47 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.192 0.52 . . . . 0.0 110.84 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.27 82.68 1.68 Allowed Glycine 0 C--N 1.325 -0.061 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.41 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.515 HD11 ' CA ' ' A' ' 17' ' ' GLY . 1.1 mm -111.18 148.0 14.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -177.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.419 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 18.3 m -89.61 129.93 35.99 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.8 t -97.33 129.75 44.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.076 0.465 . . . . 0.0 111.987 -178.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.575 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -95.18 -157.41 0.57 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.994 178.352 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -56.69 65.62 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.233 0.613 . . . . 0.0 111.83 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 80.99 16.73 74.11 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-N 115.325 -0.852 . . . . 0.0 113.123 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 62.5 m-85 -144.99 -174.1 4.27 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 117.487 0.644 . . . . 0.0 112.57 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.541 ' HB3' ' CB ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -86.86 139.05 31.05 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.79 -179.178 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.427 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 8.6 mt-30 -90.56 -44.15 9.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.479 178.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 164.99 105.61 0.19 Allowed Glycine 0 C--N 1.336 0.581 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.565 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.443 ' HB2' HD11 ' A' ' 20' ' ' ILE . 13.3 p -81.46 -127.82 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 111.42 0.155 . . . . 0.0 111.42 -179.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.3 p . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.479 -179.564 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 11.5 t . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 120.482 0.182 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.544 ' HA ' HG21 ' A' ' 5' ' ' VAL . 97.1 Cg_endo -83.14 40.52 0.96 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.017 2.478 . . . . 0.0 113.275 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.533 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.5 OUTLIER -95.07 -59.4 0.19 Allowed Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.926 178.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.533 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 67.3 Cg_endo -92.87 9.2 2.53 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.892 2.395 . . . . 0.0 113.249 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.544 HG21 ' HA ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -95.24 101.24 12.24 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 CA-C-O 120.964 0.411 . . . . 0.0 110.482 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.522 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 27.5 p-10 -90.1 165.66 13.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.13 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.4 p -177.53 174.61 1.52 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.382 0.61 . . . . 0.0 112.324 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.04 -48.28 2.35 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.367 178.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.6 p -113.47 -175.66 2.72 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.176 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.27 -62.43 1.88 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.14 4.57 2.65 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.02 -29.61 55.43 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.476 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.41 22.91 3.66 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.102 178.305 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.0 p -51.64 -26.52 6.75 Favored 'Isoleucine or valine' 0 C--N 1.345 0.391 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.313 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -25.93 60.48 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.777 0.322 . . . . 0.0 110.277 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.421 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 4.5 t -84.18 -44.91 13.49 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.557 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.526 ' CA ' HD13 ' A' ' 20' ' ' ILE . . . -170.58 -169.69 33.96 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.182 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 35.1 mt -91.02 81.89 5.61 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.111 0.482 . . . . 0.0 110.976 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.24 82.11 1.64 Allowed Glycine 0 N--CA 1.458 0.12 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.655 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.526 HD13 ' CA ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -110.71 145.93 16.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -178.126 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.418 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 19.9 m -87.06 129.07 35.06 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.8 t -95.32 127.76 41.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.072 0.463 . . . . 0.0 111.99 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.62 ' O ' ' N ' ' A' ' 25' ' ' GLY . 2.6 ptmt -95.1 -155.42 0.47 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -54.28 65.02 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.286 0.634 . . . . 0.0 111.928 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.62 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 76.88 18.24 79.03 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.842 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 54.1 m-85 -143.93 -176.58 5.05 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 117.277 0.538 . . . . 0.0 112.357 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.542 ' HB3' ' CB ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -85.11 140.34 31.03 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.74 -179.272 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' A' ' 21' ' ' SER . 15.7 mt-30 -90.53 -47.9 7.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.489 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 168.72 104.07 0.17 Allowed Glycine 0 C--N 1.335 0.523 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.417 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.456 ' HB2' HD13 ' A' ' 20' ' ' ILE . 15.6 p -80.77 -128.43 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 111.428 0.158 . . . . 0.0 111.428 -178.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.186 -0.912 . . . . 0.0 110.767 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 120.294 0.093 . . . . 0.0 110.924 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.545 ' HA ' HG22 ' A' ' 5' ' ' VAL . 96.0 Cg_endo -82.6 40.47 0.97 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.9 2.4 . . . . 0.0 113.352 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.523 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -94.24 -58.35 0.21 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.961 178.763 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.523 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 69.3 Cg_endo -94.38 10.87 1.8 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.035 2.49 . . . . 0.0 113.231 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.545 HG22 ' HA ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -97.97 98.74 7.67 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 CA-C-O 121.057 0.456 . . . . 0.0 110.667 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.514 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 12.0 p-10 -90.33 165.31 13.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.691 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.2 p -177.48 174.58 1.54 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.432 0.634 . . . . 0.0 112.559 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.7 mtpm? -119.71 -47.86 2.4 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.257 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.75 -177.53 3.15 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.01 178.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.84 -58.15 9.65 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.83 0.52 7.02 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.13 -32.35 59.09 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.5 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -90.92 20.35 4.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.384 178.397 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.403 HG12 ' N ' ' A' ' 15' ' ' MET . 13.3 p -51.3 -27.69 6.83 Favored 'Isoleucine or valine' 0 C--N 1.344 0.356 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.101 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.403 ' N ' HG12 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -55.06 -25.79 33.19 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.317 178.304 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.1 t -83.99 -43.75 14.86 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.57 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.529 ' CA ' HD12 ' A' ' 20' ' ' ILE . . . -171.24 -169.88 34.72 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.212 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -91.13 82.26 5.54 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.121 0.486 . . . . 0.0 110.658 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.76 82.12 1.63 Allowed Glycine 0 C--N 1.323 -0.178 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.554 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.529 HD12 ' CA ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -110.83 146.54 15.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.075 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.1 m -88.6 129.45 35.49 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.3 t -97.45 126.93 43.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.916 0.389 . . . . 0.0 111.589 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.624 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -99.15 -154.49 0.47 Allowed 'General case' 0 C--O 1.225 -0.209 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.434 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -50.82 64.27 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.729 0.812 . . . . 0.0 112.776 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 76.64 15.15 81.8 Favored Glycine 0 CA--C 1.522 0.511 0 CA-C-N 115.714 -0.675 . . . . 0.0 113.397 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 54.8 m-85 -142.97 -176.18 4.8 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 117.486 0.643 . . . . 0.0 112.403 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.51 ' HB3' ' CB ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -83.64 140.55 32.12 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.639 -179.35 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.481 ' CG ' ' HB3' ' A' ' 23' ' ' LYS . 16.3 mt-30 -90.81 -44.73 9.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.456 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 164.61 105.46 0.19 Allowed Glycine 0 C--N 1.336 0.528 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.522 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.451 ' HB2' HD12 ' A' ' 20' ' ' ILE . 16.9 p -81.75 -128.78 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 111.464 0.172 . . . . 0.0 111.464 -178.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.1 p . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.143 -0.932 . . . . 0.0 111.385 -179.533 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 120.472 0.177 . . . . 0.0 111.126 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.585 ' CB ' ' HB3' ' A' ' 27' ' ' CYS . 97.4 Cg_endo -82.19 43.71 1.56 Allowed 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.837 2.358 . . . . 0.0 113.168 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.56 ' HB2' ' HD3' ' A' ' 4' ' ' PRO . 3.0 m-85 -96.56 -59.44 0.17 Allowed Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.771 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.56 ' HD3' ' HB2' ' A' ' 3' ' ' TYR . 57.5 Cg_endo -95.05 12.64 1.44 Allowed 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.94 2.427 . . . . 0.0 113.13 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.493 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -94.88 102.84 14.03 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 CA-C-O 121.12 0.486 . . . . 0.0 110.548 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.558 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 7.6 p30 -90.17 164.77 14.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.012 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.0 p -178.07 174.69 1.34 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.467 0.651 . . . . 0.0 112.156 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -120.75 -44.73 2.42 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.669 178.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.17 -177.65 3.22 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.026 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.59 -63.94 1.1 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.1 1.96 3.15 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.12 -29.54 60.59 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.496 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -92.17 23.71 3.68 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.397 178.636 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.7 p -50.87 -27.44 5.19 Favored 'Isoleucine or valine' 0 C--N 1.343 0.323 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.552 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.51 -25.81 52.62 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.393 178.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.425 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 4.6 t -84.26 -43.88 14.42 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.726 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.515 ' CA ' HD12 ' A' ' 20' ' ' ILE . . . -173.25 -169.3 35.54 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.324 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.12 81.78 5.56 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.221 0.534 . . . . 0.0 110.934 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 102.69 82.87 1.68 Allowed Glycine 0 N--CA 1.458 0.161 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.43 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.515 HD12 ' CA ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -112.47 141.88 26.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -177.793 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.47 131.79 34.99 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 177.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.0 t -99.08 129.37 45.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.163 0.506 . . . . 0.0 112.021 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.608 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -94.94 -156.05 0.49 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.189 178.484 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -55.41 65.23 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 O-C-N 123.674 0.609 . . . . 0.0 111.807 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.608 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 78.76 18.24 75.72 Favored Glycine 0 CA--C 1.52 0.363 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.984 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.558 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 57.9 m-85 -144.74 -175.53 4.7 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 117.383 0.591 . . . . 0.0 112.43 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.585 ' HB3' ' CB ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -85.72 138.32 32.2 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.755 -179.164 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.404 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 10.3 mt-30 -90.27 -45.48 9.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.536 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.404 ' HA2' ' HG3' ' A' ' 2' ' ' PRO . . . 166.56 104.65 0.18 Allowed Glycine 0 C--N 1.335 0.484 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.544 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.455 ' HB2' HD12 ' A' ' 20' ' ' ILE . 13.6 p -80.28 -127.53 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 111.469 0.174 . . . . 0.0 111.469 -179.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.4 p . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.456 -0.783 . . . . 0.0 111.044 -179.455 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 17.5 p . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 120.335 0.112 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.567 ' CB ' ' HB3' ' A' ' 27' ' ' CYS . 92.2 Cg_endo -82.2 36.57 0.63 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.924 2.416 . . . . 0.0 113.363 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.751 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 16.1 t80 -91.35 -55.99 0.26 Allowed Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.177 178.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.751 ' HD3' ' HB3' ' A' ' 3' ' ' TYR . 86.5 Cg_endo -96.24 12.2 1.22 Allowed 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 123.002 2.468 . . . . 0.0 113.165 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.53 HG21 ' HA ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -98.7 101.36 12.03 Favored 'Isoleucine or valine' 0 C--N 1.34 0.152 0 CA-C-O 121.049 0.452 . . . . 0.0 110.724 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.532 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 5.3 p30 -90.55 164.51 14.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.008 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.9 p -176.89 164.31 2.33 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.389 0.614 . . . . 0.0 112.233 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -111.33 -31.27 7.11 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.572 178.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.66 -179.17 5.22 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.349 178.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.95 -62.03 2.19 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.8 -1.46 7.18 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -74.99 -31.7 61.49 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.101 0.477 . . . . 0.0 109.849 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.471 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -88.09 23.46 2.1 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.379 178.306 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.3 p -51.31 -28.0 7.24 Favored 'Isoleucine or valine' 0 C--N 1.345 0.397 0 CA-C-N 116.752 -0.204 . . . . 0.0 111.292 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 27.2 mmm -55.23 -26.01 36.88 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.714 0.293 . . . . 0.0 110.311 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.42 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 4.4 t -83.95 -45.14 13.48 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.642 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.522 ' CA ' HD13 ' A' ' 20' ' ' ILE . . . -172.86 -169.15 35.09 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.436 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.7 mt -91.12 83.36 5.56 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.059 0.457 . . . . 0.0 110.816 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.19 82.62 1.68 Allowed Glycine 0 C--N 1.322 -0.202 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.365 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.522 HD13 ' CA ' ' A' ' 17' ' ' GLY . 1.2 mm -110.96 148.13 14.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -177.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.25 133.24 34.09 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.0 t -103.34 127.68 50.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.036 0.445 . . . . 0.0 112.045 -178.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.587 ' O ' ' N ' ' A' ' 25' ' ' GLY . 8.4 pttt -94.81 -156.07 0.49 Allowed 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.56 64.71 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.299 0.64 . . . . 0.0 112.259 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 80.2 17.43 74.18 Favored Glycine 0 CA--C 1.522 0.49 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.951 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 50.0 m-85 -143.74 -176.9 5.16 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 117.39 0.595 . . . . 0.0 112.476 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.567 ' HB3' ' CB ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -85.03 138.37 32.49 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.69 -179.286 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.423 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 8.7 mt-30 -90.65 -40.21 12.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.528 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 161.07 107.1 0.22 Allowed Glycine 0 C--N 1.335 0.523 0 N-CA-C 111.562 -0.615 . . . . 0.0 111.562 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.439 ' HB2' HD13 ' A' ' 20' ' ' ILE . 12.0 p -82.51 -127.39 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 111.566 0.21 . . . . 0.0 111.566 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.0 p . . . . . 0 C--O 1.251 1.166 0 CA-C-O 118.584 -0.722 . . . . 0.0 111.397 -179.554 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.735 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.593 ' CB ' ' HB3' ' A' ' 27' ' ' CYS . 98.3 Cg_endo -83.14 42.74 1.33 Allowed 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.739 2.293 . . . . 0.0 113.248 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.537 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.8 OUTLIER -95.91 -59.29 0.18 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.778 178.857 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.537 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 61.6 Cg_endo -94.11 11.18 1.84 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.124 2.549 . . . . 0.0 113.296 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.504 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.1 OUTLIER -94.9 102.76 13.94 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 CA-C-O 121.052 0.453 . . . . 0.0 110.529 -179.89 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 26.6 p30 -90.01 164.99 14.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.076 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.3 p -178.02 174.59 1.37 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.333 0.587 . . . . 0.0 111.927 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.4 mmtt -118.95 -48.64 2.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.217 178.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.0 p -112.68 -175.87 2.78 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.217 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.05 -61.94 2.24 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.5 mtt85 -71.48 3.73 3.61 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -179.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.46 -29.37 56.89 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.456 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.19 23.15 3.42 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.332 178.475 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 p -50.91 -27.62 5.46 Favored 'Isoleucine or valine' 0 C--N 1.344 0.335 0 CA-C-N 116.737 -0.211 . . . . 0.0 111.209 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 41.2 mtt -56.72 -25.52 54.67 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.755 0.312 . . . . 0.0 110.483 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.6 t -84.08 -44.66 13.85 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.481 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.516 ' CA ' HD12 ' A' ' 20' ' ' ILE . . . -171.39 -169.3 34.15 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.415 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.13 82.08 5.55 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.246 0.546 . . . . 0.0 110.999 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.03 82.29 1.65 Allowed Glycine 0 C--O 1.23 -0.095 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.627 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.516 HD12 ' CA ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -110.68 149.53 13.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -178.066 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.425 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 42.0 m -90.7 129.86 36.76 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.9 t -97.31 128.61 44.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.091 0.472 . . . . 0.0 112.156 -178.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.59 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -94.93 -155.48 0.47 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.484 -0.78 . . . . 0.0 108.963 178.374 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -55.3 65.13 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.243 0.617 . . . . 0.0 111.913 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.59 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 78.18 18.51 76.31 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.932 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 58.9 m-85 -144.37 -175.93 4.83 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 117.382 0.591 . . . . 0.0 112.427 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.593 ' HB3' ' CB ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -86.14 139.3 31.22 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.76 -179.191 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.425 ' HB2' ' O ' ' A' ' 21' ' ' SER . 11.0 mt-30 -90.58 -45.58 8.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.538 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.408 ' HA2' ' HG3' ' A' ' 2' ' ' PRO . . . 166.98 104.79 0.18 Allowed Glycine 0 C--N 1.336 0.549 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.611 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.459 ' HB2' HD12 ' A' ' 20' ' ' ILE . 15.9 p -81.95 -128.51 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 111.452 0.167 . . . . 0.0 111.452 -179.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.487 -0.768 . . . . 0.0 110.917 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 120.474 0.178 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.579 ' HA ' HG22 ' A' ' 5' ' ' VAL . 82.1 Cg_endo -84.82 42.55 1.15 Allowed 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.711 2.274 . . . . 0.0 113.204 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.523 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -97.28 -59.19 0.16 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.816 178.837 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.523 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 66.2 Cg_endo -92.99 9.43 2.45 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.911 2.407 . . . . 0.0 113.338 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.579 HG22 ' HA ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -95.54 101.76 12.79 Favored 'Isoleucine or valine' 0 C--N 1.342 0.271 0 CA-C-O 120.99 0.424 . . . . 0.0 110.526 179.876 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.547 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 18.8 p30 -90.0 165.14 14.22 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.161 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.4 p -178.28 170.65 1.73 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.298 0.57 . . . . 0.0 112.193 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -115.85 -42.88 3.04 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.386 178.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.06 -178.18 3.44 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.163 178.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.7 -58.59 7.82 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.07 0.01 6.86 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -77.09 -30.35 55.33 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.49 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -89.79 21.21 3.66 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.246 178.079 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.9 p -51.56 -28.42 8.65 Favored 'Isoleucine or valine' 0 C--N 1.346 0.456 0 CA-C-N 116.758 -0.201 . . . . 0.0 111.247 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.6 mtp -56.96 -25.4 57.91 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.406 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.5 t -84.0 -44.8 13.79 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.587 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.537 ' CA ' HD13 ' A' ' 20' ' ' ILE . . . -169.46 -169.31 32.6 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.583 -0.818 . . . . 0.0 113.37 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.5 mt -91.27 82.06 5.48 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.105 0.478 . . . . 0.0 110.867 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.9 82.43 1.66 Allowed Glycine 0 CA--C 1.515 0.051 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.656 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.537 HD13 ' CA ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -109.82 145.45 16.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -177.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 14.9 m -85.53 129.14 34.89 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.0 t -95.74 128.96 43.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.049 0.452 . . . . 0.0 111.931 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.588 ' O ' ' N ' ' A' ' 25' ' ' GLY . 3.9 ptmt -95.29 -157.01 0.54 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.471 -0.786 . . . . 0.0 108.98 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.0 65.76 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 O-C-N 123.696 0.623 . . . . 0.0 111.785 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 78.74 18.12 75.99 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.313 -0.858 . . . . 0.0 113.016 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 51.2 m-85 -144.52 -176.26 4.97 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 117.451 0.625 . . . . 0.0 112.667 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.568 ' HB3' ' CB ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -86.74 140.94 29.26 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.784 -179.173 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.428 ' HB2' ' O ' ' A' ' 21' ' ' SER . 14.5 mt-30 -90.5 -50.15 6.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.537 179.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 171.78 103.17 0.16 Allowed Glycine 0 C--N 1.335 0.489 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.694 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.436 ' HB2' HD13 ' A' ' 20' ' ' ILE . 19.9 p -81.86 -128.7 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 111.396 0.147 . . . . 0.0 111.396 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.7 p . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.253 -0.879 . . . . 0.0 111.374 -179.608 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 60.3 p . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 120.318 0.104 . . . . 0.0 111.048 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.681 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 15.3 Cg_exo -69.17 62.02 1.43 Allowed 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.122 2.548 . . . . 0.0 112.797 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.56 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.8 OUTLIER -116.13 -60.83 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.052 178.552 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.56 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 79.4 Cg_endo -95.08 8.1 1.99 Allowed 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.975 2.45 . . . . 0.0 112.998 179.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.59 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -94.64 98.02 7.57 Favored 'Isoleucine or valine' 0 C--N 1.345 0.37 0 CA-C-O 120.931 0.396 . . . . 0.0 110.348 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.56 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 5.0 p30 -90.19 164.37 14.45 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.296 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.0 p -176.72 174.72 1.78 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.261 0.553 . . . . 0.0 111.896 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -119.97 -47.04 2.41 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.377 178.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.73 -177.72 3.21 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.138 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -60.63 -61.06 2.87 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.67 4.77 2.91 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -77.69 -28.29 50.97 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.471 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.9 22.24 4.38 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.041 178.092 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.6 p -51.12 -29.31 8.05 Favored 'Isoleucine or valine' 0 C--N 1.347 0.474 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.328 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 19.0 mtm -55.98 -25.88 45.92 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.721 0.296 . . . . 0.0 110.471 178.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.402 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 4.0 t -83.87 -45.35 13.33 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.541 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.538 ' CA ' HD13 ' A' ' 20' ' ' ILE . . . -170.23 -170.23 34.33 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.303 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.7 mp -91.11 82.17 5.55 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.234 0.54 . . . . 0.0 110.924 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.58 82.22 1.65 Allowed Glycine 0 C--N 1.325 -0.08 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.645 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.538 HD13 ' CA ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -110.75 145.12 17.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.27 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.418 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 70.4 m -86.33 129.38 34.87 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.9 t -96.73 126.68 42.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.063 0.459 . . . . 0.0 112.035 -178.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.597 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.1 OUTLIER -94.7 -154.91 0.44 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.329 -0.85 . . . . 0.0 108.768 178.285 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -54.95 65.17 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.453 0.701 . . . . 0.0 112.095 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 75.8 19.89 78.53 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.574 -179.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 39.5 m-85 -143.77 179.79 6.94 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -179.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.681 ' HB3' ' HB3' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -84.34 143.36 29.54 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.813 -179.131 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' A' ' 21' ' ' SER . 16.6 mt-30 -90.87 -56.0 3.34 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.752 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 176.99 100.73 0.14 Allowed Glycine 0 C--N 1.334 0.45 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.207 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.431 ' HB2' HD13 ' A' ' 20' ' ' ILE . 15.5 p -79.58 -127.21 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 111.526 0.195 . . . . 0.0 111.526 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.1 p . . . . . 0 C--O 1.251 1.182 0 CA-C-O 118.612 -0.709 . . . . 0.0 111.393 -179.528 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 72.1 m . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 120.378 0.132 . . . . 0.0 110.984 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.561 ' HA ' HG23 ' A' ' 5' ' ' VAL . 87.8 Cg_endo -80.83 44.52 1.77 Allowed 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.938 2.425 . . . . 0.0 112.97 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.517 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -97.52 -59.15 0.16 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.86 178.78 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.517 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 67.7 Cg_endo -93.21 9.81 2.32 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.969 2.446 . . . . 0.0 113.052 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.561 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -96.74 99.0 8.22 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 CA-C-O 121.074 0.464 . . . . 0.0 110.446 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.549 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 1.0 OUTLIER -90.21 166.35 13.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.95 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.5 p -177.85 174.41 1.45 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.275 0.559 . . . . 0.0 112.092 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.7 mmtm -119.99 -47.14 2.4 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.197 178.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.9 p -113.11 -176.89 3.0 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.253 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.14 -62.64 1.72 Allowed 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.92 4.26 2.73 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -179.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -77.26 -28.89 53.67 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.497 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.48 23.25 3.54 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.088 178.053 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.9 p -51.62 -28.2 8.62 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.417 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -26.09 45.17 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.743 0.306 . . . . 0.0 110.453 178.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.411 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 4.3 t -84.03 -45.25 13.28 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.663 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.528 ' CA ' HD12 ' A' ' 20' ' ' ILE . . . -170.77 -169.62 34.04 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.333 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.0 mt -91.16 82.72 5.51 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.167 0.508 . . . . 0.0 110.903 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.45 82.27 1.65 Allowed Glycine 0 C--N 1.324 -0.116 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.634 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.528 HD12 ' CA ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -111.25 141.97 25.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -178.175 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.415 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 11.4 m -83.77 129.01 34.94 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.0 t -95.13 127.43 41.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.128 0.49 . . . . 0.0 112.09 -178.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.596 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -95.48 -156.74 0.53 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.039 178.37 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -54.07 64.69 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 O-C-N 123.916 0.76 . . . . 0.0 112.336 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 78.39 15.55 80.77 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.922 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 44.7 m-85 -143.16 -177.99 5.63 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.519 ' HB3' ' CB ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -84.17 142.9 29.99 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.905 -179.236 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' A' ' 21' ' ' SER . 6.3 mt-30 -90.86 -52.91 4.63 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.445 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 173.07 102.91 0.16 Allowed Glycine 0 C--N 1.335 0.494 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.216 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.44 ' HB2' HD12 ' A' ' 20' ' ' ILE . 13.7 p -79.0 -127.33 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -178.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.4 p . . . . . 0 C--O 1.252 1.225 0 CA-C-O 118.614 -0.708 . . . . 0.0 111.16 -179.59 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 120.427 0.156 . . . . 0.0 111.182 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.557 ' HA ' HG22 ' A' ' 5' ' ' VAL . 87.2 Cg_endo -81.45 42.58 1.36 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.954 2.436 . . . . 0.0 113.23 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.526 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.2 OUTLIER -96.09 -58.66 0.19 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.858 178.799 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.526 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 68.8 Cg_endo -95.91 11.75 1.34 Allowed 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.049 2.5 . . . . 0.0 113.192 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.557 HG22 ' HA ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -99.0 98.35 7.01 Favored 'Isoleucine or valine' 0 C--N 1.341 0.232 0 CA-C-O 121.026 0.441 . . . . 0.0 110.665 -179.87 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.54 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 5.0 p30 -90.45 166.21 13.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.691 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.5 p -176.36 174.28 1.98 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.436 0.636 . . . . 0.0 112.397 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -120.65 -45.6 2.4 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.339 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.61 -177.82 3.22 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.977 178.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -62.46 -58.18 8.54 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.8 3.9 3.76 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.9 -30.18 56.07 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.472 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.33 21.52 4.42 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.332 178.416 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.1 p -51.44 -28.27 8.01 Favored 'Isoleucine or valine' 0 C--N 1.345 0.392 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.388 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.78 -25.18 60.17 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.718 0.294 . . . . 0.0 110.356 178.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.2 t -84.05 -45.48 13.03 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.558 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.532 ' CA ' HD12 ' A' ' 20' ' ' ILE . . . -169.07 -169.3 32.27 Favored Glycine 0 C--N 1.335 0.524 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.298 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.8 mp -91.17 81.75 5.54 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.121 0.486 . . . . 0.0 111.002 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.28 81.77 1.62 Allowed Glycine 0 C--N 1.323 -0.16 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.862 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.532 HD12 ' CA ' ' A' ' 17' ' ' GLY . 0.9 OUTLIER -109.51 144.99 16.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 112.143 0.424 . . . . 0.0 112.143 -178.17 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -86.46 129.91 34.69 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.6 t -95.0 126.35 40.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.196 0.522 . . . . 0.0 111.851 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.614 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -96.58 -155.49 0.49 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.964 178.422 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -52.77 65.43 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.647 0.779 . . . . 0.0 112.16 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.614 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 74.49 16.28 80.09 Favored Glycine 0 CA--C 1.519 0.326 0 CA-C-N 115.386 -0.825 . . . . 0.0 113.073 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 44.7 m-85 -143.34 179.47 7.07 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 117.346 0.573 . . . . 0.0 112.317 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -80.55 143.42 33.25 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.799 -179.327 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -90.83 -55.06 3.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.402 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 175.88 101.78 0.15 Allowed Glycine 0 C--N 1.333 0.373 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.286 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.409 ' HB2' HD12 ' A' ' 20' ' ' ILE . 17.1 p -80.86 -128.24 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 111.462 0.171 . . . . 0.0 111.462 -178.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.0 p . . . . . 0 C--O 1.252 1.19 0 CA-C-O 118.523 -0.751 . . . . 0.0 111.271 -179.526 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 120.432 0.158 . . . . 0.0 111.142 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.552 ' CB ' ' HB3' ' A' ' 27' ' ' CYS . 97.2 Cg_endo -82.54 40.85 1.02 Allowed 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.042 2.494 . . . . 0.0 113.302 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.56 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 0.2 OUTLIER -95.37 -57.48 0.21 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.888 178.852 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.56 ' HD3' ' HB3' ' A' ' 3' ' ' TYR . 86.5 Cg_endo -96.11 12.09 1.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.045 2.497 . . . . 0.0 113.038 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.503 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -96.95 102.42 13.46 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-O 121.189 0.518 . . . . 0.0 110.683 -179.888 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -89.8 162.66 15.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.564 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.3 p -177.99 174.45 1.4 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.399 0.619 . . . . 0.0 112.342 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.2 -47.29 2.15 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.295 178.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.9 p -112.12 -176.81 3.01 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.219 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.09 -62.76 1.63 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.7 mtt85 -71.09 4.13 2.95 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.91 -27.38 54.91 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.445 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -92.84 23.75 4.0 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.256 178.272 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.3 p -50.88 -27.81 5.62 Favored 'Isoleucine or valine' 0 C--N 1.346 0.456 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.433 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 5.8 mtt -57.05 -25.72 59.12 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.672 0.273 . . . . 0.0 110.487 178.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.6 t -84.06 -45.19 13.32 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.564 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.528 ' CA ' HD11 ' A' ' 20' ' ' ILE . . . -171.26 -168.89 33.55 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 120.485 -0.864 . . . . 0.0 113.588 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.12 82.25 5.55 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.212 0.529 . . . . 0.0 111.075 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.03 82.22 1.65 Allowed Glycine 0 C--N 1.325 -0.073 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.514 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.528 HD11 ' CA ' ' A' ' 17' ' ' GLY . 1.1 mm -109.93 150.12 12.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 0.9 OUTLIER -91.81 129.77 37.71 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.057 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.6 t -96.92 127.65 43.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.996 0.426 . . . . 0.0 111.772 -178.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.6 ' O ' ' N ' ' A' ' 25' ' ' GLY . 38.1 pttt -95.04 -155.5 0.47 Allowed 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -54.05 64.95 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 O-C-N 123.915 0.759 . . . . 0.0 112.216 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 79.1 14.67 81.58 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.31 -0.859 . . . . 0.0 113.149 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -142.37 -176.52 4.87 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 117.607 0.704 . . . . 0.0 112.568 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.552 ' HB3' ' CB ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -83.51 139.42 32.92 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.707 -179.362 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.42 ' HB2' ' O ' ' A' ' 21' ' ' SER . 12.8 mt-30 -90.36 -47.5 7.71 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.54 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 168.03 104.2 0.17 Allowed Glycine 0 C--N 1.336 0.533 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.667 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.437 ' HB2' HD11 ' A' ' 20' ' ' ILE . 14.7 p -80.76 -128.32 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 122.061 0.145 . . . . 0.0 111.224 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.455 -0.783 . . . . 0.0 110.56 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.802 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.546 ' HA ' HG23 ' A' ' 5' ' ' VAL . 93.3 Cg_endo -82.61 41.04 1.04 Allowed 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.598 2.199 . . . . 0.0 113.368 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.696 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 4.5 t80 -94.51 -56.39 0.22 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.013 178.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.696 ' HD3' ' HB3' ' A' ' 3' ' ' TYR . 94.4 Cg_endo -95.53 11.48 1.46 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.011 2.474 . . . . 0.0 113.085 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.546 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -100.06 98.7 7.3 Favored 'Isoleucine or valine' 0 C--N 1.34 0.17 0 CA-C-O 121.092 0.472 . . . . 0.0 110.823 -179.853 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.529 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 2.3 p-10 -90.37 166.91 13.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.654 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.8 p -179.1 173.17 1.18 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.445 0.641 . . . . 0.0 112.443 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.52 -47.68 2.53 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.035 178.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.9 p -113.08 -177.16 3.07 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.191 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -61.63 -56.97 14.05 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.63 -0.22 10.25 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.56 -28.71 59.12 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.453 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.7 23.61 3.5 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.414 178.546 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.6 p -51.62 -28.24 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.282 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -57.11 -26.04 59.8 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.397 178.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.5 t -83.85 -46.17 12.45 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.621 179.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.509 ' CA ' HD12 ' A' ' 20' ' ' ILE . . . -170.93 -169.09 33.56 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.454 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.3 82.56 5.44 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.276 0.56 . . . . 0.0 110.874 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.43 82.36 1.66 Allowed Glycine 0 N--CA 1.458 0.134 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.618 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.509 HD12 ' CA ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -110.16 150.12 12.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.167 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.403 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 6.0 m -91.74 129.15 37.76 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.0 t -96.5 125.86 41.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.961 0.41 . . . . 0.0 111.558 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.62 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -96.32 -152.66 0.38 Allowed 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.166 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -51.97 64.62 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.46 0.704 . . . . 0.0 112.721 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.62 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 74.48 19.62 79.81 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.8 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 89.1 m-85 -145.36 -175.44 4.71 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.492 ' HB3' ' CB ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -84.15 140.31 31.84 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.803 -179.135 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.41 ' CG ' ' HB3' ' A' ' 23' ' ' LYS . 13.0 mt-30 -90.85 -45.66 8.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.285 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.39 105.34 0.19 Allowed Glycine 0 C--N 1.336 0.577 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.25 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.438 ' HB3' HG23 ' A' ' 20' ' ' ILE . 12.8 p -80.83 -128.42 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 111.437 0.162 . . . . 0.0 111.437 -178.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.45 -0.786 . . . . 0.0 110.65 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 11.2 p . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.725 0.297 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.584 ' HA ' HG23 ' A' ' 5' ' ' VAL . 95.5 Cg_endo -79.11 49.44 3.16 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.806 2.338 . . . . 0.0 113.211 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.533 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.2 OUTLIER -100.64 -59.42 0.11 Allowed Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.633 178.562 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.533 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 68.1 Cg_endo -93.53 9.34 2.3 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.856 2.371 . . . . 0.0 113.308 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.584 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.1 OUTLIER -99.82 95.87 4.49 Favored 'Isoleucine or valine' 0 C--N 1.343 0.295 0 CA-C-O 120.966 0.413 . . . . 0.0 110.097 179.675 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.527 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -90.19 165.14 14.13 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.144 -179.099 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.8 p -179.06 169.7 1.51 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.282 0.563 . . . . 0.0 112.151 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.0 mmtt -114.25 -45.06 3.07 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.059 177.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.6 p -115.92 -177.65 3.21 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.683 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -58.37 -62.46 1.83 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -69.47 -0.28 6.29 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -75.59 -28.42 58.91 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.0 110.258 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.594 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -90.8 24.49 2.71 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.069 178.28 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.4 p -49.46 -26.2 2.17 Favored 'Isoleucine or valine' 0 C--N 1.345 0.398 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.589 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 9.8 mtm -52.46 -29.16 23.27 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.606 0.241 . . . . 0.0 110.444 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.487 ' SG ' HG22 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -83.86 -46.96 11.58 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.914 179.377 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.489 ' N ' HD13 ' A' ' 20' ' ' ILE . . . -172.76 -166.03 30.67 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.458 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.29 81.45 5.49 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.244 0.545 . . . . 0.0 111.136 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.34 81.53 1.47 Allowed Glycine 0 N--CA 1.457 0.056 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.713 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.594 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 1.0 OUTLIER -113.07 123.27 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -178.12 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 0.2 OUTLIER -61.44 138.19 58.26 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 178.088 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.6 t -109.77 130.06 55.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.989 0.423 . . . . 0.0 111.946 -178.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.571 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.1 OUTLIER -95.1 -156.72 0.53 Allowed 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.31 178.596 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 -56.67 65.9 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.753 0.658 . . . . 0.0 111.733 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 79.1 21.02 68.71 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.954 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.527 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 58.4 m-85 -145.33 179.14 7.59 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 117.445 0.622 . . . . 0.0 112.429 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -78.81 143.6 35.88 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.192 -179.74 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 21' ' ' SER . 7.3 mt-30 -90.51 -40.61 11.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.028 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -166.17 94.48 0.11 Allowed Glycine 0 C--N 1.339 0.695 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.268 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -40.91 90.55 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.85 0.86 . . . . 0.0 111.858 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.441 ' CG2' HD12 ' A' ' 20' ' ' ILE . 2.0 t . . . . . 0 C--O 1.249 1.046 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.07 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 38.5 m . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 120.358 0.123 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.593 ' CB ' ' HB3' ' A' ' 27' ' ' CYS . 92.5 Cg_endo -82.9 42.0 1.21 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.943 2.428 . . . . 0.0 113.271 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.511 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -97.4 -58.79 0.16 Allowed Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.813 178.828 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.511 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 67.4 Cg_endo -92.28 9.36 2.68 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.865 2.377 . . . . 0.0 113.27 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.532 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -95.88 102.11 13.16 Favored 'Isoleucine or valine' 0 C--N 1.342 0.254 0 CA-C-O 121.013 0.435 . . . . 0.0 110.265 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.542 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 26.1 p30 -88.9 164.94 14.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.303 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.9 p -177.19 167.86 2.37 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.29 0.567 . . . . 0.0 112.041 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.77 -46.92 3.09 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.898 178.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.6 p -114.89 -176.73 2.96 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.193 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -60.26 -61.77 2.36 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -71.4 3.86 3.44 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -178.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.96 -28.6 55.24 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.465 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -90.21 22.66 3.2 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.229 178.274 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.6 p -50.79 -28.17 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.307 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 10.8 mtt -55.76 -26.31 45.18 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.418 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.422 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 4.5 t -84.04 -44.89 13.66 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.538 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.541 ' CA ' HD13 ' A' ' 20' ' ' ILE . . . -170.69 -170.04 34.47 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.276 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.7 mp -91.1 81.52 5.59 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.129 0.49 . . . . 0.0 110.903 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.54 81.84 1.61 Allowed Glycine 0 C--N 1.325 -0.075 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.598 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.541 HD13 ' CA ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -110.49 147.74 14.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -178.053 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.2 m -86.49 136.93 32.9 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.2 t -104.97 130.85 53.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.272 0.558 . . . . 0.0 112.479 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.581 ' O ' ' N ' ' A' ' 25' ' ' GLY . 1.4 mtpp -94.03 -159.25 0.68 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.197 -0.911 . . . . 0.0 108.718 178.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -58.01 66.67 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.41 0.624 . . . . 0.0 111.025 179.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 80.53 19.27 68.98 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.969 -179.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 44.7 m-85 -143.45 -177.8 5.57 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 117.541 0.67 . . . . 0.0 112.601 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.593 ' HB3' ' CB ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -86.62 142.52 28.19 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.2 -178.923 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.406 ' HG2' ' HD2' ' A' ' 23' ' ' LYS . 7.1 mt-30 -90.89 -50.19 6.02 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.499 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 169.46 104.21 0.17 Allowed Glycine 0 C--N 1.336 0.535 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.534 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.438 ' HB2' HD13 ' A' ' 20' ' ' ILE . 15.0 p -80.15 -128.11 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 111.517 0.191 . . . . 0.0 111.517 -178.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.628 -179.636 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 120.555 0.217 . . . . 0.0 111.422 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.593 ' HA ' HG23 ' A' ' 5' ' ' VAL . 73.8 Cg_endo -73.65 53.68 2.78 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.964 2.443 . . . . 0.0 113.406 -179.832 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.563 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -100.19 -59.95 0.11 Allowed Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.462 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.563 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 61.8 Cg_endo -96.16 12.08 1.25 Allowed 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 123.193 2.595 . . . . 0.0 113.144 179.425 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.593 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.1 OUTLIER -104.83 92.28 2.1 Favored 'Isoleucine or valine' 0 C--N 1.344 0.344 0 CA-C-O 121.201 0.524 . . . . 0.0 110.512 -179.965 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.492 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 1.0 OUTLIER -90.58 164.91 14.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.621 -179.695 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.401 ' C ' ' SG ' ' A' ' 22' ' ' CYS . 10.3 p -179.25 175.28 0.95 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.353 0.597 . . . . 0.0 112.387 179.439 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -122.12 -46.67 2.18 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.28 178.264 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.91 -177.95 3.26 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.323 178.74 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -58.39 -64.32 0.96 Allowed 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.526 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.27 3.18 2.35 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -179.102 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -76.59 -30.0 56.8 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.459 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.54 22.02 4.27 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.243 178.138 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.6 p -50.4 -29.55 6.47 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 CA-C-O 120.592 0.234 . . . . 0.0 111.195 179.724 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 7.1 ptp -54.71 -25.46 27.54 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.61 178.373 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 30' ' ' CYS . 4.7 t -83.98 -43.97 14.66 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.646 179.396 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.539 ' CA ' HD13 ' A' ' 20' ' ' ILE . . . -171.11 -169.67 34.37 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.37 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -91.18 82.19 5.52 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.161 0.505 . . . . 0.0 110.776 179.744 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 100.66 82.15 1.64 Allowed Glycine 0 N--CA 1.457 0.062 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.523 -179.354 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.539 HD13 ' CA ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -110.73 150.31 13.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -177.939 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 p -91.18 138.46 31.57 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 177.7 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.401 ' SG ' ' C ' ' A' ' 7' ' ' CYS . 3.6 t -103.92 129.51 51.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.102 0.477 . . . . 0.0 111.957 -178.659 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.57 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -95.3 -157.35 0.57 Allowed 'General case' 0 C--O 1.227 -0.131 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.018 178.327 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -56.12 65.54 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.254 0.622 . . . . 0.0 112.024 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 81.21 15.25 77.27 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.16 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 65.5 m-85 -143.51 -174.87 4.35 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 117.455 0.627 . . . . 0.0 112.412 -179.55 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -81.61 140.0 34.68 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.687 -179.469 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -90.67 -36.22 14.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.467 178.647 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 156.02 107.6 0.27 Allowed Glycine 0 C--N 1.338 0.646 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.635 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.468 ' HB2' HD13 ' A' ' 20' ' ' ILE . 19.8 p -86.01 -130.63 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.575 0.188 . . . . 0.0 111.489 -178.946 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.9 p . . . . . 0 C--O 1.253 1.266 0 CA-C-O 118.512 -0.756 . . . . 0.0 111.01 -179.629 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo . . . . . 0 N--CA 1.454 -0.822 0 N-CA-C 113.312 0.466 . . . . 0.25 113.312 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.567 HG11 ' HB2' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -94.59 103.3 14.54 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 CA-C-O 121.159 0.504 . . . . 0.25 110.609 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.614 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 5.9 p30 -90.21 161.36 15.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.665 -0.698 . . . . 1.5900000000000001 111.245 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.481 ' HB2' ' CB ' ' A' ' 12' ' ' ASP . 17.7 p -175.39 172.61 2.65 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.443 0.639 . . . . 0.11 112.071 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.7 mttt -118.8 -46.68 2.54 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 114.913 -1.04 . . . . 2.96 108.935 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.6 p -110.46 -178.43 3.5 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.582 -0.735 . . . . 0.85999999999999999 110.17 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -62.28 -57.97 9.43 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 111.818 0.303 . . . . 1.9099999999999999 111.818 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 30.8 mtt180 -72.17 2.34 6.06 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.696 0.628 . . . . 4.4800000000000004 112.696 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.481 ' CB ' ' HB2' ' A' ' 7' ' ' CYS . 3.7 m-20 -75.75 -25.06 56.19 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.714 -0.476 . . . . 1.1499999999999999 109.714 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.514 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -94.25 25.15 3.96 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.583 -0.735 . . . . 0.070000000000000007 110.337 178.515 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -50.22 -30.61 7.16 Favored 'Isoleucine or valine' 0 C--N 1.345 0.397 0 N-CA-C 111.689 0.255 . . . . 0.16 111.689 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 61.6 mtt -57.27 -29.01 63.48 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.62 -0.264 . . . . 2.1400000000000001 110.83 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.567 ' HB2' HG11 ' A' ' 5' ' ' VAL . 2.0 t -83.44 -47.57 11.25 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.396 -0.365 . . . . 0.23999999999999999 110.616 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.815 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -168.08 -169.49 31.62 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 120.738 -0.744 . . . . 0.17999999999999999 113.145 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 17.8 mt -92.02 81.21 5.1 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.143 0.497 . . . . 1.6799999999999999 111.019 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.636 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 99.15 82.17 1.65 Allowed Glycine 0 N--CA 1.455 -0.064 0 CA-C-N 115.523 -0.762 . . . . 0.12 111.489 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.815 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.1 mm -109.18 133.17 55.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 112.376 0.51 . . . . 0.23000000000000001 112.376 -178.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 57.1 m -67.35 127.06 31.28 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.88 -0.785 . . . . 0.73999999999999999 108.88 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.432 ' SG ' ' C ' ' A' ' 7' ' ' CYS . 4.4 t -96.98 126.64 42.26 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.11 0.481 . . . . 0.11 112.093 -178.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.601 ' HB3' ' HG3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -94.62 -158.35 0.63 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.427 -0.806 . . . . 2.8999999999999999 109.007 178.689 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -56.42 65.72 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.343 0.657 . . . . 1.72 111.892 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 79.1 20.18 70.64 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.169 -0.923 . . . . 0.12 113.031 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.614 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 45.0 m-85 -145.33 -175.16 4.6 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.86 0.689 . . . . 1.22 112.86 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.734 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.44 138.92 31.1 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.611 -0.722 . . . . 0.13 111.826 -178.864 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.601 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 5.7 mt-30 -91.44 -51.82 5.09 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.829 -0.623 . . . . 0.48999999999999999 111.09 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.59 0 CA-C-N 116.06 -0.518 . . . . 0.45000000000000001 111.923 -179.676 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo . . . . . 0 N--CA 1.454 -0.822 0 N-CA-C 113.219 0.43 . . . . 0.0 113.219 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.56 HG11 ' HB2' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -96.04 100.02 10.17 Favored 'Isoleucine or valine' 0 C--N 1.342 0.24 0 CA-C-O 120.986 0.422 . . . . 0.0 110.616 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.557 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 26.3 p30 -90.27 166.71 13.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.986 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.401 ' HB2' ' HB3' ' A' ' 12' ' ' ASP . 7.1 p -179.73 174.22 0.96 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.385 0.612 . . . . 0.0 112.188 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -120.71 -46.2 2.37 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.344 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.5 p -113.42 -176.89 3.0 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.404 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.82 -63.22 1.38 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.49 4.2 2.52 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.401 ' HB3' ' HB2' ' A' ' 7' ' ' CYS . 3.5 m-20 -76.86 -29.35 55.81 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.535 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -92.2 23.03 4.04 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.139 178.209 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.1 p -51.21 -27.39 6.16 Favored 'Isoleucine or valine' 0 C--N 1.345 0.378 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.481 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -56.48 -25.8 52.18 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.445 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.56 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.5 t -84.08 -44.42 14.08 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.676 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.82 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -172.09 -169.2 34.57 Favored Glycine 0 C--N 1.337 0.608 0 C-N-CA 120.497 -0.858 . . . . 0.0 113.273 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.9 mt -91.09 82.39 5.56 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.194 0.521 . . . . 0.0 111.007 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.7 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 101.29 82.43 1.66 Allowed Glycine 0 C--N 1.324 -0.118 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.721 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.82 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -111.66 142.37 24.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -177.863 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 1.9 p -83.49 130.36 35.01 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.1 t -98.56 127.16 44.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.005 0.431 . . . . 0.0 111.891 -178.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.598 ' O ' ' N ' ' A' ' 25' ' ' GLY . 1.3 pttt -95.11 -155.73 0.48 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -53.64 64.08 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 O-C-N 123.956 0.785 . . . . 0.0 112.343 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 79.32 16.11 78.86 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.541 -0.754 . . . . 0.0 113.195 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 50.7 m-85 -143.64 -177.6 5.49 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 117.574 0.687 . . . . 0.0 112.403 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.672 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -83.66 140.1 32.38 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.543 -179.323 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.424 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 9.9 mt-30 -90.55 -46.61 8.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.453 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.495 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.557 -179.693 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo . . . . . 0 N--CA 1.454 -0.844 0 N-CA-C 113.091 0.381 . . . . 0.0 113.091 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.52 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -95.15 103.3 14.54 Favored 'Isoleucine or valine' 0 C--N 1.34 0.171 0 CA-C-O 121.066 0.46 . . . . 0.0 110.674 -179.849 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.579 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 1.6 p-10 -90.14 163.51 14.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.949 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.4 p -178.5 172.78 1.42 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.37 0.605 . . . . 0.0 112.201 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.0 mttm -118.39 -46.88 2.57 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.237 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 p -112.27 -177.73 3.24 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.33 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -61.39 -58.23 9.05 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.5 mmt85 -72.78 2.45 6.66 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.2 -27.64 53.61 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.507 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.94 23.73 3.56 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.141 178.123 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.3 p -50.8 -28.77 6.47 Favored 'Isoleucine or valine' 0 C--N 1.346 0.446 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.363 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -55.35 -26.59 41.94 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.733 0.302 . . . . 0.0 110.592 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.457 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.2 t -84.07 -44.64 13.88 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.696 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.826 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -173.33 -170.01 36.4 Favored Glycine 0 C--N 1.337 0.619 0 C-N-CA 120.453 -0.879 . . . . 0.0 113.419 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.3 mt -91.13 81.49 5.57 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.162 0.506 . . . . 0.0 110.878 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.69 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 103.76 82.26 1.6 Allowed Glycine 0 N--CA 1.457 0.07 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.361 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.826 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.2 mm -111.26 147.1 15.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -177.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 28.7 m -87.58 129.41 35.11 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.9 t -98.46 129.47 45.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.065 0.46 . . . . 0.0 111.89 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.577 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.1 OUTLIER -94.9 -156.92 0.53 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.024 178.385 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -57.01 66.02 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.402 0.62 . . . . 0.0 111.678 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 79.83 18.53 72.54 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 115.322 -0.854 . . . . 0.0 113.066 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.579 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 54.0 m-85 -145.2 -175.28 4.64 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 117.516 0.658 . . . . 0.0 112.705 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.707 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -88.39 137.54 32.23 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.021 -179.008 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.448 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 9.8 mt-30 -90.17 -45.38 9.14 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.689 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.537 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.749 -179.545 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo . . . . . 0 N--CA 1.455 -0.767 0 N-CA-C 113.255 0.444 . . . . 0.0 113.255 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.58 HG21 ' SG ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -99.58 96.56 5.04 Favored 'Isoleucine or valine' 0 C--N 1.342 0.259 0 CA-C-O 121.082 0.467 . . . . 0.0 110.382 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.627 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 8.0 p-10 -90.32 166.77 13.12 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.339 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.6 p -176.19 166.2 2.87 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.246 0.546 . . . . 0.0 112.27 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -109.71 -40.23 4.88 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.241 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.7 p -123.02 -177.39 3.66 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.037 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -60.76 -59.46 5.36 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -0.25 7.11 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -76.77 -30.1 56.37 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.617 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -89.63 21.85 3.29 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.972 178.042 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.2 p -49.48 -25.14 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.462 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.553 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 20.9 mmt -52.46 -28.64 20.99 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.58 ' SG ' HG21 ' A' ' 5' ' ' VAL . 0.7 OUTLIER -83.83 -45.05 13.7 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.974 179.337 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.8 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -173.12 -166.2 31.19 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.383 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.7 mt -91.48 81.24 5.39 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.078 0.466 . . . . 0.0 110.969 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.648 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 105.26 81.35 1.46 Allowed Glycine 0 N--CA 1.457 0.082 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.613 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.8 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -112.13 122.9 67.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.0 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 45.8 m -61.24 134.8 57.37 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.9 t -103.32 126.44 50.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.925 0.393 . . . . 0.0 111.559 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.583 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.1 OUTLIER -95.38 -157.5 0.58 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.225 178.735 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -55.08 64.87 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.404 0.682 . . . . 0.0 112.121 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 78.48 18.68 75.4 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.816 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.627 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 38.0 m-85 -144.14 179.62 7.1 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 117.354 0.577 . . . . 0.0 112.5 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.606 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -78.44 144.85 35.44 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.194 -179.729 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.462 ' HB2' ' O ' ' A' ' 21' ' ' SER . 10.7 mt-30 -90.34 -40.14 12.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.378 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.606 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.949 -179.472 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo . . . . . 0 N--CA 1.454 -0.819 0 N-CA-C 113.314 0.467 . . . . 0.0 113.314 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.503 HG11 ' HB2' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -94.9 101.99 13.1 Favored 'Isoleucine or valine' 0 C--N 1.341 0.223 0 CA-C-O 121.078 0.466 . . . . 0.0 110.579 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.542 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 6.4 p30 -90.15 165.15 14.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.837 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.9 p -176.73 175.64 1.63 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.306 0.574 . . . . 0.0 112.261 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.7 mttm -121.26 -49.11 2.18 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.448 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.502 HG22 ' H ' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -111.88 -176.69 2.99 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.269 178.632 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.502 ' H ' HG22 ' A' ' 9' ' ' THR . 0.5 OUTLIER -58.88 -64.26 1.0 Allowed 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.359 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.25 5.37 1.73 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.31 -31.28 58.09 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.552 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.38 22.02 4.16 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.376 178.622 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.7 p -51.61 -27.12 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.434 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 65.5 mtm -57.56 -25.04 59.37 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.646 0.26 . . . . 0.0 110.38 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.503 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.4 t -84.09 -44.05 14.44 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.523 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.828 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -171.04 -168.38 32.68 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.431 -0.89 . . . . 0.0 113.402 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.02 82.39 5.59 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.186 0.517 . . . . 0.0 111.029 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.677 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 99.05 82.79 1.69 Allowed Glycine 0 N--CA 1.457 0.061 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.843 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.828 HD11 ' C ' ' A' ' 17' ' ' GLY . 0.9 OUTLIER -111.13 139.11 36.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -177.97 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.4 m -82.32 128.65 34.42 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.9 t -94.91 128.3 41.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.938 0.399 . . . . 0.0 111.325 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.617 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -99.46 -154.71 0.48 Allowed 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.319 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -50.14 63.83 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.096 0.959 . . . . 0.0 113.031 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.617 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 76.63 14.4 82.52 Favored Glycine 0 CA--C 1.522 0.508 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.387 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 47.0 m-85 -142.71 -177.34 5.26 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 117.533 0.667 . . . . 0.0 112.645 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.667 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -82.85 141.05 32.56 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.467 -179.401 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.443 ' CG ' ' HB3' ' A' ' 23' ' ' LYS . 34.7 mt-30 -90.63 -51.24 5.49 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.569 179.154 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.489 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.784 -179.623 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo . . . . . 0 N--CA 1.455 -0.784 0 N-CA-C 113.233 0.436 . . . . 0.0 113.233 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.494 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -94.76 102.06 13.19 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 CA-C-O 121.125 0.488 . . . . 0.0 110.508 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.551 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 4.3 p-10 -90.1 164.08 14.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.055 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.2 p -176.83 174.45 1.77 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.391 0.615 . . . . 0.0 112.127 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -119.71 -46.56 2.45 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.213 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.0 p -114.26 -177.16 3.06 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.243 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.94 -61.0 2.94 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.83 1.73 5.12 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -76.74 -28.45 55.77 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.513 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -92.62 22.92 4.34 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.153 178.104 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.1 p -51.14 -28.68 7.32 Favored 'Isoleucine or valine' 0 C--N 1.345 0.401 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.377 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 23.0 mtt -55.29 -25.98 37.46 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.489 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.492 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.5 t -84.1 -45.09 13.38 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.452 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.83 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -171.35 -169.7 34.58 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.402 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.7 mp -91.28 82.26 5.46 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.219 0.533 . . . . 0.0 110.835 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.689 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 101.61 82.41 1.65 Allowed Glycine 0 C--N 1.324 -0.097 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.514 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.83 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -111.23 146.63 15.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -177.958 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 67.0 m -87.8 129.63 35.12 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.5 t -96.53 127.71 42.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.074 0.464 . . . . 0.0 111.886 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.594 ' O ' ' N ' ' A' ' 25' ' ' GLY . 1.0 OUTLIER -95.05 -155.73 0.48 Allowed 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.364 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -54.97 65.21 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.375 0.67 . . . . 0.0 112.045 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 77.8 17.2 79.04 Favored Glycine 0 CA--C 1.521 0.444 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.95 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 41.1 m-85 -142.99 -176.67 5.0 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 117.392 0.596 . . . . 0.0 112.517 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.663 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -86.02 138.74 31.74 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.738 -179.284 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.458 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 16.2 mt-30 -89.94 -46.65 8.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.694 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.543 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 -179.672 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo . . . . . 0 N--CA 1.454 -0.814 0 N-CA-C 113.319 0.469 . . . . 0.0 113.319 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.567 HG11 ' HB2' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -97.13 100.91 11.55 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 CA-C-O 120.994 0.426 . . . . 0.0 110.735 -179.903 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.567 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 1.0 OUTLIER -90.37 165.25 13.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.789 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.402 ' HB2' ' CB ' ' A' ' 12' ' ' ASP . 7.9 p -178.79 173.86 1.2 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.363 0.602 . . . . 0.0 112.222 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.73 -48.59 2.37 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.152 178.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.543 HG22 ' H ' ' A' ' 10' ' ' ASP . 0.5 OUTLIER -112.62 -178.36 3.38 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.899 178.344 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.543 ' H ' HG22 ' A' ' 9' ' ' THR . 42.9 m-20 -58.92 -60.88 3.16 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.3 0.57 4.79 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.402 ' CB ' ' HB2' ' A' ' 7' ' ' CYS . 0.5 OUTLIER -75.38 -30.52 60.18 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.056 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.493 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.21 23.29 3.38 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.536 178.563 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.6 p -51.3 -27.63 6.79 Favored 'Isoleucine or valine' 0 C--N 1.345 0.384 0 CA-C-N 116.68 -0.237 . . . . 0.0 111.384 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 10.3 mmt -56.06 -25.73 46.36 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.404 178.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.567 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.4 t -84.09 -44.91 13.58 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.624 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.827 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -172.73 -169.12 34.96 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.434 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 mt -91.23 82.98 5.47 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.192 0.52 . . . . 0.0 110.84 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.689 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 101.27 82.68 1.68 Allowed Glycine 0 C--N 1.325 -0.061 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.41 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.827 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.1 mm -111.18 148.0 14.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -177.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 18.3 m -89.61 129.93 35.99 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.8 t -97.33 129.75 44.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.076 0.465 . . . . 0.0 111.987 -178.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.575 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -95.18 -157.41 0.57 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.994 178.352 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -56.69 65.62 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.233 0.613 . . . . 0.0 111.83 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 80.99 16.73 74.11 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-N 115.325 -0.852 . . . . 0.0 113.123 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 62.5 m-85 -144.99 -174.1 4.27 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 117.487 0.644 . . . . 0.0 112.57 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.694 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -86.86 139.05 31.05 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.79 -179.178 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.457 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 8.6 mt-30 -90.56 -44.15 9.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.479 178.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.581 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.565 -179.544 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo . . . . . 0 N--CA 1.454 -0.796 0 N-CA-C 113.249 0.442 . . . . 0.0 113.249 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.519 HG11 ' HB2' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -95.24 101.24 12.24 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 CA-C-O 120.964 0.411 . . . . 0.0 110.482 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.545 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 27.5 p-10 -90.1 165.66 13.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.13 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.403 ' HB2' ' HB3' ' A' ' 12' ' ' ASP . 7.4 p -177.53 174.61 1.52 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.382 0.61 . . . . 0.0 112.324 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.04 -48.28 2.35 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.367 178.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.6 p -113.47 -175.66 2.72 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.176 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.27 -62.43 1.88 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.14 4.57 2.65 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.403 ' HB3' ' HB2' ' A' ' 7' ' ' CYS . 0.7 OUTLIER -77.02 -29.61 55.43 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.581 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.511 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.41 22.91 3.66 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.102 178.305 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.0 p -51.64 -26.52 6.75 Favored 'Isoleucine or valine' 0 C--N 1.345 0.391 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.313 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -25.93 60.48 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.777 0.322 . . . . 0.0 110.277 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.519 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.5 t -84.18 -44.91 13.49 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.557 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.824 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -170.58 -169.69 33.96 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.182 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 35.1 mt -91.02 81.89 5.61 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.111 0.482 . . . . 0.0 110.976 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.676 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 101.24 82.11 1.64 Allowed Glycine 0 N--CA 1.458 0.12 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.655 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.824 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -110.71 145.93 16.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -178.126 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.417 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 19.9 m -87.06 129.07 35.06 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.8 t -95.32 127.76 41.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.072 0.463 . . . . 0.0 111.99 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.62 ' O ' ' N ' ' A' ' 25' ' ' GLY . 2.6 ptmt -95.1 -155.42 0.47 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -54.28 65.02 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.286 0.634 . . . . 0.0 111.928 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.62 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 76.88 18.24 79.03 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.842 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 54.1 m-85 -143.93 -176.58 5.05 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 117.277 0.538 . . . . 0.0 112.357 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.665 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -85.11 140.34 31.03 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.74 -179.272 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.425 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 15.7 mt-30 -90.53 -47.9 7.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.489 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.523 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.417 -179.591 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo . . . . . 0 N--CA 1.455 -0.75 0 N-CA-C 113.231 0.435 . . . . 0.0 113.231 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.59 HG11 ' HB2' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -97.97 98.74 7.67 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 CA-C-O 121.057 0.456 . . . . 0.0 110.667 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.535 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 12.0 p-10 -90.33 165.31 13.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.691 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.2 p -177.48 174.58 1.54 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.432 0.634 . . . . 0.0 112.559 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.7 mtpm? -119.71 -47.86 2.4 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.257 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.75 -177.53 3.15 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.01 178.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.84 -58.15 9.65 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.83 0.52 7.02 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.13 -32.35 59.09 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.537 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -90.92 20.35 4.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.384 178.397 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.3 p -51.3 -27.69 6.83 Favored 'Isoleucine or valine' 0 C--N 1.344 0.356 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.101 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.06 -25.79 33.19 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.317 178.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.59 ' HB2' HG11 ' A' ' 5' ' ' VAL . 5.1 t -83.99 -43.75 14.86 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.57 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.838 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -171.24 -169.88 34.72 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.212 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.415 HD22 ' N ' ' A' ' 18' ' ' LEU . 3.8 mm? -91.13 82.26 5.54 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.121 0.486 . . . . 0.0 110.658 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.701 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 101.76 82.12 1.63 Allowed Glycine 0 C--N 1.323 -0.178 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.554 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.838 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -110.83 146.54 15.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.075 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.1 m -88.6 129.45 35.49 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.3 t -97.45 126.93 43.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.916 0.389 . . . . 0.0 111.589 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.624 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -99.15 -154.49 0.47 Allowed 'General case' 0 C--O 1.225 -0.209 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.434 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -50.82 64.27 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.729 0.812 . . . . 0.0 112.776 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 76.64 15.15 81.8 Favored Glycine 0 CA--C 1.522 0.511 0 CA-C-N 115.714 -0.675 . . . . 0.0 113.397 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 54.8 m-85 -142.97 -176.18 4.8 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 117.486 0.643 . . . . 0.0 112.403 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.656 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -83.64 140.55 32.12 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.639 -179.35 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.482 ' CG ' ' HB3' ' A' ' 23' ' ' LYS . 16.3 mt-30 -90.81 -44.73 9.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.456 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.528 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.522 -179.598 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 N--CA 1.453 -0.881 0 N-CA-C 113.13 0.396 . . . . 0.0 113.13 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.515 HG11 ' HB2' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -94.88 102.84 14.03 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 CA-C-O 121.12 0.486 . . . . 0.0 110.548 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.578 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 7.6 p30 -90.17 164.77 14.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.012 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.0 p -178.07 174.69 1.34 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.467 0.651 . . . . 0.0 112.156 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -120.75 -44.73 2.42 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.669 178.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.499 HG22 ' H ' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -116.17 -177.65 3.22 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.026 178.954 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.499 ' H ' HG22 ' A' ' 9' ' ' THR . 0.9 OUTLIER -58.59 -63.94 1.1 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -179.453 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.1 1.96 3.15 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.12 -29.54 60.59 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.533 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -92.17 23.71 3.68 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.397 178.636 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.7 p -50.87 -27.44 5.19 Favored 'Isoleucine or valine' 0 C--N 1.343 0.323 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.552 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.51 -25.81 52.62 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.393 178.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.515 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.6 t -84.26 -43.88 14.42 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.726 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.84 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -173.25 -169.3 35.54 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.324 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.12 81.78 5.56 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.221 0.534 . . . . 0.0 110.934 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.725 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 102.69 82.87 1.68 Allowed Glycine 0 N--CA 1.458 0.161 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.43 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.84 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -112.47 141.88 26.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -177.793 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 0.9 OUTLIER -83.47 131.79 34.99 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 177.908 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.0 t -99.08 129.37 45.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.163 0.506 . . . . 0.0 112.021 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.608 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -94.94 -156.05 0.49 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.189 178.484 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -55.41 65.23 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 O-C-N 123.674 0.609 . . . . 0.0 111.807 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.608 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 78.76 18.24 75.72 Favored Glycine 0 CA--C 1.52 0.363 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.984 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.578 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 57.9 m-85 -144.74 -175.53 4.7 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 117.383 0.591 . . . . 0.0 112.43 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.688 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -85.72 138.32 32.2 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.755 -179.164 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.438 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 10.3 mt-30 -90.27 -45.48 9.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.536 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.484 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.544 -179.559 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo . . . . . 0 N--CA 1.454 -0.796 0 N-CA-C 113.165 0.41 . . . . 0.0 113.165 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.575 HG11 ' HB2' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -98.7 101.36 12.03 Favored 'Isoleucine or valine' 0 C--N 1.34 0.152 0 CA-C-O 121.049 0.452 . . . . 0.0 110.724 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.541 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 5.3 p30 -90.55 164.51 14.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.008 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.9 p -176.89 164.31 2.33 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.389 0.614 . . . . 0.0 112.233 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -111.33 -31.27 7.11 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.572 178.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.466 ' H ' ' HB2' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -131.66 -179.17 5.22 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.349 178.532 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.95 -62.03 2.19 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.8 -1.46 7.18 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.466 ' HB2' ' H ' ' A' ' 9' ' ' THR . 2.4 m-20 -74.99 -31.7 61.49 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.101 0.477 . . . . 0.0 109.849 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.506 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -88.09 23.46 2.1 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.379 178.306 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.3 p -51.31 -28.0 7.24 Favored 'Isoleucine or valine' 0 C--N 1.345 0.397 0 CA-C-N 116.752 -0.204 . . . . 0.0 111.292 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 27.2 mmm -55.23 -26.01 36.88 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.714 0.293 . . . . 0.0 110.311 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.575 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.4 t -83.95 -45.14 13.48 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.642 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.837 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -172.86 -169.15 35.09 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.436 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.7 mt -91.12 83.36 5.56 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.059 0.457 . . . . 0.0 110.816 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.682 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 101.19 82.62 1.68 Allowed Glycine 0 C--N 1.322 -0.202 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.365 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.837 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.2 mm -110.96 148.13 14.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -177.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.25 133.24 34.09 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.0 t -103.34 127.68 50.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.036 0.445 . . . . 0.0 112.045 -178.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.587 ' O ' ' N ' ' A' ' 25' ' ' GLY . 8.4 pttt -94.81 -156.07 0.49 Allowed 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.56 64.71 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.299 0.64 . . . . 0.0 112.259 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 80.2 17.43 74.18 Favored Glycine 0 CA--C 1.522 0.49 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.951 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 50.0 m-85 -143.74 -176.9 5.16 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 117.39 0.595 . . . . 0.0 112.476 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.718 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -85.03 138.37 32.49 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.69 -179.286 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.456 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 8.7 mt-30 -90.65 -40.21 12.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.528 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.523 0 N-CA-C 111.562 -0.615 . . . . 0.0 111.562 -179.516 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo . . . . . 0 N--CA 1.454 -0.814 0 N-CA-C 113.296 0.46 . . . . 0.0 113.296 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.535 HG11 ' HB2' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -94.9 102.76 13.94 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 CA-C-O 121.052 0.453 . . . . 0.0 110.529 -179.89 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 26.6 p30 -90.01 164.99 14.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.076 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.46 ' HB2' ' HB3' ' A' ' 12' ' ' ASP . 7.3 p -178.02 174.59 1.37 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.333 0.587 . . . . 0.0 111.927 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.4 mmtt -118.95 -48.64 2.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.217 178.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.0 p -112.68 -175.87 2.78 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.217 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.05 -61.94 2.24 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.5 mtt85 -71.48 3.73 3.61 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -179.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.46 ' HB3' ' HB2' ' A' ' 7' ' ' CYS . 0.6 OUTLIER -76.46 -29.37 56.89 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.6 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.491 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.19 23.15 3.42 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.332 178.475 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 p -50.91 -27.62 5.46 Favored 'Isoleucine or valine' 0 C--N 1.344 0.335 0 CA-C-N 116.737 -0.211 . . . . 0.0 111.209 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 41.2 mtt -56.72 -25.52 54.67 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.755 0.312 . . . . 0.0 110.483 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.535 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.6 t -84.08 -44.66 13.85 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.481 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.825 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -171.39 -169.3 34.15 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.415 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.13 82.08 5.55 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.246 0.546 . . . . 0.0 110.999 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.688 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 101.03 82.29 1.65 Allowed Glycine 0 C--O 1.23 -0.095 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.627 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.825 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -110.68 149.53 13.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -178.066 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 42.0 m -90.7 129.86 36.76 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.039 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.9 t -97.31 128.61 44.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.091 0.472 . . . . 0.0 112.156 -178.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.594 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -94.93 -155.48 0.47 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.484 -0.78 . . . . 0.0 108.963 178.374 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -55.3 65.13 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.243 0.617 . . . . 0.0 111.913 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 78.18 18.51 76.31 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.932 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 58.9 m-85 -144.37 -175.93 4.83 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 117.382 0.591 . . . . 0.0 112.427 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.66 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -86.14 139.3 31.22 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.76 -179.191 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.443 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 11.0 mt-30 -90.58 -45.58 8.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.538 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.549 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.611 -179.541 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo . . . . . 0 N--CA 1.455 -0.749 0 N-CA-C 113.338 0.476 . . . . 0.0 113.338 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.531 HG11 ' HB2' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -95.54 101.76 12.79 Favored 'Isoleucine or valine' 0 C--N 1.342 0.271 0 CA-C-O 120.99 0.424 . . . . 0.0 110.526 179.876 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.567 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 18.8 p30 -90.0 165.14 14.22 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.161 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.4 p -178.28 170.65 1.73 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.298 0.57 . . . . 0.0 112.193 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -115.85 -42.88 3.04 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.386 178.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.06 -178.18 3.44 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.163 178.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.7 -58.59 7.82 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.07 0.01 6.86 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -77.09 -30.35 55.33 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.524 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -89.79 21.21 3.66 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.246 178.079 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.9 p -51.56 -28.42 8.65 Favored 'Isoleucine or valine' 0 C--N 1.346 0.456 0 CA-C-N 116.758 -0.201 . . . . 0.0 111.247 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.6 mtp -56.96 -25.4 57.91 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.406 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.531 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.5 t -84.0 -44.8 13.79 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.587 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.841 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -169.46 -169.31 32.6 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.583 -0.818 . . . . 0.0 113.37 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.5 mt -91.27 82.06 5.48 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.105 0.478 . . . . 0.0 110.867 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.667 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 98.9 82.43 1.66 Allowed Glycine 0 CA--C 1.515 0.051 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.656 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.841 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -109.82 145.45 16.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -177.936 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 14.9 m -85.53 129.14 34.89 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.046 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.0 t -95.74 128.96 43.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.049 0.452 . . . . 0.0 111.931 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.588 ' O ' ' N ' ' A' ' 25' ' ' GLY . 3.9 ptmt -95.29 -157.01 0.54 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.471 -0.786 . . . . 0.0 108.98 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.0 65.76 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 O-C-N 123.696 0.623 . . . . 0.0 111.785 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 78.74 18.12 75.99 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.313 -0.858 . . . . 0.0 113.016 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 51.2 m-85 -144.52 -176.26 4.97 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 117.451 0.625 . . . . 0.0 112.667 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.631 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -86.74 140.94 29.26 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.784 -179.173 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.436 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 14.5 mt-30 -90.5 -50.15 6.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.537 179.04 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.489 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.694 -179.715 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo . . . . . 0 N--CA 1.451 -0.994 0 N-CA-C 112.998 0.346 . . . . 0.0 112.998 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.412 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -94.64 98.02 7.57 Favored 'Isoleucine or valine' 0 C--N 1.345 0.37 0 CA-C-O 120.931 0.396 . . . . 0.0 110.348 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.573 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 5.0 p30 -90.19 164.37 14.45 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.296 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.0 p -176.72 174.72 1.78 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.261 0.553 . . . . 0.0 111.896 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -119.97 -47.04 2.41 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.377 178.45 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.73 -177.72 3.21 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.138 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -60.63 -61.06 2.87 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.67 4.77 2.91 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -77.69 -28.29 50.97 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.503 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.9 22.24 4.38 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.041 178.092 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.6 p -51.12 -29.31 8.05 Favored 'Isoleucine or valine' 0 C--N 1.347 0.474 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.328 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 19.0 mtm -55.98 -25.88 45.92 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.721 0.296 . . . . 0.0 110.471 178.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.0 t -83.87 -45.35 13.33 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.541 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.831 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -170.23 -170.23 34.33 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.303 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.7 mp -91.11 82.17 5.55 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.234 0.54 . . . . 0.0 110.924 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.66 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 100.58 82.22 1.65 Allowed Glycine 0 C--N 1.325 -0.08 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.645 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.831 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -110.75 145.12 17.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.27 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.418 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 70.4 m -86.33 129.38 34.87 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.271 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.9 t -96.73 126.68 42.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.063 0.459 . . . . 0.0 112.035 -178.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.597 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.1 OUTLIER -94.7 -154.91 0.44 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.329 -0.85 . . . . 0.0 108.768 178.285 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -54.95 65.17 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.453 0.701 . . . . 0.0 112.095 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 75.8 19.89 78.53 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.574 -179.305 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 39.5 m-85 -143.77 179.79 6.94 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -179.243 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.687 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -84.34 143.36 29.54 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.813 -179.131 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' A' ' 21' ' ' SER . 11.3 mt-30 -90.87 -56.0 3.34 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.752 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.45 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.207 -179.572 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo . . . . . 0 N--CA 1.456 -0.717 0 N-CA-C 113.052 0.366 . . . . 0.0 113.052 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.518 HG11 ' HB2' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -96.74 99.0 8.22 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 CA-C-O 121.074 0.464 . . . . 0.0 110.446 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.565 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 1.0 OUTLIER -90.21 166.35 13.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.95 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.5 p -177.85 174.41 1.45 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.275 0.559 . . . . 0.0 112.092 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.7 mmtm -119.99 -47.14 2.4 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.197 178.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.9 p -113.11 -176.89 3.0 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.253 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.14 -62.64 1.72 Allowed 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.92 4.26 2.73 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -179.192 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -77.26 -28.89 53.67 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.53 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.48 23.25 3.54 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.088 178.053 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.9 p -51.62 -28.2 8.62 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.417 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -26.09 45.17 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.743 0.306 . . . . 0.0 110.453 178.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.518 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.3 t -84.03 -45.25 13.28 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.663 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.831 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -170.77 -169.62 34.04 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.333 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.0 mt -91.16 82.72 5.51 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.167 0.508 . . . . 0.0 110.903 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.655 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 100.45 82.27 1.65 Allowed Glycine 0 C--N 1.324 -0.116 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.634 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.831 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -111.25 141.97 25.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -178.175 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.417 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 11.4 m -83.77 129.01 34.94 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.0 t -95.13 127.43 41.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.128 0.49 . . . . 0.0 112.09 -178.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.596 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -95.48 -156.74 0.53 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.039 178.37 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -54.07 64.69 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 O-C-N 123.916 0.76 . . . . 0.0 112.336 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 78.39 15.55 80.77 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.922 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 44.7 m-85 -143.16 -177.99 5.63 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.687 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -84.17 142.9 29.99 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.905 -179.236 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.417 ' HB2' ' O ' ' A' ' 21' ' ' SER . 9.7 mt-30 -90.86 -52.91 4.63 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.445 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.494 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.216 -179.61 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo . . . . . 0 N--CA 1.453 -0.854 0 N-CA-C 113.192 0.42 . . . . 0.0 113.192 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.501 HG11 ' HB2' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -99.0 98.35 7.01 Favored 'Isoleucine or valine' 0 C--N 1.341 0.232 0 CA-C-O 121.026 0.441 . . . . 0.0 110.665 -179.87 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 5.0 p30 -90.45 166.21 13.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.691 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.5 p -176.36 174.28 1.98 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.436 0.636 . . . . 0.0 112.397 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -120.65 -45.6 2.4 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.339 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.444 HG22 ' H ' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -114.61 -177.82 3.22 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.977 178.895 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.444 ' H ' HG22 ' A' ' 9' ' ' THR . 2.0 p-10 -62.46 -58.18 8.54 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.8 3.9 3.76 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.9 -30.18 56.07 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.507 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.33 21.52 4.42 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.332 178.416 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.1 p -51.44 -28.27 8.01 Favored 'Isoleucine or valine' 0 C--N 1.345 0.392 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.388 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.78 -25.18 60.17 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.718 0.294 . . . . 0.0 110.356 178.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.501 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.2 t -84.05 -45.48 13.03 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.558 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.826 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -169.07 -169.3 32.27 Favored Glycine 0 C--N 1.335 0.524 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.298 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.8 mp -91.17 81.75 5.54 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.121 0.486 . . . . 0.0 111.002 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.65 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 99.28 81.77 1.62 Allowed Glycine 0 C--N 1.323 -0.16 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.862 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.826 HD11 ' C ' ' A' ' 17' ' ' GLY . 0.9 OUTLIER -109.51 144.99 16.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 112.143 0.424 . . . . 0.0 112.143 -178.17 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -86.46 129.91 34.69 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.6 t -95.0 126.35 40.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.196 0.522 . . . . 0.0 111.851 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.614 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -96.58 -155.49 0.49 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.964 178.422 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -52.77 65.43 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.647 0.779 . . . . 0.0 112.16 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.614 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 74.49 16.28 80.09 Favored Glycine 0 CA--C 1.519 0.326 0 CA-C-N 115.386 -0.825 . . . . 0.0 113.073 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 44.7 m-85 -143.34 179.47 7.07 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 117.346 0.573 . . . . 0.0 112.317 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.645 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -80.55 143.42 33.25 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.799 -179.327 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -90.83 -55.06 3.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.402 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.373 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.286 -179.674 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo . . . . . 0 N--CA 1.453 -0.872 0 N-CA-C 113.038 0.361 . . . . 0.0 113.038 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.587 HG11 ' HB2' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -96.95 102.42 13.46 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-O 121.189 0.518 . . . . 0.0 110.683 -179.888 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -89.8 162.66 15.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.564 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.3 p -177.99 174.45 1.4 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.399 0.619 . . . . 0.0 112.342 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.2 -47.29 2.15 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.295 178.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.9 p -112.12 -176.81 3.01 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.219 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.09 -62.76 1.63 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.7 mtt85 -71.09 4.13 2.95 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.91 -27.38 54.91 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.479 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -92.84 23.75 4.0 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.256 178.272 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.3 p -50.88 -27.81 5.62 Favored 'Isoleucine or valine' 0 C--N 1.346 0.456 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.433 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 5.8 mtt -57.05 -25.72 59.12 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.672 0.273 . . . . 0.0 110.487 178.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.587 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.6 t -84.06 -45.19 13.32 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.564 179.29 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.83 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -171.26 -168.89 33.55 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 120.485 -0.864 . . . . 0.0 113.588 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.12 82.25 5.55 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.212 0.529 . . . . 0.0 111.075 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.671 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 100.03 82.22 1.65 Allowed Glycine 0 C--N 1.325 -0.073 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.514 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.83 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.1 mm -109.93 150.12 12.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.062 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.419 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 0.9 OUTLIER -91.81 129.77 37.71 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.057 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.6 t -96.92 127.65 43.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.996 0.426 . . . . 0.0 111.772 -178.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.6 ' O ' ' N ' ' A' ' 25' ' ' GLY . 38.1 pttt -95.04 -155.5 0.47 Allowed 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -54.05 64.95 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 O-C-N 123.915 0.759 . . . . 0.0 112.216 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 79.1 14.67 81.58 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.31 -0.859 . . . . 0.0 113.149 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -142.37 -176.52 4.87 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 117.607 0.704 . . . . 0.0 112.568 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.657 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -83.51 139.42 32.92 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.707 -179.362 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.435 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 12.8 mt-30 -90.36 -47.5 7.71 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.54 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.533 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.667 -179.718 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo . . . . . 0 N--CA 1.452 -0.923 0 N-CA-C 113.085 0.379 . . . . 0.0 113.085 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.624 HG11 ' HB2' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -100.06 98.7 7.3 Favored 'Isoleucine or valine' 0 C--N 1.34 0.17 0 CA-C-O 121.092 0.472 . . . . 0.0 110.823 -179.853 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.541 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 2.3 p-10 -90.37 166.91 13.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.654 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.415 ' HB2' ' HB3' ' A' ' 12' ' ' ASP . 7.8 p -179.1 173.17 1.18 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.445 0.641 . . . . 0.0 112.443 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.52 -47.68 2.53 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.035 178.162 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.9 p -113.08 -177.16 3.07 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.191 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -61.63 -56.97 14.05 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.63 -0.22 10.25 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 7' ' ' CYS . 0.8 OUTLIER -75.56 -28.71 59.12 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.045 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.484 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.7 23.61 3.5 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.414 178.546 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.6 p -51.62 -28.24 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.282 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -57.11 -26.04 59.8 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.397 178.495 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.624 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.5 t -83.85 -46.17 12.45 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.621 179.37 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.819 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -170.93 -169.09 33.56 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.454 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.3 82.56 5.44 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.276 0.56 . . . . 0.0 110.874 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.681 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 100.43 82.36 1.66 Allowed Glycine 0 N--CA 1.458 0.134 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.618 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.819 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -110.16 150.12 12.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.167 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.404 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 6.0 m -91.74 129.15 37.76 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.342 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.0 t -96.5 125.86 41.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.961 0.41 . . . . 0.0 111.558 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.62 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -96.32 -152.66 0.38 Allowed 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.166 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -51.97 64.62 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.46 0.704 . . . . 0.0 112.721 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.62 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 74.48 19.62 79.81 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.8 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 89.1 m-85 -145.36 -175.44 4.71 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.678 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -84.15 140.31 31.84 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.803 -179.135 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.413 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 13.0 mt-30 -90.85 -45.66 8.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.285 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.577 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.25 -179.514 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo . . . . . 0 N--CA 1.455 -0.761 0 N-CA-C 113.308 0.465 . . . . 0.0 113.308 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.602 HG11 ' SG ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -99.82 95.87 4.49 Favored 'Isoleucine or valine' 0 C--N 1.343 0.295 0 CA-C-O 120.966 0.413 . . . . 0.0 110.097 179.675 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.548 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -90.19 165.14 14.13 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.144 -179.099 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.8 p -179.06 169.7 1.51 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.282 0.563 . . . . 0.0 112.151 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.0 mmtt -114.25 -45.06 3.07 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.059 177.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.6 p -115.92 -177.65 3.21 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.683 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -58.37 -62.46 1.83 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -69.47 -0.28 6.29 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -75.59 -28.42 58.91 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.0 110.258 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.632 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -90.8 24.49 2.71 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.069 178.28 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.4 p -49.46 -26.2 2.17 Favored 'Isoleucine or valine' 0 C--N 1.345 0.398 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.589 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 9.8 mtm -52.46 -29.16 23.27 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.606 0.241 . . . . 0.0 110.444 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.602 ' SG ' HG11 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -83.86 -46.96 11.58 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.914 179.377 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.793 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -172.76 -166.03 30.67 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.458 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.29 81.45 5.49 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.244 0.545 . . . . 0.0 111.136 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.649 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 105.34 81.53 1.47 Allowed Glycine 0 N--CA 1.457 0.056 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.713 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.793 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -113.07 123.27 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -178.12 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 0.2 OUTLIER -61.44 138.19 58.26 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 178.088 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.6 t -109.77 130.06 55.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.989 0.423 . . . . 0.0 111.946 -178.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.571 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.1 OUTLIER -95.1 -156.72 0.53 Allowed 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.31 178.596 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 -56.67 65.9 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.753 0.658 . . . . 0.0 111.733 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 79.1 21.02 68.71 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.954 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 58.4 m-85 -145.33 179.14 7.59 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 117.445 0.622 . . . . 0.0 112.429 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.622 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -78.81 143.6 35.88 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.192 -179.74 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.447 ' HB2' ' O ' ' A' ' 21' ' ' SER . 7.3 mt-30 -90.51 -40.61 11.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.028 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.695 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.268 -179.501 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo . . . . . 0 N--CA 1.454 -0.811 0 N-CA-C 113.27 0.45 . . . . 0.0 113.27 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.448 HG11 ' HB2' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -95.88 102.11 13.16 Favored 'Isoleucine or valine' 0 C--N 1.342 0.254 0 CA-C-O 121.013 0.435 . . . . 0.0 110.265 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.565 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 26.1 p30 -88.9 164.94 14.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.303 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.9 p -177.19 167.86 2.37 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.29 0.567 . . . . 0.0 112.041 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.77 -46.92 3.09 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.898 178.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.6 p -114.89 -176.73 2.96 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.193 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -60.26 -61.77 2.36 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -71.4 3.86 3.44 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -178.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.96 -28.6 55.24 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.5 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -90.21 22.66 3.2 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.229 178.274 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.6 p -50.79 -28.17 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.307 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 10.8 mtt -55.76 -26.31 45.18 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.418 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.448 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.5 t -84.04 -44.89 13.66 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.538 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.836 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -170.69 -170.04 34.47 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.276 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.7 mp -91.1 81.52 5.59 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.129 0.49 . . . . 0.0 110.903 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.676 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 101.54 81.84 1.61 Allowed Glycine 0 C--N 1.325 -0.075 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.598 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.836 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -110.49 147.74 14.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -178.053 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.2 m -86.49 136.93 32.9 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.2 t -104.97 130.85 53.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.272 0.558 . . . . 0.0 112.479 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.581 ' O ' ' N ' ' A' ' 25' ' ' GLY . 1.4 mtpp -94.03 -159.25 0.68 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.197 -0.911 . . . . 0.0 108.718 178.397 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -58.01 66.67 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.41 0.624 . . . . 0.0 111.025 179.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 80.53 19.27 68.98 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.969 -179.317 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 44.7 m-85 -143.45 -177.8 5.57 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 117.541 0.67 . . . . 0.0 112.601 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.674 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -86.62 142.52 28.19 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.2 -178.923 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.452 ' HG2' ' HD2' ' A' ' 23' ' ' LYS . 7.1 mt-30 -90.89 -50.19 6.02 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.499 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.535 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.534 -179.406 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo . . . . . 0 N--CA 1.454 -0.798 0 N-CA-C 113.144 0.402 . . . . 0.0 113.144 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.673 HG11 ' HB2' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -104.83 92.28 2.1 Favored 'Isoleucine or valine' 0 C--N 1.344 0.344 0 CA-C-O 121.201 0.524 . . . . 0.0 110.512 -179.965 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.508 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 1.0 OUTLIER -90.58 164.91 14.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.621 -179.695 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.416 ' HB2' ' HB3' ' A' ' 12' ' ' ASP . 10.3 p -179.25 175.28 0.95 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.353 0.597 . . . . 0.0 112.387 179.439 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -122.12 -46.67 2.18 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.28 178.264 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.91 -177.95 3.26 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.323 178.74 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -58.39 -64.32 0.96 Allowed 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.526 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.27 3.18 2.35 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -179.102 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.416 ' HB3' ' HB2' ' A' ' 7' ' ' CYS . 4.2 m-20 -76.59 -30.0 56.8 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.912 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.496 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.54 22.02 4.27 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.243 178.138 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.6 p -50.4 -29.55 6.47 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 CA-C-O 120.592 0.234 . . . . 0.0 111.195 179.724 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.516 ' HG3' HG12 ' A' ' 5' ' ' VAL . 7.1 ptp -54.71 -25.46 27.54 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.61 178.373 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.673 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.7 t -83.98 -43.97 14.66 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.646 179.396 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.839 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -171.11 -169.67 34.37 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.37 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.518 HD22 ' N ' ' A' ' 18' ' ' LEU . 2.9 mm? -91.18 82.19 5.52 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.161 0.505 . . . . 0.0 110.776 179.744 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.686 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 100.66 82.15 1.64 Allowed Glycine 0 N--CA 1.457 0.062 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.523 -179.354 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.839 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -110.73 150.31 13.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -177.939 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 2.1 p -91.18 138.46 31.57 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 177.7 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.401 ' SG ' ' C ' ' A' ' 7' ' ' CYS . 3.6 t -103.92 129.51 51.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.102 0.477 . . . . 0.0 111.957 -178.659 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.57 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -95.3 -157.35 0.57 Allowed 'General case' 0 C--O 1.227 -0.131 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.018 178.327 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -56.12 65.54 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.254 0.622 . . . . 0.0 112.024 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 81.21 15.25 77.27 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.16 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 65.5 m-85 -143.51 -174.87 4.35 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 117.455 0.627 . . . . 0.0 112.412 -179.55 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.658 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -81.61 140.0 34.68 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.687 -179.469 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' A' ' 21' ' ' SER . 5.8 mt-30 -90.67 -36.22 14.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.467 178.647 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.646 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.635 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 34.0 p . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 120.576 0.226 . . . . 2.0699999999999998 111.302 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.69 ' CB ' ' HB3' ' A' ' 27' ' ' CYS . 69.7 Cg_endo -84.46 40.64 0.88 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.237 2.624 . . . . 0.5 113.13 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.582 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -90.41 -60.62 0.22 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 1.8899999999999999 110.147 179.048 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.582 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 65.6 Cg_endo -94.69 13.05 1.47 Allowed 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.079 2.52 . . . . 0.25 113.312 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.633 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.2 OUTLIER -94.59 103.3 14.54 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 CA-C-O 121.159 0.504 . . . . 0.25 110.609 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.614 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 5.9 p30 -90.21 161.36 15.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.665 -0.698 . . . . 1.5900000000000001 111.245 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.481 ' HB2' ' CB ' ' A' ' 12' ' ' ASP . 17.7 p -175.39 172.61 2.65 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.443 0.639 . . . . 0.11 112.071 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.7 mttt -118.8 -46.68 2.54 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 114.913 -1.04 . . . . 2.96 108.935 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.6 p -110.46 -178.43 3.5 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.582 -0.735 . . . . 0.85999999999999999 110.17 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -62.28 -57.97 9.43 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 111.818 0.303 . . . . 1.9099999999999999 111.818 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 30.8 mtt180 -72.17 2.34 6.06 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.696 0.628 . . . . 4.4800000000000004 112.696 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.481 ' CB ' ' HB2' ' A' ' 7' ' ' CYS . 3.7 m-20 -75.75 -25.06 56.19 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.714 -0.476 . . . . 1.1499999999999999 109.714 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.514 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -94.25 25.15 3.96 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.583 -0.735 . . . . 0.070000000000000007 110.337 178.515 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -50.22 -30.61 7.16 Favored 'Isoleucine or valine' 0 C--N 1.345 0.397 0 N-CA-C 111.689 0.255 . . . . 0.16 111.689 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 61.6 mtt -57.27 -29.01 63.48 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.62 -0.264 . . . . 2.1400000000000001 110.83 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.567 ' HB2' HG11 ' A' ' 5' ' ' VAL . 2.0 t -83.44 -47.57 11.25 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.396 -0.365 . . . . 0.23999999999999999 110.616 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.815 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -168.08 -169.49 31.62 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 120.738 -0.744 . . . . 0.17999999999999999 113.145 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 17.8 mt -92.02 81.21 5.1 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.143 0.497 . . . . 1.6799999999999999 111.019 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.636 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 99.15 82.17 1.65 Allowed Glycine 0 N--CA 1.455 -0.064 0 CA-C-N 115.523 -0.762 . . . . 0.12 111.489 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.815 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.1 mm -109.18 133.17 55.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 112.376 0.51 . . . . 0.23000000000000001 112.376 -178.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 57.1 m -67.35 127.06 31.28 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.88 -0.785 . . . . 0.73999999999999999 108.88 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.432 ' SG ' ' C ' ' A' ' 7' ' ' CYS . 4.4 t -96.98 126.64 42.26 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.11 0.481 . . . . 0.11 112.093 -178.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.601 ' HB3' ' HG3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -94.62 -158.35 0.63 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.427 -0.806 . . . . 2.8999999999999999 109.007 178.689 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -56.42 65.72 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.343 0.657 . . . . 1.72 111.892 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 79.1 20.18 70.64 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.169 -0.923 . . . . 0.12 113.031 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.614 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 45.0 m-85 -145.33 -175.16 4.6 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.86 0.689 . . . . 1.22 112.86 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.734 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.44 138.92 31.1 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.611 -0.722 . . . . 0.13 111.826 -178.864 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.601 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 5.7 mt-30 -91.44 -51.82 5.09 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.829 -0.623 . . . . 0.48999999999999999 111.09 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.484 ' HA2' ' HG3' ' A' ' 2' ' ' PRO . . . 179.9 100.09 0.13 Allowed Glycine 0 C--N 1.337 0.59 0 CA-C-N 116.06 -0.518 . . . . 0.45000000000000001 111.923 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.631 ' CB ' HD12 ' A' ' 20' ' ' ILE . 15.6 p -78.98 -128.79 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 111.446 0.165 . . . . 1.04 111.446 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 46.1 p . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.497 -0.763 . . . . 1.71 111.191 -179.537 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 120.484 0.183 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.672 ' HA ' HG23 ' A' ' 5' ' ' VAL . 87.7 Cg_endo -81.39 43.73 1.59 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.909 2.406 . . . . 0.0 113.17 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.555 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.2 OUTLIER -96.49 -59.65 0.17 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.795 178.797 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.555 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 63.4 Cg_endo -93.84 10.37 2.03 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.997 2.465 . . . . 0.0 113.219 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.672 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -96.04 100.02 10.17 Favored 'Isoleucine or valine' 0 C--N 1.342 0.24 0 CA-C-O 120.986 0.422 . . . . 0.0 110.616 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.557 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 26.3 p30 -90.27 166.71 13.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.986 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.401 ' HB2' ' HB3' ' A' ' 12' ' ' ASP . 7.1 p -179.73 174.22 0.96 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.385 0.612 . . . . 0.0 112.188 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -120.71 -46.2 2.37 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.344 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.5 p -113.42 -176.89 3.0 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.404 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.82 -63.22 1.38 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.49 4.2 2.52 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.401 ' HB3' ' HB2' ' A' ' 7' ' ' CYS . 3.5 m-20 -76.86 -29.35 55.81 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.535 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -92.2 23.03 4.04 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.139 178.209 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.1 p -51.21 -27.39 6.16 Favored 'Isoleucine or valine' 0 C--N 1.345 0.378 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.481 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -56.48 -25.8 52.18 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.445 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.56 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.5 t -84.08 -44.42 14.08 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.676 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.82 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -172.09 -169.2 34.57 Favored Glycine 0 C--N 1.337 0.608 0 C-N-CA 120.497 -0.858 . . . . 0.0 113.273 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.9 mt -91.09 82.39 5.56 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.194 0.521 . . . . 0.0 111.007 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.7 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 101.29 82.43 1.66 Allowed Glycine 0 C--N 1.324 -0.118 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.721 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.82 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -111.66 142.37 24.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -177.863 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 1.9 p -83.49 130.36 35.01 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.1 t -98.56 127.16 44.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.005 0.431 . . . . 0.0 111.891 -178.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.598 ' O ' ' N ' ' A' ' 25' ' ' GLY . 1.3 pttt -95.11 -155.73 0.48 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -53.64 64.08 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 O-C-N 123.956 0.785 . . . . 0.0 112.343 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 79.32 16.11 78.86 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.541 -0.754 . . . . 0.0 113.195 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 50.7 m-85 -143.64 -177.6 5.49 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 117.574 0.687 . . . . 0.0 112.403 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.672 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -83.66 140.1 32.38 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.543 -179.323 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.424 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 9.9 mt-30 -90.55 -46.61 8.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.453 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 167.48 104.52 0.18 Allowed Glycine 0 C--N 1.335 0.495 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.557 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.716 ' CB ' HD12 ' A' ' 20' ' ' ILE . 14.9 p -80.71 -128.2 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 111.415 0.154 . . . . 0.0 111.415 -179.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.9 p . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.167 -0.92 . . . . 0.0 111.353 -179.575 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 120.539 0.209 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.629 ' HA ' HG23 ' A' ' 5' ' ' VAL . 97.9 Cg_endo -82.62 42.27 1.27 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.938 2.426 . . . . 0.0 113.027 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.788 ' HB2' ' HD3' ' A' ' 4' ' ' PRO . 34.6 m-85 -96.03 -57.47 0.2 Allowed Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.896 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.788 ' HD3' ' HB2' ' A' ' 3' ' ' TYR . 63.7 Cg_endo -96.95 13.21 0.96 Allowed 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.021 2.481 . . . . 0.0 113.091 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.629 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.1 OUTLIER -95.15 103.3 14.54 Favored 'Isoleucine or valine' 0 C--N 1.34 0.171 0 CA-C-O 121.066 0.46 . . . . 0.0 110.674 -179.849 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.579 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 1.6 p-10 -90.14 163.51 14.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.949 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.4 p -178.5 172.78 1.42 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.37 0.605 . . . . 0.0 112.201 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.0 mttm -118.39 -46.88 2.57 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.237 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 p -112.27 -177.73 3.24 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.33 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -61.39 -58.23 9.05 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.5 mmt85 -72.78 2.45 6.66 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.2 -27.64 53.61 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.507 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.94 23.73 3.56 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.141 178.123 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.3 p -50.8 -28.77 6.47 Favored 'Isoleucine or valine' 0 C--N 1.346 0.446 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.363 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -55.35 -26.59 41.94 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.733 0.302 . . . . 0.0 110.592 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.457 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.2 t -84.07 -44.64 13.88 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.696 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.826 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -173.33 -170.01 36.4 Favored Glycine 0 C--N 1.337 0.619 0 C-N-CA 120.453 -0.879 . . . . 0.0 113.419 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.3 mt -91.13 81.49 5.57 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.162 0.506 . . . . 0.0 110.878 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.69 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 103.76 82.26 1.6 Allowed Glycine 0 N--CA 1.457 0.07 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.361 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.826 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.2 mm -111.26 147.1 15.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -177.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 28.7 m -87.58 129.41 35.11 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.9 t -98.46 129.47 45.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.065 0.46 . . . . 0.0 111.89 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.577 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.1 OUTLIER -94.9 -156.92 0.53 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.024 178.385 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -57.01 66.02 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.402 0.62 . . . . 0.0 111.678 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 79.83 18.53 72.54 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 115.322 -0.854 . . . . 0.0 113.066 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.579 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 54.0 m-85 -145.2 -175.28 4.64 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 117.516 0.658 . . . . 0.0 112.705 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.707 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -88.39 137.54 32.23 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.021 -179.008 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.448 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 9.8 mt-30 -90.17 -45.38 9.14 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.689 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.409 ' HA2' ' HG3' ' A' ' 2' ' ' PRO . . . 167.13 105.22 0.18 Allowed Glycine 0 C--N 1.336 0.537 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.749 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.791 ' CB ' HD12 ' A' ' 20' ' ' ILE . 10.1 p -79.63 -126.45 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.4 p . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.213 -0.898 . . . . 0.0 111.224 -179.57 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 12.2 t . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 120.425 0.155 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.803 ' HA ' HG23 ' A' ' 5' ' ' VAL . 85.1 Cg_endo -81.4 41.62 1.18 Allowed 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.967 2.445 . . . . 0.0 113.372 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.535 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.9 OUTLIER -95.71 -59.23 0.19 Allowed Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.876 178.851 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.535 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 69.7 Cg_endo -92.44 8.08 2.91 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.908 2.405 . . . . 0.0 113.255 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.803 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -99.58 96.56 5.04 Favored 'Isoleucine or valine' 0 C--N 1.342 0.259 0 CA-C-O 121.082 0.467 . . . . 0.0 110.382 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.627 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 8.0 p-10 -90.32 166.77 13.12 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.339 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.6 p -176.19 166.2 2.87 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.246 0.546 . . . . 0.0 112.27 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -109.71 -40.23 4.88 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.241 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.7 p -123.02 -177.39 3.66 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.037 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -60.76 -59.46 5.36 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -0.25 7.11 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -76.77 -30.1 56.37 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.617 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -89.63 21.85 3.29 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.972 178.042 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.2 p -49.48 -25.14 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.462 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.553 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 20.9 mmt -52.46 -28.64 20.99 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.58 ' SG ' HG21 ' A' ' 5' ' ' VAL . 0.7 OUTLIER -83.83 -45.05 13.7 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.974 179.337 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.8 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -173.12 -166.2 31.19 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.383 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.7 mt -91.48 81.24 5.39 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.078 0.466 . . . . 0.0 110.969 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.648 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 105.26 81.35 1.46 Allowed Glycine 0 N--CA 1.457 0.082 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.613 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.8 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -112.13 122.9 67.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.0 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 45.8 m -61.24 134.8 57.37 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.9 t -103.32 126.44 50.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.925 0.393 . . . . 0.0 111.559 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.583 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.1 OUTLIER -95.38 -157.5 0.58 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.225 178.735 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -55.08 64.87 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.404 0.682 . . . . 0.0 112.121 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 78.48 18.68 75.4 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.816 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.627 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 38.0 m-85 -144.14 179.62 7.1 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 117.354 0.577 . . . . 0.0 112.5 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.606 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -78.44 144.85 35.44 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.194 -179.729 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.462 ' HB2' ' O ' ' A' ' 21' ' ' SER . 10.7 mt-30 -90.34 -40.14 12.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.378 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -170.27 96.72 0.12 Allowed Glycine 0 C--N 1.337 0.606 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.949 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -40.24 90.31 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 123.809 0.844 . . . . 0.0 111.889 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.725 HG22 HD12 ' A' ' 20' ' ' ILE . 2.6 t . . . . . 0 C--O 1.25 1.089 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.129 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.43 ' HB ' ' HD3' ' A' ' 2' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.77 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.633 ' HA ' HG23 ' A' ' 5' ' ' VAL . 96.5 Cg_endo -82.83 43.33 1.46 Allowed 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 122.66 2.24 . . . . 0.0 113.166 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.562 ' HB2' ' HD3' ' A' ' 4' ' ' PRO . 2.1 m-85 -96.31 -59.38 0.17 Allowed Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.84 178.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.562 ' HD3' ' HB2' ' A' ' 3' ' ' TYR . 58.0 Cg_endo -94.36 11.06 1.78 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.062 2.508 . . . . 0.0 113.314 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.633 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.1 OUTLIER -94.9 101.99 13.1 Favored 'Isoleucine or valine' 0 C--N 1.341 0.223 0 CA-C-O 121.078 0.466 . . . . 0.0 110.579 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.542 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 6.4 p30 -90.15 165.15 14.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.837 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.9 p -176.73 175.64 1.63 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.306 0.574 . . . . 0.0 112.261 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.7 mttm -121.26 -49.11 2.18 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.448 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.502 HG22 ' H ' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -111.88 -176.69 2.99 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.269 178.632 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.502 ' H ' HG22 ' A' ' 9' ' ' THR . 0.5 OUTLIER -58.88 -64.26 1.0 Allowed 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.359 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.25 5.37 1.73 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.31 -31.28 58.09 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.552 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.38 22.02 4.16 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.376 178.622 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.7 p -51.61 -27.12 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.434 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 65.5 mtm -57.56 -25.04 59.37 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.646 0.26 . . . . 0.0 110.38 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.503 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.4 t -84.09 -44.05 14.44 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.523 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.828 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -171.04 -168.38 32.68 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.431 -0.89 . . . . 0.0 113.402 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.02 82.39 5.59 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.186 0.517 . . . . 0.0 111.029 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.677 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 99.05 82.79 1.69 Allowed Glycine 0 N--CA 1.457 0.061 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.843 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.828 HD11 ' C ' ' A' ' 17' ' ' GLY . 0.9 OUTLIER -111.13 139.11 36.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -177.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.4 m -82.32 128.65 34.42 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.9 t -94.91 128.3 41.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.938 0.399 . . . . 0.0 111.325 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.617 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -99.46 -154.71 0.48 Allowed 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.319 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -50.14 63.83 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.096 0.959 . . . . 0.0 113.031 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.617 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 76.63 14.4 82.52 Favored Glycine 0 CA--C 1.522 0.508 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.387 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 47.0 m-85 -142.71 -177.34 5.26 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 117.533 0.667 . . . . 0.0 112.645 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.667 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -82.85 141.05 32.56 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.467 -179.401 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.443 ' CG ' ' HB3' ' A' ' 23' ' ' LYS . 34.7 mt-30 -90.63 -51.24 5.49 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.569 179.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.449 ' HA2' ' HG3' ' A' ' 2' ' ' PRO . . . 173.48 102.41 0.16 Allowed Glycine 0 C--N 1.335 0.489 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.784 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.643 ' CB ' HD12 ' A' ' 20' ' ' ILE . 15.5 p -80.93 -127.66 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 111.402 0.149 . . . . 0.0 111.402 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.1 p . . . . . 0 C--O 1.253 1.254 0 CA-C-O 118.548 -0.739 . . . . 0.0 110.994 -179.56 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 120.564 0.221 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.632 ' HA ' HG23 ' A' ' 5' ' ' VAL . 94.7 Cg_endo -83.1 42.48 1.29 Allowed 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.922 2.415 . . . . 0.0 113.359 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.537 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.2 OUTLIER -96.66 -59.37 0.17 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.761 178.775 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.537 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 62.0 Cg_endo -93.48 10.67 2.09 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.975 2.45 . . . . 0.0 113.233 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.632 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.1 OUTLIER -94.76 102.06 13.19 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 CA-C-O 121.125 0.488 . . . . 0.0 110.508 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.551 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 4.3 p-10 -90.1 164.08 14.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.055 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.2 p -176.83 174.45 1.77 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.391 0.615 . . . . 0.0 112.127 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -119.71 -46.56 2.45 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.213 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.0 p -114.26 -177.16 3.06 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.243 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.94 -61.0 2.94 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.83 1.73 5.12 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -76.74 -28.45 55.77 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.513 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -92.62 22.92 4.34 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.153 178.104 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.1 p -51.14 -28.68 7.32 Favored 'Isoleucine or valine' 0 C--N 1.345 0.401 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.377 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 23.0 mtt -55.29 -25.98 37.46 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.489 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.492 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.5 t -84.1 -45.09 13.38 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.452 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.83 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -171.35 -169.7 34.58 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.402 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.7 mp -91.28 82.26 5.46 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.219 0.533 . . . . 0.0 110.835 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.689 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 101.61 82.41 1.65 Allowed Glycine 0 C--N 1.324 -0.097 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.514 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.83 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -111.23 146.63 15.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -177.958 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 67.0 m -87.8 129.63 35.12 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.5 t -96.53 127.71 42.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.074 0.464 . . . . 0.0 111.886 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.594 ' O ' ' N ' ' A' ' 25' ' ' GLY . 1.0 OUTLIER -95.05 -155.73 0.48 Allowed 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.364 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -54.97 65.21 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.375 0.67 . . . . 0.0 112.045 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 77.8 17.2 79.04 Favored Glycine 0 CA--C 1.521 0.444 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.95 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 41.1 m-85 -142.99 -176.67 5.0 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 117.392 0.596 . . . . 0.0 112.517 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.663 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -86.02 138.74 31.74 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.738 -179.284 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.458 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 16.2 mt-30 -89.94 -46.65 8.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.694 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 167.97 104.44 0.18 Allowed Glycine 0 C--N 1.336 0.543 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.736 ' CB ' HD12 ' A' ' 20' ' ' ILE . 13.9 p -81.15 -127.96 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 121.971 0.108 . . . . 0.0 111.252 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.567 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 120.543 0.211 . . . . 0.0 111.283 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.683 ' HA ' HG23 ' A' ' 5' ' ' VAL . 96.7 Cg_endo -82.65 41.12 1.05 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.008 2.472 . . . . 0.0 113.36 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.555 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.2 OUTLIER -93.73 -59.72 0.2 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.854 178.811 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.555 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 64.9 Cg_endo -94.69 12.05 1.59 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.057 2.504 . . . . 0.0 113.319 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.683 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -97.13 100.91 11.55 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 CA-C-O 120.994 0.426 . . . . 0.0 110.735 -179.903 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.567 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 1.0 OUTLIER -90.37 165.25 13.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.789 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.402 ' HB2' ' CB ' ' A' ' 12' ' ' ASP . 7.9 p -178.79 173.86 1.2 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.363 0.602 . . . . 0.0 112.222 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.73 -48.59 2.37 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.152 178.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.543 HG22 ' H ' ' A' ' 10' ' ' ASP . 0.5 OUTLIER -112.62 -178.36 3.38 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.899 178.344 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.543 ' H ' HG22 ' A' ' 9' ' ' THR . 42.9 m-20 -58.92 -60.88 3.16 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.3 0.57 4.79 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.402 ' CB ' ' HB2' ' A' ' 7' ' ' CYS . 0.5 OUTLIER -75.38 -30.52 60.18 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.056 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.493 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.21 23.29 3.38 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.536 178.563 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.6 p -51.3 -27.63 6.79 Favored 'Isoleucine or valine' 0 C--N 1.345 0.384 0 CA-C-N 116.68 -0.237 . . . . 0.0 111.384 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 10.3 mmt -56.06 -25.73 46.36 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.404 178.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.567 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.4 t -84.09 -44.91 13.58 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.624 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.827 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -172.73 -169.12 34.96 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.434 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 mt -91.23 82.98 5.47 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.192 0.52 . . . . 0.0 110.84 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.689 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 101.27 82.68 1.68 Allowed Glycine 0 C--N 1.325 -0.061 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.41 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.827 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.1 mm -111.18 148.0 14.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -177.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 18.3 m -89.61 129.93 35.99 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.8 t -97.33 129.75 44.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.076 0.465 . . . . 0.0 111.987 -178.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.575 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -95.18 -157.41 0.57 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.994 178.352 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -56.69 65.62 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.233 0.613 . . . . 0.0 111.83 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 80.99 16.73 74.11 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-N 115.325 -0.852 . . . . 0.0 113.123 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 62.5 m-85 -144.99 -174.1 4.27 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 117.487 0.644 . . . . 0.0 112.57 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.694 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -86.86 139.05 31.05 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.79 -179.178 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.457 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 8.6 mt-30 -90.56 -44.15 9.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.479 178.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 164.99 105.61 0.19 Allowed Glycine 0 C--N 1.336 0.581 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.565 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.758 ' CB ' HD12 ' A' ' 20' ' ' ILE . 13.3 p -81.46 -127.82 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 111.42 0.155 . . . . 0.0 111.42 -179.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.3 p . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.479 -179.564 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 11.5 t . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 120.482 0.182 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.682 ' HA ' HG23 ' A' ' 5' ' ' VAL . 97.1 Cg_endo -83.14 40.52 0.96 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.017 2.478 . . . . 0.0 113.275 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.54 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.5 OUTLIER -95.07 -59.4 0.19 Allowed Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.926 178.959 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.54 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 67.3 Cg_endo -92.87 9.2 2.53 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.892 2.395 . . . . 0.0 113.249 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.682 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -95.24 101.24 12.24 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 CA-C-O 120.964 0.411 . . . . 0.0 110.482 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.545 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 27.5 p-10 -90.1 165.66 13.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.13 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.403 ' HB2' ' HB3' ' A' ' 12' ' ' ASP . 7.4 p -177.53 174.61 1.52 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.382 0.61 . . . . 0.0 112.324 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.04 -48.28 2.35 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.367 178.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.6 p -113.47 -175.66 2.72 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.176 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.27 -62.43 1.88 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.14 4.57 2.65 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.403 ' HB3' ' HB2' ' A' ' 7' ' ' CYS . 0.7 OUTLIER -77.02 -29.61 55.43 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.581 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.511 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.41 22.91 3.66 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.102 178.305 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.0 p -51.64 -26.52 6.75 Favored 'Isoleucine or valine' 0 C--N 1.345 0.391 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.313 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -25.93 60.48 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.777 0.322 . . . . 0.0 110.277 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.519 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.5 t -84.18 -44.91 13.49 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.557 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.824 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -170.58 -169.69 33.96 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.182 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 35.1 mt -91.02 81.89 5.61 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.111 0.482 . . . . 0.0 110.976 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.676 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 101.24 82.11 1.64 Allowed Glycine 0 N--CA 1.458 0.12 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.655 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.824 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -110.71 145.93 16.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -178.126 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.417 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 19.9 m -87.06 129.07 35.06 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.8 t -95.32 127.76 41.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.072 0.463 . . . . 0.0 111.99 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.62 ' O ' ' N ' ' A' ' 25' ' ' GLY . 2.6 ptmt -95.1 -155.42 0.47 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -54.28 65.02 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.286 0.634 . . . . 0.0 111.928 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.62 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 76.88 18.24 79.03 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.842 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 54.1 m-85 -143.93 -176.58 5.05 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 117.277 0.538 . . . . 0.0 112.357 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.665 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -85.11 140.34 31.03 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.74 -179.272 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.425 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 15.7 mt-30 -90.53 -47.9 7.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.489 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 168.72 104.07 0.17 Allowed Glycine 0 C--N 1.335 0.523 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.417 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.703 ' CB ' HD12 ' A' ' 20' ' ' ILE . 15.6 p -80.77 -128.43 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 111.428 0.158 . . . . 0.0 111.428 -178.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.186 -0.912 . . . . 0.0 110.767 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 120.294 0.093 . . . . 0.0 110.924 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.697 ' HA ' HG23 ' A' ' 5' ' ' VAL . 96.0 Cg_endo -82.6 40.47 0.97 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.9 2.4 . . . . 0.0 113.352 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.533 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -94.24 -58.35 0.21 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.961 178.763 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.533 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 69.3 Cg_endo -94.38 10.87 1.8 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.035 2.49 . . . . 0.0 113.231 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.697 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -97.97 98.74 7.67 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 CA-C-O 121.057 0.456 . . . . 0.0 110.667 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.535 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 12.0 p-10 -90.33 165.31 13.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.691 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.2 p -177.48 174.58 1.54 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.432 0.634 . . . . 0.0 112.559 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.7 mtpm? -119.71 -47.86 2.4 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.257 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.75 -177.53 3.15 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.01 178.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.84 -58.15 9.65 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.83 0.52 7.02 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.13 -32.35 59.09 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.537 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -90.92 20.35 4.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.384 178.397 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.3 p -51.3 -27.69 6.83 Favored 'Isoleucine or valine' 0 C--N 1.344 0.356 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.101 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.06 -25.79 33.19 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.317 178.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.59 ' HB2' HG11 ' A' ' 5' ' ' VAL . 5.1 t -83.99 -43.75 14.86 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.57 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.838 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -171.24 -169.88 34.72 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.212 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.415 ' N ' HD22 ' A' ' 18' ' ' LEU . 3.8 mm? -91.13 82.26 5.54 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.121 0.486 . . . . 0.0 110.658 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.701 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 101.76 82.12 1.63 Allowed Glycine 0 C--N 1.323 -0.178 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.554 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.838 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -110.83 146.54 15.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.075 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.1 m -88.6 129.45 35.49 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.3 t -97.45 126.93 43.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.916 0.389 . . . . 0.0 111.589 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.624 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -99.15 -154.49 0.47 Allowed 'General case' 0 C--O 1.225 -0.209 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.434 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -50.82 64.27 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.729 0.812 . . . . 0.0 112.776 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 76.64 15.15 81.8 Favored Glycine 0 CA--C 1.522 0.511 0 CA-C-N 115.714 -0.675 . . . . 0.0 113.397 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 54.8 m-85 -142.97 -176.18 4.8 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 117.486 0.643 . . . . 0.0 112.403 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.656 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -83.64 140.55 32.12 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.639 -179.35 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.482 ' CG ' ' HB3' ' A' ' 23' ' ' LYS . 16.3 mt-30 -90.81 -44.73 9.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.456 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 164.61 105.46 0.19 Allowed Glycine 0 C--N 1.336 0.528 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.522 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.722 ' CB ' HD12 ' A' ' 20' ' ' ILE . 16.9 p -81.75 -128.78 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 111.464 0.172 . . . . 0.0 111.464 -178.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.1 p . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.143 -0.932 . . . . 0.0 111.385 -179.533 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 120.472 0.177 . . . . 0.0 111.126 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.605 ' HA ' HG23 ' A' ' 5' ' ' VAL . 97.4 Cg_endo -82.19 43.71 1.56 Allowed 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.837 2.358 . . . . 0.0 113.168 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.608 ' HB2' ' HD3' ' A' ' 4' ' ' PRO . 3.0 m-85 -96.56 -59.44 0.17 Allowed Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.771 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.608 ' HD3' ' HB2' ' A' ' 3' ' ' TYR . 57.5 Cg_endo -95.05 12.64 1.44 Allowed 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.94 2.427 . . . . 0.0 113.13 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.605 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.1 OUTLIER -94.88 102.84 14.03 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 CA-C-O 121.12 0.486 . . . . 0.0 110.548 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.578 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 7.6 p30 -90.17 164.77 14.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.012 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.0 p -178.07 174.69 1.34 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.467 0.651 . . . . 0.0 112.156 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -120.75 -44.73 2.42 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.669 178.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.499 HG22 ' H ' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -116.17 -177.65 3.22 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.026 178.954 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.499 ' H ' HG22 ' A' ' 9' ' ' THR . 0.9 OUTLIER -58.59 -63.94 1.1 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -179.453 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.1 1.96 3.15 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.12 -29.54 60.59 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.533 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -92.17 23.71 3.68 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.397 178.636 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.7 p -50.87 -27.44 5.19 Favored 'Isoleucine or valine' 0 C--N 1.343 0.323 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.552 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.51 -25.81 52.62 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.393 178.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.515 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.6 t -84.26 -43.88 14.42 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.726 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.84 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -173.25 -169.3 35.54 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.324 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.12 81.78 5.56 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.221 0.534 . . . . 0.0 110.934 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.725 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 102.69 82.87 1.68 Allowed Glycine 0 N--CA 1.458 0.161 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.43 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.84 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -112.47 141.88 26.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -177.793 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 0.9 OUTLIER -83.47 131.79 34.99 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 177.908 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.0 t -99.08 129.37 45.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.163 0.506 . . . . 0.0 112.021 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.608 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -94.94 -156.05 0.49 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.189 178.484 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -55.41 65.23 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 O-C-N 123.674 0.609 . . . . 0.0 111.807 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.608 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 78.76 18.24 75.72 Favored Glycine 0 CA--C 1.52 0.363 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.984 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.578 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 57.9 m-85 -144.74 -175.53 4.7 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 117.383 0.591 . . . . 0.0 112.43 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.688 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -85.72 138.32 32.2 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.755 -179.164 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.438 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 10.3 mt-30 -90.27 -45.48 9.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.536 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.409 ' HA2' ' HG3' ' A' ' 2' ' ' PRO . . . 166.56 104.65 0.18 Allowed Glycine 0 C--N 1.335 0.484 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.544 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.747 ' CB ' HD12 ' A' ' 20' ' ' ILE . 13.6 p -80.28 -127.53 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 111.469 0.174 . . . . 0.0 111.469 -179.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.4 p . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.456 -0.783 . . . . 0.0 111.044 -179.455 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 17.5 p . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 120.335 0.112 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.686 ' HA ' HG23 ' A' ' 5' ' ' VAL . 92.2 Cg_endo -82.2 36.57 0.63 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.924 2.416 . . . . 0.0 113.363 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.772 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 16.1 t80 -91.35 -55.99 0.26 Allowed Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.177 178.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.772 ' HD3' ' HB3' ' A' ' 3' ' ' TYR . 86.5 Cg_endo -96.24 12.2 1.22 Allowed 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 123.002 2.468 . . . . 0.0 113.165 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.686 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -98.7 101.36 12.03 Favored 'Isoleucine or valine' 0 C--N 1.34 0.152 0 CA-C-O 121.049 0.452 . . . . 0.0 110.724 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.541 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 5.3 p30 -90.55 164.51 14.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.008 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.9 p -176.89 164.31 2.33 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.389 0.614 . . . . 0.0 112.233 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -111.33 -31.27 7.11 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.572 178.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.466 ' H ' ' HB2' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -131.66 -179.17 5.22 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.349 178.532 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.95 -62.03 2.19 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.8 -1.46 7.18 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.466 ' HB2' ' H ' ' A' ' 9' ' ' THR . 2.4 m-20 -74.99 -31.7 61.49 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.101 0.477 . . . . 0.0 109.849 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.506 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -88.09 23.46 2.1 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.379 178.306 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.3 p -51.31 -28.0 7.24 Favored 'Isoleucine or valine' 0 C--N 1.345 0.397 0 CA-C-N 116.752 -0.204 . . . . 0.0 111.292 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 27.2 mmm -55.23 -26.01 36.88 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.714 0.293 . . . . 0.0 110.311 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.575 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.4 t -83.95 -45.14 13.48 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.642 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.837 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -172.86 -169.15 35.09 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.436 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.7 mt -91.12 83.36 5.56 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.059 0.457 . . . . 0.0 110.816 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.682 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 101.19 82.62 1.68 Allowed Glycine 0 C--N 1.322 -0.202 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.365 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.837 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.2 mm -110.96 148.13 14.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -177.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.25 133.24 34.09 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.0 t -103.34 127.68 50.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.036 0.445 . . . . 0.0 112.045 -178.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.587 ' O ' ' N ' ' A' ' 25' ' ' GLY . 8.4 pttt -94.81 -156.07 0.49 Allowed 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.56 64.71 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.299 0.64 . . . . 0.0 112.259 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 80.2 17.43 74.18 Favored Glycine 0 CA--C 1.522 0.49 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.951 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 50.0 m-85 -143.74 -176.9 5.16 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 117.39 0.595 . . . . 0.0 112.476 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.718 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -85.03 138.37 32.49 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.69 -179.286 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.456 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 8.7 mt-30 -90.65 -40.21 12.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.528 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 161.07 107.1 0.22 Allowed Glycine 0 C--N 1.335 0.523 0 N-CA-C 111.562 -0.615 . . . . 0.0 111.562 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.785 ' CB ' HD12 ' A' ' 20' ' ' ILE . 12.0 p -82.51 -127.39 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 111.566 0.21 . . . . 0.0 111.566 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.0 p . . . . . 0 C--O 1.251 1.166 0 CA-C-O 118.584 -0.722 . . . . 0.0 111.397 -179.554 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.735 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.632 ' HA ' HG23 ' A' ' 5' ' ' VAL . 98.3 Cg_endo -83.14 42.74 1.33 Allowed 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.739 2.293 . . . . 0.0 113.248 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.551 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.8 OUTLIER -95.91 -59.29 0.18 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.778 178.857 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.551 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 61.6 Cg_endo -94.11 11.18 1.84 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.124 2.549 . . . . 0.0 113.296 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.632 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.1 OUTLIER -94.9 102.76 13.94 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 CA-C-O 121.052 0.453 . . . . 0.0 110.529 -179.89 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 26.6 p30 -90.01 164.99 14.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.076 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.46 ' HB2' ' HB3' ' A' ' 12' ' ' ASP . 7.3 p -178.02 174.59 1.37 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.333 0.587 . . . . 0.0 111.927 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.4 mmtt -118.95 -48.64 2.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.217 178.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.0 p -112.68 -175.87 2.78 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.217 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.05 -61.94 2.24 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.5 mtt85 -71.48 3.73 3.61 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -179.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.46 ' HB3' ' HB2' ' A' ' 7' ' ' CYS . 0.6 OUTLIER -76.46 -29.37 56.89 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.6 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.491 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.19 23.15 3.42 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.332 178.475 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 p -50.91 -27.62 5.46 Favored 'Isoleucine or valine' 0 C--N 1.344 0.335 0 CA-C-N 116.737 -0.211 . . . . 0.0 111.209 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 41.2 mtt -56.72 -25.52 54.67 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.755 0.312 . . . . 0.0 110.483 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.535 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.6 t -84.08 -44.66 13.85 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.481 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.825 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -171.39 -169.3 34.15 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.415 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.13 82.08 5.55 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.246 0.546 . . . . 0.0 110.999 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.688 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 101.03 82.29 1.65 Allowed Glycine 0 C--O 1.23 -0.095 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.627 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.825 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -110.68 149.53 13.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -178.066 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 42.0 m -90.7 129.86 36.76 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.9 t -97.31 128.61 44.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.091 0.472 . . . . 0.0 112.156 -178.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.594 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -94.93 -155.48 0.47 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.484 -0.78 . . . . 0.0 108.963 178.374 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -55.3 65.13 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.243 0.617 . . . . 0.0 111.913 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 78.18 18.51 76.31 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.932 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 58.9 m-85 -144.37 -175.93 4.83 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 117.382 0.591 . . . . 0.0 112.427 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.66 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -86.14 139.3 31.22 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.76 -179.191 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.443 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 11.0 mt-30 -90.58 -45.58 8.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.538 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.411 ' HA2' ' HG3' ' A' ' 2' ' ' PRO . . . 166.98 104.79 0.18 Allowed Glycine 0 C--N 1.336 0.549 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.611 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.723 ' CB ' HD12 ' A' ' 20' ' ' ILE . 15.9 p -81.95 -128.51 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 111.452 0.167 . . . . 0.0 111.452 -179.215 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.487 -0.768 . . . . 0.0 110.917 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 120.474 0.178 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.684 ' HA ' HG23 ' A' ' 5' ' ' VAL . 82.1 Cg_endo -84.82 42.55 1.15 Allowed 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.711 2.274 . . . . 0.0 113.204 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.535 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -97.28 -59.19 0.16 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.816 178.837 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.535 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 66.2 Cg_endo -92.99 9.43 2.45 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.911 2.407 . . . . 0.0 113.338 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.684 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -95.54 101.76 12.79 Favored 'Isoleucine or valine' 0 C--N 1.342 0.271 0 CA-C-O 120.99 0.424 . . . . 0.0 110.526 179.876 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.567 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 18.8 p30 -90.0 165.14 14.22 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.161 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.4 p -178.28 170.65 1.73 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.298 0.57 . . . . 0.0 112.193 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -115.85 -42.88 3.04 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.386 178.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.06 -178.18 3.44 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.163 178.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.7 -58.59 7.82 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.07 0.01 6.86 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -77.09 -30.35 55.33 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.524 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -89.79 21.21 3.66 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.246 178.079 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.9 p -51.56 -28.42 8.65 Favored 'Isoleucine or valine' 0 C--N 1.346 0.456 0 CA-C-N 116.758 -0.201 . . . . 0.0 111.247 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.6 mtp -56.96 -25.4 57.91 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.406 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.531 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.5 t -84.0 -44.8 13.79 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.587 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.841 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -169.46 -169.31 32.6 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.583 -0.818 . . . . 0.0 113.37 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.5 mt -91.27 82.06 5.48 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.105 0.478 . . . . 0.0 110.867 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.667 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 98.9 82.43 1.66 Allowed Glycine 0 CA--C 1.515 0.051 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.656 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.841 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -109.82 145.45 16.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -177.936 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 14.9 m -85.53 129.14 34.89 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.0 t -95.74 128.96 43.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.049 0.452 . . . . 0.0 111.931 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.588 ' O ' ' N ' ' A' ' 25' ' ' GLY . 3.9 ptmt -95.29 -157.01 0.54 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.471 -0.786 . . . . 0.0 108.98 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.0 65.76 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 O-C-N 123.696 0.623 . . . . 0.0 111.785 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 78.74 18.12 75.99 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.313 -0.858 . . . . 0.0 113.016 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 51.2 m-85 -144.52 -176.26 4.97 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 117.451 0.625 . . . . 0.0 112.667 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.631 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -86.74 140.94 29.26 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.784 -179.173 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.436 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 14.5 mt-30 -90.5 -50.15 6.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.537 179.04 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 171.78 103.17 0.16 Allowed Glycine 0 C--N 1.335 0.489 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.694 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.637 ' CB ' HD12 ' A' ' 20' ' ' ILE . 19.9 p -81.86 -128.7 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 111.396 0.147 . . . . 0.0 111.396 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.7 p . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.253 -0.879 . . . . 0.0 111.374 -179.608 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 60.3 p . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 120.318 0.104 . . . . 0.0 111.048 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.697 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 15.3 Cg_exo -69.17 62.02 1.43 Allowed 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.122 2.548 . . . . 0.0 112.797 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.57 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.8 OUTLIER -116.13 -60.83 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.052 178.552 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.57 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 79.4 Cg_endo -95.08 8.1 1.99 Allowed 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.975 2.45 . . . . 0.0 112.998 179.028 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.678 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -94.64 98.02 7.57 Favored 'Isoleucine or valine' 0 C--N 1.345 0.37 0 CA-C-O 120.931 0.396 . . . . 0.0 110.348 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.573 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 5.0 p30 -90.19 164.37 14.45 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.296 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.0 p -176.72 174.72 1.78 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.261 0.553 . . . . 0.0 111.896 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -119.97 -47.04 2.41 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.377 178.45 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.73 -177.72 3.21 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.138 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -60.63 -61.06 2.87 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.67 4.77 2.91 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -77.69 -28.29 50.97 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.503 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.9 22.24 4.38 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.041 178.092 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.6 p -51.12 -29.31 8.05 Favored 'Isoleucine or valine' 0 C--N 1.347 0.474 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.328 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 19.0 mtm -55.98 -25.88 45.92 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.721 0.296 . . . . 0.0 110.471 178.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.0 t -83.87 -45.35 13.33 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.541 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.831 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -170.23 -170.23 34.33 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.303 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.7 mp -91.11 82.17 5.55 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.234 0.54 . . . . 0.0 110.924 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.66 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 100.58 82.22 1.65 Allowed Glycine 0 C--N 1.325 -0.08 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.645 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.831 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -110.75 145.12 17.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.27 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.418 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 70.4 m -86.33 129.38 34.87 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.271 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.9 t -96.73 126.68 42.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.063 0.459 . . . . 0.0 112.035 -178.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.597 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.1 OUTLIER -94.7 -154.91 0.44 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.329 -0.85 . . . . 0.0 108.768 178.285 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -54.95 65.17 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.453 0.701 . . . . 0.0 112.095 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 75.8 19.89 78.53 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.574 -179.305 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 39.5 m-85 -143.77 179.79 6.94 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -179.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.697 ' HB3' ' HB3' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -84.34 143.36 29.54 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.813 -179.131 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' A' ' 21' ' ' SER . 11.3 mt-30 -90.87 -56.0 3.34 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.752 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 176.99 100.73 0.14 Allowed Glycine 0 C--N 1.334 0.45 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.207 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.651 ' CB ' HD12 ' A' ' 20' ' ' ILE . 15.5 p -79.58 -127.21 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 111.526 0.195 . . . . 0.0 111.526 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.1 p . . . . . 0 C--O 1.251 1.182 0 CA-C-O 118.612 -0.709 . . . . 0.0 111.393 -179.528 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 72.1 m . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 120.378 0.132 . . . . 0.0 110.984 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.683 ' HA ' HG23 ' A' ' 5' ' ' VAL . 87.8 Cg_endo -80.83 44.52 1.77 Allowed 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.938 2.425 . . . . 0.0 112.97 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.523 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -97.52 -59.15 0.16 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.86 178.78 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.523 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 67.7 Cg_endo -93.21 9.81 2.32 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.969 2.446 . . . . 0.0 113.052 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.683 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -96.74 99.0 8.22 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 CA-C-O 121.074 0.464 . . . . 0.0 110.446 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.565 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 1.0 OUTLIER -90.21 166.35 13.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.95 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.5 p -177.85 174.41 1.45 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.275 0.559 . . . . 0.0 112.092 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.7 mmtm -119.99 -47.14 2.4 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.197 178.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.9 p -113.11 -176.89 3.0 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.253 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.14 -62.64 1.72 Allowed 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.92 4.26 2.73 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -179.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -77.26 -28.89 53.67 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.53 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.48 23.25 3.54 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.088 178.053 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.9 p -51.62 -28.2 8.62 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.417 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -26.09 45.17 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.743 0.306 . . . . 0.0 110.453 178.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.518 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.3 t -84.03 -45.25 13.28 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.663 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.831 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -170.77 -169.62 34.04 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.333 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.0 mt -91.16 82.72 5.51 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.167 0.508 . . . . 0.0 110.903 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.655 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 100.45 82.27 1.65 Allowed Glycine 0 C--N 1.324 -0.116 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.634 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.831 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -111.25 141.97 25.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -178.175 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.417 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 11.4 m -83.77 129.01 34.94 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.0 t -95.13 127.43 41.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.128 0.49 . . . . 0.0 112.09 -178.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.596 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -95.48 -156.74 0.53 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.039 178.37 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -54.07 64.69 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 O-C-N 123.916 0.76 . . . . 0.0 112.336 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 78.39 15.55 80.77 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.922 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 44.7 m-85 -143.16 -177.99 5.63 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.687 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -84.17 142.9 29.99 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.905 -179.236 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.417 ' HB2' ' O ' ' A' ' 21' ' ' SER . 9.7 mt-30 -90.86 -52.91 4.63 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.445 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 173.07 102.91 0.16 Allowed Glycine 0 C--N 1.335 0.494 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.216 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.69 ' CB ' HD12 ' A' ' 20' ' ' ILE . 13.7 p -79.0 -127.33 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -178.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.4 p . . . . . 0 C--O 1.252 1.225 0 CA-C-O 118.614 -0.708 . . . . 0.0 111.16 -179.59 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 120.427 0.156 . . . . 0.0 111.182 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.707 ' HA ' HG23 ' A' ' 5' ' ' VAL . 87.2 Cg_endo -81.45 42.58 1.36 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.954 2.436 . . . . 0.0 113.23 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.535 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.2 OUTLIER -96.09 -58.66 0.19 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.858 178.799 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.535 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 68.8 Cg_endo -95.91 11.75 1.34 Allowed 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.049 2.5 . . . . 0.0 113.192 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.707 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -99.0 98.35 7.01 Favored 'Isoleucine or valine' 0 C--N 1.341 0.232 0 CA-C-O 121.026 0.441 . . . . 0.0 110.665 -179.87 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 5.0 p30 -90.45 166.21 13.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.691 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.5 p -176.36 174.28 1.98 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.436 0.636 . . . . 0.0 112.397 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -120.65 -45.6 2.4 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.339 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.444 HG22 ' H ' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -114.61 -177.82 3.22 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.977 178.895 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.444 ' H ' HG22 ' A' ' 9' ' ' THR . 2.0 p-10 -62.46 -58.18 8.54 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.8 3.9 3.76 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.9 -30.18 56.07 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.507 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.33 21.52 4.42 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.332 178.416 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.1 p -51.44 -28.27 8.01 Favored 'Isoleucine or valine' 0 C--N 1.345 0.392 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.388 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.78 -25.18 60.17 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.718 0.294 . . . . 0.0 110.356 178.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.501 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.2 t -84.05 -45.48 13.03 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.558 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.826 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -169.07 -169.3 32.27 Favored Glycine 0 C--N 1.335 0.524 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.298 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.8 mp -91.17 81.75 5.54 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.121 0.486 . . . . 0.0 111.002 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.65 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 99.28 81.77 1.62 Allowed Glycine 0 C--N 1.323 -0.16 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.862 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.826 HD11 ' C ' ' A' ' 17' ' ' GLY . 0.9 OUTLIER -109.51 144.99 16.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 112.143 0.424 . . . . 0.0 112.143 -178.17 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -86.46 129.91 34.69 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.6 t -95.0 126.35 40.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.196 0.522 . . . . 0.0 111.851 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.614 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -96.58 -155.49 0.49 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.964 178.422 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -52.77 65.43 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.647 0.779 . . . . 0.0 112.16 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.614 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 74.49 16.28 80.09 Favored Glycine 0 CA--C 1.519 0.326 0 CA-C-N 115.386 -0.825 . . . . 0.0 113.073 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 44.7 m-85 -143.34 179.47 7.07 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 117.346 0.573 . . . . 0.0 112.317 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.645 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -80.55 143.42 33.25 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.799 -179.327 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -90.83 -55.06 3.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.402 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 175.88 101.78 0.15 Allowed Glycine 0 C--N 1.333 0.373 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.286 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.601 ' CB ' HD12 ' A' ' 20' ' ' ILE . 17.1 p -80.86 -128.24 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 111.462 0.171 . . . . 0.0 111.462 -178.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.0 p . . . . . 0 C--O 1.252 1.19 0 CA-C-O 118.523 -0.751 . . . . 0.0 111.271 -179.526 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 120.432 0.158 . . . . 0.0 111.142 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.668 ' HA ' HG23 ' A' ' 5' ' ' VAL . 97.2 Cg_endo -82.54 40.85 1.02 Allowed 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.042 2.494 . . . . 0.0 113.302 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.57 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 0.2 OUTLIER -95.37 -57.48 0.21 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.888 178.852 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.57 ' HD3' ' HB3' ' A' ' 3' ' ' TYR . 86.5 Cg_endo -96.11 12.09 1.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.045 2.497 . . . . 0.0 113.038 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.668 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -96.95 102.42 13.46 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-O 121.189 0.518 . . . . 0.0 110.683 -179.888 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -89.8 162.66 15.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.564 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.3 p -177.99 174.45 1.4 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.399 0.619 . . . . 0.0 112.342 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.2 -47.29 2.15 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.295 178.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.9 p -112.12 -176.81 3.01 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.219 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.09 -62.76 1.63 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.7 mtt85 -71.09 4.13 2.95 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.91 -27.38 54.91 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.479 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -92.84 23.75 4.0 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.256 178.272 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.3 p -50.88 -27.81 5.62 Favored 'Isoleucine or valine' 0 C--N 1.346 0.456 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.433 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 5.8 mtt -57.05 -25.72 59.12 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.672 0.273 . . . . 0.0 110.487 178.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.587 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.6 t -84.06 -45.19 13.32 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.564 179.29 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.83 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -171.26 -168.89 33.55 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 120.485 -0.864 . . . . 0.0 113.588 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.12 82.25 5.55 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.212 0.529 . . . . 0.0 111.075 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.671 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 100.03 82.22 1.65 Allowed Glycine 0 C--N 1.325 -0.073 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.514 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.83 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.1 mm -109.93 150.12 12.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.062 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.419 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 0.9 OUTLIER -91.81 129.77 37.71 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.057 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.6 t -96.92 127.65 43.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.996 0.426 . . . . 0.0 111.772 -178.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.6 ' O ' ' N ' ' A' ' 25' ' ' GLY . 38.1 pttt -95.04 -155.5 0.47 Allowed 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -54.05 64.95 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 O-C-N 123.915 0.759 . . . . 0.0 112.216 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 79.1 14.67 81.58 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.31 -0.859 . . . . 0.0 113.149 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -142.37 -176.52 4.87 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 117.607 0.704 . . . . 0.0 112.568 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.657 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -83.51 139.42 32.92 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.707 -179.362 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.435 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 12.8 mt-30 -90.36 -47.5 7.71 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.54 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 168.03 104.2 0.17 Allowed Glycine 0 C--N 1.336 0.533 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.667 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.716 ' CB ' HD12 ' A' ' 20' ' ' ILE . 14.7 p -80.76 -128.32 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 122.061 0.145 . . . . 0.0 111.224 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.455 -0.783 . . . . 0.0 110.56 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.802 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.71 ' HA ' HG23 ' A' ' 5' ' ' VAL . 93.3 Cg_endo -82.61 41.04 1.04 Allowed 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.598 2.199 . . . . 0.0 113.368 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.716 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 4.5 t80 -94.51 -56.39 0.22 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.013 178.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.716 ' HD3' ' HB3' ' A' ' 3' ' ' TYR . 94.4 Cg_endo -95.53 11.48 1.46 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.011 2.474 . . . . 0.0 113.085 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.71 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -100.06 98.7 7.3 Favored 'Isoleucine or valine' 0 C--N 1.34 0.17 0 CA-C-O 121.092 0.472 . . . . 0.0 110.823 -179.853 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.541 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 2.3 p-10 -90.37 166.91 13.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.654 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.415 ' HB2' ' HB3' ' A' ' 12' ' ' ASP . 7.8 p -179.1 173.17 1.18 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.445 0.641 . . . . 0.0 112.443 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.52 -47.68 2.53 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.035 178.162 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.9 p -113.08 -177.16 3.07 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.191 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -61.63 -56.97 14.05 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.63 -0.22 10.25 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 7' ' ' CYS . 0.8 OUTLIER -75.56 -28.71 59.12 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.045 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.484 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.7 23.61 3.5 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.414 178.546 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.6 p -51.62 -28.24 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.282 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -57.11 -26.04 59.8 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.397 178.495 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.624 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.5 t -83.85 -46.17 12.45 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.621 179.37 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.819 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -170.93 -169.09 33.56 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.454 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.3 82.56 5.44 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.276 0.56 . . . . 0.0 110.874 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.681 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 100.43 82.36 1.66 Allowed Glycine 0 N--CA 1.458 0.134 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.618 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.819 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -110.16 150.12 12.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.167 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.404 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 6.0 m -91.74 129.15 37.76 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.0 t -96.5 125.86 41.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.961 0.41 . . . . 0.0 111.558 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.62 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -96.32 -152.66 0.38 Allowed 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.166 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -51.97 64.62 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.46 0.704 . . . . 0.0 112.721 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.62 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 74.48 19.62 79.81 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.8 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 89.1 m-85 -145.36 -175.44 4.71 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.678 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -84.15 140.31 31.84 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.803 -179.135 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.413 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 13.0 mt-30 -90.85 -45.66 8.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.285 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.39 105.34 0.19 Allowed Glycine 0 C--N 1.336 0.577 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.25 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.73 ' CB ' HD12 ' A' ' 20' ' ' ILE . 12.8 p -80.83 -128.42 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 111.437 0.162 . . . . 0.0 111.437 -178.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.45 -0.786 . . . . 0.0 110.65 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 11.2 p . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.725 0.297 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.79 ' HA ' HG23 ' A' ' 5' ' ' VAL . 95.5 Cg_endo -79.11 49.44 3.16 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.806 2.338 . . . . 0.0 113.211 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.544 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.2 OUTLIER -100.64 -59.42 0.11 Allowed Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.633 178.562 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.544 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 68.1 Cg_endo -93.53 9.34 2.3 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.856 2.371 . . . . 0.0 113.308 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.79 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.1 OUTLIER -99.82 95.87 4.49 Favored 'Isoleucine or valine' 0 C--N 1.343 0.295 0 CA-C-O 120.966 0.413 . . . . 0.0 110.097 179.675 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.548 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -90.19 165.14 14.13 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.144 -179.099 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.8 p -179.06 169.7 1.51 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.282 0.563 . . . . 0.0 112.151 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.0 mmtt -114.25 -45.06 3.07 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.059 177.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.6 p -115.92 -177.65 3.21 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.683 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -58.37 -62.46 1.83 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -69.47 -0.28 6.29 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -75.59 -28.42 58.91 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.0 110.258 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.632 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -90.8 24.49 2.71 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.069 178.28 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.4 p -49.46 -26.2 2.17 Favored 'Isoleucine or valine' 0 C--N 1.345 0.398 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.589 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 9.8 mtm -52.46 -29.16 23.27 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.606 0.241 . . . . 0.0 110.444 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.602 ' SG ' HG11 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -83.86 -46.96 11.58 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.914 179.377 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.793 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -172.76 -166.03 30.67 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.458 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.29 81.45 5.49 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.244 0.545 . . . . 0.0 111.136 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.649 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 105.34 81.53 1.47 Allowed Glycine 0 N--CA 1.457 0.056 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.713 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.793 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -113.07 123.27 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -178.12 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 0.2 OUTLIER -61.44 138.19 58.26 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 178.088 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.6 t -109.77 130.06 55.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.989 0.423 . . . . 0.0 111.946 -178.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.571 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.1 OUTLIER -95.1 -156.72 0.53 Allowed 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.31 178.596 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 -56.67 65.9 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.753 0.658 . . . . 0.0 111.733 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 79.1 21.02 68.71 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.954 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 58.4 m-85 -145.33 179.14 7.59 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 117.445 0.622 . . . . 0.0 112.429 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.622 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -78.81 143.6 35.88 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.192 -179.74 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.447 ' HB2' ' O ' ' A' ' 21' ' ' SER . 7.3 mt-30 -90.51 -40.61 11.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.028 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -166.17 94.48 0.11 Allowed Glycine 0 C--N 1.339 0.695 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.268 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -40.91 90.55 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.85 0.86 . . . . 0.0 111.858 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.762 HG22 HD12 ' A' ' 20' ' ' ILE . 2.0 t . . . . . 0 C--O 1.249 1.046 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.07 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 38.5 m . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 120.358 0.123 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.682 ' HA ' HG23 ' A' ' 5' ' ' VAL . 92.5 Cg_endo -82.9 42.0 1.21 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.943 2.428 . . . . 0.0 113.271 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.519 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -97.4 -58.79 0.16 Allowed Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.813 178.828 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.519 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 67.4 Cg_endo -92.28 9.36 2.68 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.865 2.377 . . . . 0.0 113.27 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.682 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -95.88 102.11 13.16 Favored 'Isoleucine or valine' 0 C--N 1.342 0.254 0 CA-C-O 121.013 0.435 . . . . 0.0 110.265 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.565 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 26.1 p30 -88.9 164.94 14.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.303 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.9 p -177.19 167.86 2.37 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.29 0.567 . . . . 0.0 112.041 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.77 -46.92 3.09 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.898 178.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.6 p -114.89 -176.73 2.96 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.193 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -60.26 -61.77 2.36 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -71.4 3.86 3.44 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -178.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.96 -28.6 55.24 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.5 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -90.21 22.66 3.2 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.229 178.274 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.6 p -50.79 -28.17 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.307 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 10.8 mtt -55.76 -26.31 45.18 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.418 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.448 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.5 t -84.04 -44.89 13.66 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.538 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.836 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -170.69 -170.04 34.47 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.276 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.7 mp -91.1 81.52 5.59 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.129 0.49 . . . . 0.0 110.903 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.676 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 101.54 81.84 1.61 Allowed Glycine 0 C--N 1.325 -0.075 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.598 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.836 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -110.49 147.74 14.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -178.053 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.2 m -86.49 136.93 32.9 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.2 t -104.97 130.85 53.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.272 0.558 . . . . 0.0 112.479 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.581 ' O ' ' N ' ' A' ' 25' ' ' GLY . 1.4 mtpp -94.03 -159.25 0.68 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.197 -0.911 . . . . 0.0 108.718 178.397 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -58.01 66.67 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.41 0.624 . . . . 0.0 111.025 179.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 80.53 19.27 68.98 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.969 -179.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 44.7 m-85 -143.45 -177.8 5.57 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 117.541 0.67 . . . . 0.0 112.601 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.674 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -86.62 142.52 28.19 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.2 -178.923 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.452 ' HG2' ' HD2' ' A' ' 23' ' ' LYS . 7.1 mt-30 -90.89 -50.19 6.02 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.499 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 169.46 104.21 0.17 Allowed Glycine 0 C--N 1.336 0.535 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.534 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.715 ' CB ' HD12 ' A' ' 20' ' ' ILE . 15.0 p -80.15 -128.11 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 111.517 0.191 . . . . 0.0 111.517 -178.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.628 -179.636 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 120.555 0.217 . . . . 0.0 111.422 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.764 ' HA ' HG23 ' A' ' 5' ' ' VAL . 73.8 Cg_endo -73.65 53.68 2.78 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.964 2.443 . . . . 0.0 113.406 -179.832 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.574 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -100.19 -59.95 0.11 Allowed Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.462 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.574 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 61.8 Cg_endo -96.16 12.08 1.25 Allowed 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 123.193 2.595 . . . . 0.0 113.144 179.425 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.764 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.1 OUTLIER -104.83 92.28 2.1 Favored 'Isoleucine or valine' 0 C--N 1.344 0.344 0 CA-C-O 121.201 0.524 . . . . 0.0 110.512 -179.965 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.508 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 1.0 OUTLIER -90.58 164.91 14.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.621 -179.695 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.416 ' HB2' ' HB3' ' A' ' 12' ' ' ASP . 10.3 p -179.25 175.28 0.95 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.353 0.597 . . . . 0.0 112.387 179.439 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -122.12 -46.67 2.18 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.28 178.264 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.91 -177.95 3.26 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.323 178.74 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -58.39 -64.32 0.96 Allowed 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.526 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.27 3.18 2.35 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -179.102 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.416 ' HB3' ' HB2' ' A' ' 7' ' ' CYS . 4.2 m-20 -76.59 -30.0 56.8 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.912 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.496 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.54 22.02 4.27 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.243 178.138 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.6 p -50.4 -29.55 6.47 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 CA-C-O 120.592 0.234 . . . . 0.0 111.195 179.724 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.516 ' HG3' HG12 ' A' ' 5' ' ' VAL . 7.1 ptp -54.71 -25.46 27.54 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.61 178.373 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.673 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.7 t -83.98 -43.97 14.66 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.646 179.396 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.839 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -171.11 -169.67 34.37 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.37 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.518 ' N ' HD22 ' A' ' 18' ' ' LEU . 2.9 mm? -91.18 82.19 5.52 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.161 0.505 . . . . 0.0 110.776 179.744 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.686 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 100.66 82.15 1.64 Allowed Glycine 0 N--CA 1.457 0.062 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.523 -179.354 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.839 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -110.73 150.31 13.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -177.939 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 2.1 p -91.18 138.46 31.57 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 177.7 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.401 ' SG ' ' C ' ' A' ' 7' ' ' CYS . 3.6 t -103.92 129.51 51.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.102 0.477 . . . . 0.0 111.957 -178.659 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.57 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -95.3 -157.35 0.57 Allowed 'General case' 0 C--O 1.227 -0.131 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.018 178.327 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -56.12 65.54 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.254 0.622 . . . . 0.0 112.024 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 81.21 15.25 77.27 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.16 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 65.5 m-85 -143.51 -174.87 4.35 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 117.455 0.627 . . . . 0.0 112.412 -179.55 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.658 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -81.61 140.0 34.68 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.687 -179.469 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' A' ' 21' ' ' SER . 5.8 mt-30 -90.67 -36.22 14.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.467 178.647 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 156.02 107.6 0.27 Allowed Glycine 0 C--N 1.338 0.646 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.635 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.706 ' CB ' HD12 ' A' ' 20' ' ' ILE . 19.8 p -86.01 -130.63 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.575 0.188 . . . . 0.0 111.489 -178.946 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.9 p . . . . . 0 C--O 1.253 1.266 0 CA-C-O 118.512 -0.756 . . . . 0.0 111.01 -179.629 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo . . . . . 0 N--CA 1.454 -0.822 0 N-CA-C 113.312 0.466 . . . . 0.25 113.312 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.567 HG11 ' HB2' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -94.59 103.3 14.54 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 CA-C-O 121.159 0.504 . . . . 0.25 110.609 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.614 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 5.9 p30 -90.21 161.36 15.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.665 -0.698 . . . . 1.5900000000000001 111.245 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.481 ' HB2' ' CB ' ' A' ' 12' ' ' ASP . 17.7 p -175.39 172.61 2.65 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.443 0.639 . . . . 0.11 112.071 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.7 mttt -118.8 -46.68 2.54 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 114.913 -1.04 . . . . 2.96 108.935 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.6 p -110.46 -178.43 3.5 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.582 -0.735 . . . . 0.85999999999999999 110.17 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -62.28 -57.97 9.43 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 111.818 0.303 . . . . 1.9099999999999999 111.818 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 30.8 mtt180 -72.17 2.34 6.06 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.696 0.628 . . . . 4.4800000000000004 112.696 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.481 ' CB ' ' HB2' ' A' ' 7' ' ' CYS . 3.7 m-20 -75.75 -25.06 56.19 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.714 -0.476 . . . . 1.1499999999999999 109.714 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.514 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -94.25 25.15 3.96 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.583 -0.735 . . . . 0.070000000000000007 110.337 178.515 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -50.22 -30.61 7.16 Favored 'Isoleucine or valine' 0 C--N 1.345 0.397 0 N-CA-C 111.689 0.255 . . . . 0.16 111.689 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 61.6 mtt -57.27 -29.01 63.48 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.62 -0.264 . . . . 2.1400000000000001 110.83 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.567 ' HB2' HG11 ' A' ' 5' ' ' VAL . 2.0 t -83.44 -47.57 11.25 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.396 -0.365 . . . . 0.23999999999999999 110.616 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.815 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -168.08 -169.49 31.62 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 120.738 -0.744 . . . . 0.17999999999999999 113.145 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 17.8 mt -92.02 81.21 5.1 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.143 0.497 . . . . 1.6799999999999999 111.019 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.636 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 99.15 82.17 1.65 Allowed Glycine 0 N--CA 1.455 -0.064 0 CA-C-N 115.523 -0.762 . . . . 0.12 111.489 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.815 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.1 mm -109.18 133.17 55.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 112.376 0.51 . . . . 0.23000000000000001 112.376 -178.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 57.1 m -67.35 127.06 31.28 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.88 -0.785 . . . . 0.73999999999999999 108.88 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.432 ' SG ' ' C ' ' A' ' 7' ' ' CYS . 4.4 t -96.98 126.64 42.26 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.11 0.481 . . . . 0.11 112.093 -178.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.601 ' HB3' ' HG3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -94.62 -158.35 0.63 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.427 -0.806 . . . . 2.8999999999999999 109.007 178.689 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -56.42 65.72 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.343 0.657 . . . . 1.72 111.892 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 79.1 20.18 70.64 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.169 -0.923 . . . . 0.12 113.031 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.614 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 45.0 m-85 -145.33 -175.16 4.6 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.86 0.689 . . . . 1.22 112.86 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.734 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.44 138.92 31.1 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.611 -0.722 . . . . 0.13 111.826 -178.864 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.601 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 5.7 mt-30 -91.44 -51.82 5.09 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.829 -0.623 . . . . 0.48999999999999999 111.09 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.59 0 CA-C-N 116.06 -0.518 . . . . 0.45000000000000001 111.923 -179.676 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo . . . . . 0 N--CA 1.454 -0.822 0 N-CA-C 113.219 0.43 . . . . 0.0 113.219 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.56 HG11 ' HB2' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -96.04 100.02 10.17 Favored 'Isoleucine or valine' 0 C--N 1.342 0.24 0 CA-C-O 120.986 0.422 . . . . 0.0 110.616 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.557 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 26.3 p30 -90.27 166.71 13.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.986 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.401 ' HB2' ' HB3' ' A' ' 12' ' ' ASP . 7.1 p -179.73 174.22 0.96 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.385 0.612 . . . . 0.0 112.188 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -120.71 -46.2 2.37 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.344 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.5 p -113.42 -176.89 3.0 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.404 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.82 -63.22 1.38 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.49 4.2 2.52 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.401 ' HB3' ' HB2' ' A' ' 7' ' ' CYS . 3.5 m-20 -76.86 -29.35 55.81 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.535 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -92.2 23.03 4.04 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.139 178.209 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.1 p -51.21 -27.39 6.16 Favored 'Isoleucine or valine' 0 C--N 1.345 0.378 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.481 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -56.48 -25.8 52.18 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.445 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.56 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.5 t -84.08 -44.42 14.08 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.676 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.82 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -172.09 -169.2 34.57 Favored Glycine 0 C--N 1.337 0.608 0 C-N-CA 120.497 -0.858 . . . . 0.0 113.273 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.9 mt -91.09 82.39 5.56 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.194 0.521 . . . . 0.0 111.007 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.7 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 101.29 82.43 1.66 Allowed Glycine 0 C--N 1.324 -0.118 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.721 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.82 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -111.66 142.37 24.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -177.863 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 1.9 p -83.49 130.36 35.01 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.1 t -98.56 127.16 44.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.005 0.431 . . . . 0.0 111.891 -178.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.598 ' O ' ' N ' ' A' ' 25' ' ' GLY . 1.3 pttt -95.11 -155.73 0.48 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -53.64 64.08 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 O-C-N 123.956 0.785 . . . . 0.0 112.343 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 79.32 16.11 78.86 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.541 -0.754 . . . . 0.0 113.195 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 50.7 m-85 -143.64 -177.6 5.49 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 117.574 0.687 . . . . 0.0 112.403 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.672 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -83.66 140.1 32.38 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.543 -179.323 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.424 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 14.5 mt-30 -90.55 -46.61 8.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.453 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.495 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.557 -179.693 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo . . . . . 0 N--CA 1.454 -0.844 0 N-CA-C 113.091 0.381 . . . . 0.0 113.091 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.52 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -95.15 103.3 14.54 Favored 'Isoleucine or valine' 0 C--N 1.34 0.171 0 CA-C-O 121.066 0.46 . . . . 0.0 110.674 -179.849 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.579 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 1.6 p-10 -90.14 163.51 14.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.949 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.4 p -178.5 172.78 1.42 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.37 0.605 . . . . 0.0 112.201 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.0 mttm -118.39 -46.88 2.57 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.237 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 p -112.27 -177.73 3.24 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.33 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -61.39 -58.23 9.05 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.5 mmt85 -72.78 2.45 6.66 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.2 -27.64 53.61 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.507 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.94 23.73 3.56 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.141 178.123 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.3 p -50.8 -28.77 6.47 Favored 'Isoleucine or valine' 0 C--N 1.346 0.446 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.363 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -55.35 -26.59 41.94 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.733 0.302 . . . . 0.0 110.592 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.457 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.2 t -84.07 -44.64 13.88 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.696 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.826 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -173.33 -170.01 36.4 Favored Glycine 0 C--N 1.337 0.619 0 C-N-CA 120.453 -0.879 . . . . 0.0 113.419 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.3 mt -91.13 81.49 5.57 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.162 0.506 . . . . 0.0 110.878 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.69 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 103.76 82.26 1.6 Allowed Glycine 0 N--CA 1.457 0.07 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.361 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.826 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.2 mm -111.26 147.1 15.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -177.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 28.7 m -87.58 129.41 35.11 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.9 t -98.46 129.47 45.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.065 0.46 . . . . 0.0 111.89 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.577 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.1 OUTLIER -94.9 -156.92 0.53 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.024 178.385 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -57.01 66.02 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.402 0.62 . . . . 0.0 111.678 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 79.83 18.53 72.54 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 115.322 -0.854 . . . . 0.0 113.066 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.579 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 54.0 m-85 -145.2 -175.28 4.64 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 117.516 0.658 . . . . 0.0 112.705 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.707 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -88.39 137.54 32.23 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.021 -179.008 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.448 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 9.8 mt-30 -90.17 -45.38 9.14 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.689 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.537 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.749 -179.545 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo . . . . . 0 N--CA 1.455 -0.767 0 N-CA-C 113.255 0.444 . . . . 0.0 113.255 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.58 HG21 ' SG ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -99.58 96.56 5.04 Favored 'Isoleucine or valine' 0 C--N 1.342 0.259 0 CA-C-O 121.082 0.467 . . . . 0.0 110.382 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.627 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 8.0 p-10 -90.32 166.77 13.12 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.339 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.6 p -176.19 166.2 2.87 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.246 0.546 . . . . 0.0 112.27 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -109.71 -40.23 4.88 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.241 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.7 p -123.02 -177.39 3.66 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.037 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -60.76 -59.46 5.36 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -0.25 7.11 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -76.77 -30.1 56.37 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.617 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -89.63 21.85 3.29 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.972 178.042 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.2 p -49.48 -25.14 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.462 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.553 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 20.9 mmt -52.46 -28.64 20.99 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.58 ' SG ' HG21 ' A' ' 5' ' ' VAL . 0.7 OUTLIER -83.83 -45.05 13.7 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.974 179.337 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.8 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -173.12 -166.2 31.19 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.383 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.7 mt -91.48 81.24 5.39 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.078 0.466 . . . . 0.0 110.969 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.648 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 105.26 81.35 1.46 Allowed Glycine 0 N--CA 1.457 0.082 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.613 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.8 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -112.13 122.9 67.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.0 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 45.8 m -61.24 134.8 57.37 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.9 t -103.32 126.44 50.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.925 0.393 . . . . 0.0 111.559 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.583 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.1 OUTLIER -95.38 -157.5 0.58 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.225 178.735 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -55.08 64.87 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.404 0.682 . . . . 0.0 112.121 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 78.48 18.68 75.4 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.816 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.627 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 38.0 m-85 -144.14 179.62 7.1 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 117.354 0.577 . . . . 0.0 112.5 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.606 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -78.44 144.85 35.44 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.194 -179.729 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.462 ' HB2' ' O ' ' A' ' 21' ' ' SER . 10.7 mt-30 -90.34 -40.14 12.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.378 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.606 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.949 -179.472 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo . . . . . 0 N--CA 1.454 -0.819 0 N-CA-C 113.314 0.467 . . . . 0.0 113.314 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.503 HG11 ' HB2' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -94.9 101.99 13.1 Favored 'Isoleucine or valine' 0 C--N 1.341 0.223 0 CA-C-O 121.078 0.466 . . . . 0.0 110.579 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.542 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 6.4 p30 -90.15 165.15 14.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.837 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.9 p -176.73 175.64 1.63 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.306 0.574 . . . . 0.0 112.261 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.7 mttm -121.26 -49.11 2.18 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.448 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.502 HG22 ' H ' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -111.88 -176.69 2.99 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.269 178.632 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.502 ' H ' HG22 ' A' ' 9' ' ' THR . 0.5 OUTLIER -58.88 -64.26 1.0 Allowed 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.359 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.25 5.37 1.73 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.31 -31.28 58.09 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.552 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.38 22.02 4.16 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.376 178.622 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.7 p -51.61 -27.12 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.434 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 65.5 mtm -57.56 -25.04 59.37 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.646 0.26 . . . . 0.0 110.38 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.503 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.4 t -84.09 -44.05 14.44 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.523 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.828 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -171.04 -168.38 32.68 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.431 -0.89 . . . . 0.0 113.402 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.02 82.39 5.59 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.186 0.517 . . . . 0.0 111.029 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.677 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 99.05 82.79 1.69 Allowed Glycine 0 N--CA 1.457 0.061 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.843 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.828 HD11 ' C ' ' A' ' 17' ' ' GLY . 0.9 OUTLIER -111.13 139.11 36.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -177.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.4 m -82.32 128.65 34.42 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.9 t -94.91 128.3 41.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.938 0.399 . . . . 0.0 111.325 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.617 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -99.46 -154.71 0.48 Allowed 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.319 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -50.14 63.83 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.096 0.959 . . . . 0.0 113.031 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.617 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 76.63 14.4 82.52 Favored Glycine 0 CA--C 1.522 0.508 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.387 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 47.0 m-85 -142.71 -177.34 5.26 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 117.533 0.667 . . . . 0.0 112.645 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.667 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -82.85 141.05 32.56 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.467 -179.401 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.443 ' CG ' ' HB3' ' A' ' 23' ' ' LYS . 34.7 mt-30 -90.63 -51.24 5.49 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.569 179.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.489 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.784 -179.623 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo . . . . . 0 N--CA 1.455 -0.784 0 N-CA-C 113.233 0.436 . . . . 0.0 113.233 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.494 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 0.1 OUTLIER -94.76 102.06 13.19 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 CA-C-O 121.125 0.488 . . . . 0.0 110.508 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.551 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 4.3 p-10 -90.1 164.08 14.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.055 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.2 p -176.83 174.45 1.77 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.391 0.615 . . . . 0.0 112.127 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -119.71 -46.56 2.45 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.213 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.0 p -114.26 -177.16 3.06 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.243 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.94 -61.0 2.94 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.83 1.73 5.12 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -76.74 -28.45 55.77 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.513 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -92.62 22.92 4.34 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.153 178.104 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.1 p -51.14 -28.68 7.32 Favored 'Isoleucine or valine' 0 C--N 1.345 0.401 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.377 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 23.0 mtt -55.29 -25.98 37.46 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.489 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.492 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.5 t -84.1 -45.09 13.38 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.452 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.83 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -171.35 -169.7 34.58 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.402 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.7 mp -91.28 82.26 5.46 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.219 0.533 . . . . 0.0 110.835 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.689 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 101.61 82.41 1.65 Allowed Glycine 0 C--N 1.324 -0.097 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.514 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.83 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -111.23 146.63 15.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -177.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 67.0 m -87.8 129.63 35.12 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.5 t -96.53 127.71 42.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.074 0.464 . . . . 0.0 111.886 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.594 ' O ' ' N ' ' A' ' 25' ' ' GLY . 1.0 OUTLIER -95.05 -155.73 0.48 Allowed 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.364 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -54.97 65.21 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.375 0.67 . . . . 0.0 112.045 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 77.8 17.2 79.04 Favored Glycine 0 CA--C 1.521 0.444 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.95 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 41.1 m-85 -142.99 -176.67 5.0 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 117.392 0.596 . . . . 0.0 112.517 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.663 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -86.02 138.74 31.74 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.738 -179.284 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.458 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 16.2 mt-30 -89.94 -46.65 8.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.694 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.543 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 -179.672 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo . . . . . 0 N--CA 1.454 -0.814 0 N-CA-C 113.319 0.469 . . . . 0.0 113.319 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.567 HG11 ' HB2' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -97.13 100.91 11.55 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 CA-C-O 120.994 0.426 . . . . 0.0 110.735 -179.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.567 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 1.0 OUTLIER -90.37 165.25 13.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.789 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.402 ' HB2' ' CB ' ' A' ' 12' ' ' ASP . 7.9 p -178.79 173.86 1.2 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.363 0.602 . . . . 0.0 112.222 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.73 -48.59 2.37 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.152 178.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.543 HG22 ' H ' ' A' ' 10' ' ' ASP . 0.5 OUTLIER -112.62 -178.36 3.38 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.899 178.344 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.543 ' H ' HG22 ' A' ' 9' ' ' THR . 42.9 m-20 -58.92 -60.88 3.16 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.3 0.57 4.79 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.402 ' CB ' ' HB2' ' A' ' 7' ' ' CYS . 0.5 OUTLIER -75.38 -30.52 60.18 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.056 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.493 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.21 23.29 3.38 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.536 178.563 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.6 p -51.3 -27.63 6.79 Favored 'Isoleucine or valine' 0 C--N 1.345 0.384 0 CA-C-N 116.68 -0.237 . . . . 0.0 111.384 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 10.3 mmt -56.06 -25.73 46.36 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.404 178.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.567 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.4 t -84.09 -44.91 13.58 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.624 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.827 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -172.73 -169.12 34.96 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.434 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 mt -91.23 82.98 5.47 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.192 0.52 . . . . 0.0 110.84 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.689 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 101.27 82.68 1.68 Allowed Glycine 0 C--N 1.325 -0.061 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.41 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.827 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.1 mm -111.18 148.0 14.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -177.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 18.3 m -89.61 129.93 35.99 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.8 t -97.33 129.75 44.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.076 0.465 . . . . 0.0 111.987 -178.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.575 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -95.18 -157.41 0.57 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.994 178.352 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -56.69 65.62 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.233 0.613 . . . . 0.0 111.83 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 80.99 16.73 74.11 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-N 115.325 -0.852 . . . . 0.0 113.123 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 62.5 m-85 -144.99 -174.1 4.27 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 117.487 0.644 . . . . 0.0 112.57 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.694 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -86.86 139.05 31.05 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.79 -179.178 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.457 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 8.6 mt-30 -90.56 -44.15 9.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.479 178.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.581 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.565 -179.544 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo . . . . . 0 N--CA 1.454 -0.796 0 N-CA-C 113.249 0.442 . . . . 0.0 113.249 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.519 HG11 ' HB2' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -95.24 101.24 12.24 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 CA-C-O 120.964 0.411 . . . . 0.0 110.482 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.545 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 27.5 p-10 -90.1 165.66 13.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.13 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.403 ' HB2' ' HB3' ' A' ' 12' ' ' ASP . 7.4 p -177.53 174.61 1.52 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.382 0.61 . . . . 0.0 112.324 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.04 -48.28 2.35 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.367 178.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.6 p -113.47 -175.66 2.72 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.176 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.27 -62.43 1.88 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.14 4.57 2.65 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.403 ' HB3' ' HB2' ' A' ' 7' ' ' CYS . 0.7 OUTLIER -77.02 -29.61 55.43 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.581 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.511 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.41 22.91 3.66 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.102 178.305 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.0 p -51.64 -26.52 6.75 Favored 'Isoleucine or valine' 0 C--N 1.345 0.391 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.313 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -25.93 60.48 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.777 0.322 . . . . 0.0 110.277 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.519 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.5 t -84.18 -44.91 13.49 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.557 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.824 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -170.58 -169.69 33.96 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.182 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 35.1 mt -91.02 81.89 5.61 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.111 0.482 . . . . 0.0 110.976 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.676 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 101.24 82.11 1.64 Allowed Glycine 0 N--CA 1.458 0.12 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.655 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.824 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -110.71 145.93 16.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -178.126 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.417 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 19.9 m -87.06 129.07 35.06 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.8 t -95.32 127.76 41.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.072 0.463 . . . . 0.0 111.99 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.62 ' O ' ' N ' ' A' ' 25' ' ' GLY . 2.6 ptmt -95.1 -155.42 0.47 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -54.28 65.02 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.286 0.634 . . . . 0.0 111.928 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.62 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 76.88 18.24 79.03 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.842 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 54.1 m-85 -143.93 -176.58 5.05 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 117.277 0.538 . . . . 0.0 112.357 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.665 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -85.11 140.34 31.03 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.74 -179.272 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.425 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 15.7 mt-30 -90.53 -47.9 7.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.489 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.523 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.417 -179.591 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo . . . . . 0 N--CA 1.455 -0.75 0 N-CA-C 113.231 0.435 . . . . 0.0 113.231 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.59 HG11 ' HB2' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -97.97 98.74 7.67 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 CA-C-O 121.057 0.456 . . . . 0.0 110.667 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.535 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 12.0 p-10 -90.33 165.31 13.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.691 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.2 p -177.48 174.58 1.54 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.432 0.634 . . . . 0.0 112.559 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.7 mtpm? -119.71 -47.86 2.4 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.257 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.75 -177.53 3.15 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.01 178.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.84 -58.15 9.65 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.83 0.52 7.02 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.13 -32.35 59.09 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.537 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -90.92 20.35 4.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.384 178.397 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.3 p -51.3 -27.69 6.83 Favored 'Isoleucine or valine' 0 C--N 1.344 0.356 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.101 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.06 -25.79 33.19 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.317 178.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.59 ' HB2' HG11 ' A' ' 5' ' ' VAL . 5.1 t -83.99 -43.75 14.86 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.57 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.838 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -171.24 -169.88 34.72 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.212 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.415 HD22 ' N ' ' A' ' 18' ' ' LEU . 3.8 mm? -91.13 82.26 5.54 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.121 0.486 . . . . 0.0 110.658 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.701 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 101.76 82.12 1.63 Allowed Glycine 0 C--N 1.323 -0.178 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.554 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.838 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -110.83 146.54 15.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.075 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.1 m -88.6 129.45 35.49 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.3 t -97.45 126.93 43.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.916 0.389 . . . . 0.0 111.589 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.624 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -99.15 -154.49 0.47 Allowed 'General case' 0 C--O 1.225 -0.209 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.434 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -50.82 64.27 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.729 0.812 . . . . 0.0 112.776 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 76.64 15.15 81.8 Favored Glycine 0 CA--C 1.522 0.511 0 CA-C-N 115.714 -0.675 . . . . 0.0 113.397 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 54.8 m-85 -142.97 -176.18 4.8 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 117.486 0.643 . . . . 0.0 112.403 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.656 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -83.64 140.55 32.12 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.639 -179.35 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.482 ' CG ' ' HB3' ' A' ' 23' ' ' LYS . 16.3 mt-30 -90.81 -44.73 9.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.456 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.528 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.522 -179.598 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 N--CA 1.453 -0.881 0 N-CA-C 113.13 0.396 . . . . 0.0 113.13 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.515 HG11 ' HB2' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -94.88 102.84 14.03 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 CA-C-O 121.12 0.486 . . . . 0.0 110.548 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.578 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 7.6 p30 -90.17 164.77 14.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.012 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.0 p -178.07 174.69 1.34 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.467 0.651 . . . . 0.0 112.156 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -120.75 -44.73 2.42 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.669 178.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.499 HG22 ' H ' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -116.17 -177.65 3.22 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.026 178.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.499 ' H ' HG22 ' A' ' 9' ' ' THR . 0.9 OUTLIER -58.59 -63.94 1.1 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -179.453 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.1 1.96 3.15 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.12 -29.54 60.59 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.533 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -92.17 23.71 3.68 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.397 178.636 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.7 p -50.87 -27.44 5.19 Favored 'Isoleucine or valine' 0 C--N 1.343 0.323 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.552 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.51 -25.81 52.62 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.393 178.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.515 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.6 t -84.26 -43.88 14.42 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.726 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.84 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -173.25 -169.3 35.54 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.324 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.12 81.78 5.56 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.221 0.534 . . . . 0.0 110.934 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.725 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 102.69 82.87 1.68 Allowed Glycine 0 N--CA 1.458 0.161 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.43 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.84 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -112.47 141.88 26.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -177.793 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 0.9 OUTLIER -83.47 131.79 34.99 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 177.908 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.0 t -99.08 129.37 45.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.163 0.506 . . . . 0.0 112.021 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.608 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -94.94 -156.05 0.49 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.189 178.484 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -55.41 65.23 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 O-C-N 123.674 0.609 . . . . 0.0 111.807 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.608 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 78.76 18.24 75.72 Favored Glycine 0 CA--C 1.52 0.363 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.984 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.578 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 57.9 m-85 -144.74 -175.53 4.7 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 117.383 0.591 . . . . 0.0 112.43 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.688 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -85.72 138.32 32.2 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.755 -179.164 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.438 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 10.3 mt-30 -90.27 -45.48 9.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.536 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.484 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.544 -179.559 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo . . . . . 0 N--CA 1.454 -0.796 0 N-CA-C 113.165 0.41 . . . . 0.0 113.165 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.575 HG11 ' HB2' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -98.7 101.36 12.03 Favored 'Isoleucine or valine' 0 C--N 1.34 0.152 0 CA-C-O 121.049 0.452 . . . . 0.0 110.724 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.541 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 5.3 p30 -90.55 164.51 14.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.008 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.9 p -176.89 164.31 2.33 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.389 0.614 . . . . 0.0 112.233 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -111.33 -31.27 7.11 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.572 178.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.466 ' H ' ' HB2' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -131.66 -179.17 5.22 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.349 178.532 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.95 -62.03 2.19 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.8 -1.46 7.18 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.466 ' HB2' ' H ' ' A' ' 9' ' ' THR . 2.4 m-20 -74.99 -31.7 61.49 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.101 0.477 . . . . 0.0 109.849 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.506 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -88.09 23.46 2.1 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.379 178.306 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.3 p -51.31 -28.0 7.24 Favored 'Isoleucine or valine' 0 C--N 1.345 0.397 0 CA-C-N 116.752 -0.204 . . . . 0.0 111.292 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 27.2 mmm -55.23 -26.01 36.88 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.714 0.293 . . . . 0.0 110.311 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.575 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.4 t -83.95 -45.14 13.48 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.642 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.837 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -172.86 -169.15 35.09 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.436 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.7 mt -91.12 83.36 5.56 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.059 0.457 . . . . 0.0 110.816 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.682 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 101.19 82.62 1.68 Allowed Glycine 0 C--N 1.322 -0.202 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.365 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.837 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.2 mm -110.96 148.13 14.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -177.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.25 133.24 34.09 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.0 t -103.34 127.68 50.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.036 0.445 . . . . 0.0 112.045 -178.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.587 ' O ' ' N ' ' A' ' 25' ' ' GLY . 8.4 pttt -94.81 -156.07 0.49 Allowed 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.56 64.71 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.299 0.64 . . . . 0.0 112.259 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 80.2 17.43 74.18 Favored Glycine 0 CA--C 1.522 0.49 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.951 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 50.0 m-85 -143.74 -176.9 5.16 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 117.39 0.595 . . . . 0.0 112.476 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.718 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -85.03 138.37 32.49 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.69 -179.286 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.456 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 8.7 mt-30 -90.65 -40.21 12.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.528 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.523 0 N-CA-C 111.562 -0.615 . . . . 0.0 111.562 -179.516 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo . . . . . 0 N--CA 1.454 -0.814 0 N-CA-C 113.296 0.46 . . . . 0.0 113.296 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.535 HG11 ' HB2' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -94.9 102.76 13.94 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 CA-C-O 121.052 0.453 . . . . 0.0 110.529 -179.89 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 26.6 p30 -90.01 164.99 14.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.076 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.46 ' HB2' ' HB3' ' A' ' 12' ' ' ASP . 7.3 p -178.02 174.59 1.37 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.333 0.587 . . . . 0.0 111.927 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.4 mmtt -118.95 -48.64 2.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.217 178.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.0 p -112.68 -175.87 2.78 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.217 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.05 -61.94 2.24 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.5 mtt85 -71.48 3.73 3.61 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -179.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.46 ' HB3' ' HB2' ' A' ' 7' ' ' CYS . 0.6 OUTLIER -76.46 -29.37 56.89 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.6 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.491 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.19 23.15 3.42 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.332 178.475 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 p -50.91 -27.62 5.46 Favored 'Isoleucine or valine' 0 C--N 1.344 0.335 0 CA-C-N 116.737 -0.211 . . . . 0.0 111.209 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 41.2 mtt -56.72 -25.52 54.67 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.755 0.312 . . . . 0.0 110.483 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.535 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.6 t -84.08 -44.66 13.85 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.481 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.825 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -171.39 -169.3 34.15 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.415 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.13 82.08 5.55 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.246 0.546 . . . . 0.0 110.999 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.688 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 101.03 82.29 1.65 Allowed Glycine 0 C--O 1.23 -0.095 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.627 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.825 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -110.68 149.53 13.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -178.066 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 42.0 m -90.7 129.86 36.76 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.9 t -97.31 128.61 44.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.091 0.472 . . . . 0.0 112.156 -178.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.594 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -94.93 -155.48 0.47 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.484 -0.78 . . . . 0.0 108.963 178.374 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -55.3 65.13 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.243 0.617 . . . . 0.0 111.913 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 78.18 18.51 76.31 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.932 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 58.9 m-85 -144.37 -175.93 4.83 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 117.382 0.591 . . . . 0.0 112.427 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.66 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -86.14 139.3 31.22 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.76 -179.191 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.443 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 11.0 mt-30 -90.58 -45.58 8.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.538 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.549 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.611 -179.541 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo . . . . . 0 N--CA 1.455 -0.749 0 N-CA-C 113.338 0.476 . . . . 0.0 113.338 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.531 HG11 ' HB2' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -95.54 101.76 12.79 Favored 'Isoleucine or valine' 0 C--N 1.342 0.271 0 CA-C-O 120.99 0.424 . . . . 0.0 110.526 179.876 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.567 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 18.8 p30 -90.0 165.14 14.22 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.161 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.4 p -178.28 170.65 1.73 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.298 0.57 . . . . 0.0 112.193 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -115.85 -42.88 3.04 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.386 178.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.06 -178.18 3.44 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.163 178.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.7 -58.59 7.82 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.07 0.01 6.86 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -77.09 -30.35 55.33 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.524 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -89.79 21.21 3.66 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.246 178.079 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.9 p -51.56 -28.42 8.65 Favored 'Isoleucine or valine' 0 C--N 1.346 0.456 0 CA-C-N 116.758 -0.201 . . . . 0.0 111.247 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.6 mtp -56.96 -25.4 57.91 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.406 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.531 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.5 t -84.0 -44.8 13.79 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.587 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.841 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -169.46 -169.31 32.6 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.583 -0.818 . . . . 0.0 113.37 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.5 mt -91.27 82.06 5.48 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.105 0.478 . . . . 0.0 110.867 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.667 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 98.9 82.43 1.66 Allowed Glycine 0 CA--C 1.515 0.051 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.656 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.841 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -109.82 145.45 16.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -177.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 14.9 m -85.53 129.14 34.89 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.0 t -95.74 128.96 43.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.049 0.452 . . . . 0.0 111.931 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.588 ' O ' ' N ' ' A' ' 25' ' ' GLY . 3.9 ptmt -95.29 -157.01 0.54 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.471 -0.786 . . . . 0.0 108.98 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.0 65.76 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 O-C-N 123.696 0.623 . . . . 0.0 111.785 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 78.74 18.12 75.99 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.313 -0.858 . . . . 0.0 113.016 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 51.2 m-85 -144.52 -176.26 4.97 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 117.451 0.625 . . . . 0.0 112.667 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.631 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -86.74 140.94 29.26 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.784 -179.173 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.436 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 14.5 mt-30 -90.5 -50.15 6.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.537 179.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.489 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.694 -179.715 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo . . . . . 0 N--CA 1.451 -0.994 0 N-CA-C 112.998 0.346 . . . . 0.0 112.998 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.412 ' HB ' ' HB2' ' A' ' 27' ' ' CYS . 0.0 OUTLIER -94.64 98.02 7.57 Favored 'Isoleucine or valine' 0 C--N 1.345 0.37 0 CA-C-O 120.931 0.396 . . . . 0.0 110.348 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.573 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 5.0 p30 -90.19 164.37 14.45 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.296 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.0 p -176.72 174.72 1.78 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.261 0.553 . . . . 0.0 111.896 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -119.97 -47.04 2.41 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.377 178.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.73 -177.72 3.21 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.138 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -60.63 -61.06 2.87 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.67 4.77 2.91 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -77.69 -28.29 50.97 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.503 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.9 22.24 4.38 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.041 178.092 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.6 p -51.12 -29.31 8.05 Favored 'Isoleucine or valine' 0 C--N 1.347 0.474 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.328 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 19.0 mtm -55.98 -25.88 45.92 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.721 0.296 . . . . 0.0 110.471 178.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.0 t -83.87 -45.35 13.33 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.541 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.831 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -170.23 -170.23 34.33 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.303 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.7 mp -91.11 82.17 5.55 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.234 0.54 . . . . 0.0 110.924 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.66 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 100.58 82.22 1.65 Allowed Glycine 0 C--N 1.325 -0.08 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.645 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.831 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -110.75 145.12 17.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.27 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.418 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 70.4 m -86.33 129.38 34.87 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.9 t -96.73 126.68 42.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.063 0.459 . . . . 0.0 112.035 -178.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.597 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.1 OUTLIER -94.7 -154.91 0.44 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.329 -0.85 . . . . 0.0 108.768 178.285 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -54.95 65.17 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.453 0.701 . . . . 0.0 112.095 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 75.8 19.89 78.53 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.574 -179.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 39.5 m-85 -143.77 179.79 6.94 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -179.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.687 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -84.34 143.36 29.54 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.813 -179.131 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' A' ' 21' ' ' SER . 16.6 mt-30 -90.87 -56.0 3.34 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.752 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.45 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.207 -179.572 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo . . . . . 0 N--CA 1.456 -0.717 0 N-CA-C 113.052 0.366 . . . . 0.0 113.052 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.518 HG11 ' HB2' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -96.74 99.0 8.22 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 CA-C-O 121.074 0.464 . . . . 0.0 110.446 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.565 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 1.0 OUTLIER -90.21 166.35 13.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.95 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.5 p -177.85 174.41 1.45 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.275 0.559 . . . . 0.0 112.092 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.7 mmtm -119.99 -47.14 2.4 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.197 178.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.9 p -113.11 -176.89 3.0 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.253 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.14 -62.64 1.72 Allowed 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.92 4.26 2.73 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -179.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -77.26 -28.89 53.67 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.53 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.48 23.25 3.54 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.088 178.053 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.9 p -51.62 -28.2 8.62 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.417 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -26.09 45.17 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.743 0.306 . . . . 0.0 110.453 178.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.518 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.3 t -84.03 -45.25 13.28 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.663 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.831 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -170.77 -169.62 34.04 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.333 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.0 mt -91.16 82.72 5.51 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.167 0.508 . . . . 0.0 110.903 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.655 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 100.45 82.27 1.65 Allowed Glycine 0 C--N 1.324 -0.116 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.634 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.831 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -111.25 141.97 25.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -178.175 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.417 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 11.4 m -83.77 129.01 34.94 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.0 t -95.13 127.43 41.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.128 0.49 . . . . 0.0 112.09 -178.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.596 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -95.48 -156.74 0.53 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.039 178.37 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -54.07 64.69 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 O-C-N 123.916 0.76 . . . . 0.0 112.336 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 78.39 15.55 80.77 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.922 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 44.7 m-85 -143.16 -177.99 5.63 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.687 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -84.17 142.9 29.99 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.905 -179.236 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.417 ' HB2' ' O ' ' A' ' 21' ' ' SER . 6.3 mt-30 -90.86 -52.91 4.63 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.445 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.494 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.216 -179.61 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo . . . . . 0 N--CA 1.453 -0.854 0 N-CA-C 113.192 0.42 . . . . 0.0 113.192 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.501 HG11 ' HB2' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -99.0 98.35 7.01 Favored 'Isoleucine or valine' 0 C--N 1.341 0.232 0 CA-C-O 121.026 0.441 . . . . 0.0 110.665 -179.87 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 5.0 p30 -90.45 166.21 13.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.691 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.5 p -176.36 174.28 1.98 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.436 0.636 . . . . 0.0 112.397 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -120.65 -45.6 2.4 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.339 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.444 HG22 ' H ' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -114.61 -177.82 3.22 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.977 178.895 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.444 ' H ' HG22 ' A' ' 9' ' ' THR . 2.0 p-10 -62.46 -58.18 8.54 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.8 3.9 3.76 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.9 -30.18 56.07 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.507 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.33 21.52 4.42 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.332 178.416 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.1 p -51.44 -28.27 8.01 Favored 'Isoleucine or valine' 0 C--N 1.345 0.392 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.388 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.78 -25.18 60.17 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.718 0.294 . . . . 0.0 110.356 178.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.501 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.2 t -84.05 -45.48 13.03 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.558 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.826 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -169.07 -169.3 32.27 Favored Glycine 0 C--N 1.335 0.524 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.298 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.8 mp -91.17 81.75 5.54 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.121 0.486 . . . . 0.0 111.002 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.65 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 99.28 81.77 1.62 Allowed Glycine 0 C--N 1.323 -0.16 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.862 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.826 HD11 ' C ' ' A' ' 17' ' ' GLY . 0.9 OUTLIER -109.51 144.99 16.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 112.143 0.424 . . . . 0.0 112.143 -178.17 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -86.46 129.91 34.69 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.6 t -95.0 126.35 40.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.196 0.522 . . . . 0.0 111.851 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.614 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -96.58 -155.49 0.49 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.964 178.422 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -52.77 65.43 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.647 0.779 . . . . 0.0 112.16 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.614 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 74.49 16.28 80.09 Favored Glycine 0 CA--C 1.519 0.326 0 CA-C-N 115.386 -0.825 . . . . 0.0 113.073 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 44.7 m-85 -143.34 179.47 7.07 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 117.346 0.573 . . . . 0.0 112.317 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.645 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -80.55 143.42 33.25 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.799 -179.327 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -90.83 -55.06 3.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.402 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.373 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.286 -179.674 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo . . . . . 0 N--CA 1.453 -0.872 0 N-CA-C 113.038 0.361 . . . . 0.0 113.038 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.587 HG11 ' HB2' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -96.95 102.42 13.46 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-O 121.189 0.518 . . . . 0.0 110.683 -179.888 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -89.8 162.66 15.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.564 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.3 p -177.99 174.45 1.4 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.399 0.619 . . . . 0.0 112.342 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.2 -47.29 2.15 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.295 178.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.9 p -112.12 -176.81 3.01 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.219 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.09 -62.76 1.63 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.7 mtt85 -71.09 4.13 2.95 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.91 -27.38 54.91 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.479 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -92.84 23.75 4.0 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.256 178.272 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.3 p -50.88 -27.81 5.62 Favored 'Isoleucine or valine' 0 C--N 1.346 0.456 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.433 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 5.8 mtt -57.05 -25.72 59.12 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.672 0.273 . . . . 0.0 110.487 178.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.587 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.6 t -84.06 -45.19 13.32 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.564 179.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.83 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -171.26 -168.89 33.55 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 120.485 -0.864 . . . . 0.0 113.588 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.12 82.25 5.55 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.212 0.529 . . . . 0.0 111.075 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.671 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 100.03 82.22 1.65 Allowed Glycine 0 C--N 1.325 -0.073 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.514 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.83 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.1 mm -109.93 150.12 12.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.419 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 0.9 OUTLIER -91.81 129.77 37.71 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.057 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.6 t -96.92 127.65 43.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.996 0.426 . . . . 0.0 111.772 -178.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.6 ' O ' ' N ' ' A' ' 25' ' ' GLY . 38.1 pttt -95.04 -155.5 0.47 Allowed 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -54.05 64.95 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 O-C-N 123.915 0.759 . . . . 0.0 112.216 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 79.1 14.67 81.58 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.31 -0.859 . . . . 0.0 113.149 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -142.37 -176.52 4.87 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 117.607 0.704 . . . . 0.0 112.568 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.657 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -83.51 139.42 32.92 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.707 -179.362 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.435 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 12.8 mt-30 -90.36 -47.5 7.71 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.54 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.533 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.667 -179.718 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo . . . . . 0 N--CA 1.452 -0.923 0 N-CA-C 113.085 0.379 . . . . 0.0 113.085 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.624 HG11 ' HB2' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -100.06 98.7 7.3 Favored 'Isoleucine or valine' 0 C--N 1.34 0.17 0 CA-C-O 121.092 0.472 . . . . 0.0 110.823 -179.853 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.541 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 2.3 p-10 -90.37 166.91 13.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.654 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.415 ' HB2' ' HB3' ' A' ' 12' ' ' ASP . 7.8 p -179.1 173.17 1.18 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.445 0.641 . . . . 0.0 112.443 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.52 -47.68 2.53 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.035 178.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.9 p -113.08 -177.16 3.07 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.191 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -61.63 -56.97 14.05 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.63 -0.22 10.25 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 7' ' ' CYS . 0.8 OUTLIER -75.56 -28.71 59.12 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.045 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.484 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.7 23.61 3.5 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.414 178.546 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.6 p -51.62 -28.24 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.282 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -57.11 -26.04 59.8 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.397 178.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.624 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.5 t -83.85 -46.17 12.45 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.621 179.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.819 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -170.93 -169.09 33.56 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.454 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.3 82.56 5.44 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.276 0.56 . . . . 0.0 110.874 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.681 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 100.43 82.36 1.66 Allowed Glycine 0 N--CA 1.458 0.134 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.618 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.819 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -110.16 150.12 12.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.167 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.404 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 6.0 m -91.74 129.15 37.76 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.0 t -96.5 125.86 41.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.961 0.41 . . . . 0.0 111.558 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.62 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -96.32 -152.66 0.38 Allowed 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.166 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -51.97 64.62 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.46 0.704 . . . . 0.0 112.721 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.62 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 74.48 19.62 79.81 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.8 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 89.1 m-85 -145.36 -175.44 4.71 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.678 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -84.15 140.31 31.84 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.803 -179.135 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.413 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 13.0 mt-30 -90.85 -45.66 8.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.285 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.577 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.25 -179.514 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo . . . . . 0 N--CA 1.455 -0.761 0 N-CA-C 113.308 0.465 . . . . 0.0 113.308 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.602 HG11 ' SG ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -99.82 95.87 4.49 Favored 'Isoleucine or valine' 0 C--N 1.343 0.295 0 CA-C-O 120.966 0.413 . . . . 0.0 110.097 179.675 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.548 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -90.19 165.14 14.13 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.144 -179.099 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.8 p -179.06 169.7 1.51 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.282 0.563 . . . . 0.0 112.151 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.0 mmtt -114.25 -45.06 3.07 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.059 177.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.6 p -115.92 -177.65 3.21 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.683 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -58.37 -62.46 1.83 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -69.47 -0.28 6.29 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -75.59 -28.42 58.91 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.0 110.258 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.632 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -90.8 24.49 2.71 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.069 178.28 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.4 p -49.46 -26.2 2.17 Favored 'Isoleucine or valine' 0 C--N 1.345 0.398 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.589 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 9.8 mtm -52.46 -29.16 23.27 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.606 0.241 . . . . 0.0 110.444 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.602 ' SG ' HG11 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -83.86 -46.96 11.58 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.914 179.377 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.793 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -172.76 -166.03 30.67 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.458 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.29 81.45 5.49 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.244 0.545 . . . . 0.0 111.136 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.649 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 105.34 81.53 1.47 Allowed Glycine 0 N--CA 1.457 0.056 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.713 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.793 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -113.07 123.27 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -178.12 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 0.2 OUTLIER -61.44 138.19 58.26 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 178.088 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.6 t -109.77 130.06 55.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.989 0.423 . . . . 0.0 111.946 -178.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.571 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.1 OUTLIER -95.1 -156.72 0.53 Allowed 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.31 178.596 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 -56.67 65.9 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.753 0.658 . . . . 0.0 111.733 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 79.1 21.02 68.71 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.954 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 58.4 m-85 -145.33 179.14 7.59 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 117.445 0.622 . . . . 0.0 112.429 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.622 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -78.81 143.6 35.88 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.192 -179.74 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.447 ' HB2' ' O ' ' A' ' 21' ' ' SER . 7.3 mt-30 -90.51 -40.61 11.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.028 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.695 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.268 -179.501 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo . . . . . 0 N--CA 1.454 -0.811 0 N-CA-C 113.27 0.45 . . . . 0.0 113.27 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.448 HG11 ' HB2' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -95.88 102.11 13.16 Favored 'Isoleucine or valine' 0 C--N 1.342 0.254 0 CA-C-O 121.013 0.435 . . . . 0.0 110.265 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.565 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 26.1 p30 -88.9 164.94 14.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.303 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.9 p -177.19 167.86 2.37 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.29 0.567 . . . . 0.0 112.041 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.77 -46.92 3.09 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.898 178.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.6 p -114.89 -176.73 2.96 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.193 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -60.26 -61.77 2.36 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -71.4 3.86 3.44 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -178.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.96 -28.6 55.24 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.5 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -90.21 22.66 3.2 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.229 178.274 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.6 p -50.79 -28.17 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.307 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 10.8 mtt -55.76 -26.31 45.18 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.418 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.448 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.5 t -84.04 -44.89 13.66 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.538 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.836 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -170.69 -170.04 34.47 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.276 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.7 mp -91.1 81.52 5.59 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.129 0.49 . . . . 0.0 110.903 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.676 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 101.54 81.84 1.61 Allowed Glycine 0 C--N 1.325 -0.075 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.598 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.836 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -110.49 147.74 14.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -178.053 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.2 m -86.49 136.93 32.9 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.2 t -104.97 130.85 53.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.272 0.558 . . . . 0.0 112.479 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.581 ' O ' ' N ' ' A' ' 25' ' ' GLY . 1.4 mtpp -94.03 -159.25 0.68 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.197 -0.911 . . . . 0.0 108.718 178.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -58.01 66.67 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.41 0.624 . . . . 0.0 111.025 179.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 80.53 19.27 68.98 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.969 -179.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 44.7 m-85 -143.45 -177.8 5.57 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 117.541 0.67 . . . . 0.0 112.601 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.674 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -86.62 142.52 28.19 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.2 -178.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.452 ' HG2' ' HD2' ' A' ' 23' ' ' LYS . 7.1 mt-30 -90.89 -50.19 6.02 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.499 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.535 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.534 -179.406 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo . . . . . 0 N--CA 1.454 -0.798 0 N-CA-C 113.144 0.402 . . . . 0.0 113.144 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.673 HG11 ' HB2' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -104.83 92.28 2.1 Favored 'Isoleucine or valine' 0 C--N 1.344 0.344 0 CA-C-O 121.201 0.524 . . . . 0.0 110.512 -179.965 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.508 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 1.0 OUTLIER -90.58 164.91 14.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.621 -179.695 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.416 ' HB2' ' HB3' ' A' ' 12' ' ' ASP . 10.3 p -179.25 175.28 0.95 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.353 0.597 . . . . 0.0 112.387 179.439 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -122.12 -46.67 2.18 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.28 178.264 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.91 -177.95 3.26 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.323 178.74 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -58.39 -64.32 0.96 Allowed 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.526 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.27 3.18 2.35 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -179.102 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.416 ' HB3' ' HB2' ' A' ' 7' ' ' CYS . 4.2 m-20 -76.59 -30.0 56.8 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.496 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.54 22.02 4.27 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.243 178.138 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.6 p -50.4 -29.55 6.47 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 CA-C-O 120.592 0.234 . . . . 0.0 111.195 179.724 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.516 ' HG3' HG12 ' A' ' 5' ' ' VAL . 7.1 ptp -54.71 -25.46 27.54 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.61 178.373 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.673 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.7 t -83.98 -43.97 14.66 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.646 179.396 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.839 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -171.11 -169.67 34.37 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.37 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.518 HD22 ' N ' ' A' ' 18' ' ' LEU . 2.9 mm? -91.18 82.19 5.52 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.161 0.505 . . . . 0.0 110.776 179.744 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.686 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 100.66 82.15 1.64 Allowed Glycine 0 N--CA 1.457 0.062 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.523 -179.354 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.839 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -110.73 150.31 13.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -177.939 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 2.1 p -91.18 138.46 31.57 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 177.7 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.401 ' SG ' ' C ' ' A' ' 7' ' ' CYS . 3.6 t -103.92 129.51 51.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.102 0.477 . . . . 0.0 111.957 -178.659 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.57 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -95.3 -157.35 0.57 Allowed 'General case' 0 C--O 1.227 -0.131 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.018 178.327 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -56.12 65.54 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.254 0.622 . . . . 0.0 112.024 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 81.21 15.25 77.27 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.16 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 65.5 m-85 -143.51 -174.87 4.35 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 117.455 0.627 . . . . 0.0 112.412 -179.55 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.658 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -81.61 140.0 34.68 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.687 -179.469 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' A' ' 21' ' ' SER . 5.8 mt-30 -90.67 -36.22 14.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.467 178.647 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.338 0.646 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.635 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 34.0 p . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 120.576 0.226 . . . . 2.0699999999999998 111.302 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.69 ' CB ' ' HB3' ' A' ' 27' ' ' CYS . 69.7 Cg_endo -84.46 40.64 0.88 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.237 2.624 . . . . 0.5 113.13 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.582 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -90.41 -60.62 0.22 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 1.8899999999999999 110.147 179.048 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.582 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 65.6 Cg_endo -94.69 13.05 1.47 Allowed 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.079 2.52 . . . . 0.25 113.312 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.633 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.2 OUTLIER -94.59 103.3 14.54 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 CA-C-O 121.159 0.504 . . . . 0.25 110.609 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.614 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 5.9 p30 -90.21 161.36 15.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.665 -0.698 . . . . 1.5900000000000001 111.245 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.481 ' HB2' ' CB ' ' A' ' 12' ' ' ASP . 17.7 p -175.39 172.61 2.65 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.443 0.639 . . . . 0.11 112.071 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.7 mttt -118.8 -46.68 2.54 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 114.913 -1.04 . . . . 2.96 108.935 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.6 p -110.46 -178.43 3.5 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.582 -0.735 . . . . 0.85999999999999999 110.17 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -62.28 -57.97 9.43 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 111.818 0.303 . . . . 1.9099999999999999 111.818 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 30.8 mtt180 -72.17 2.34 6.06 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.696 0.628 . . . . 4.4800000000000004 112.696 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.481 ' CB ' ' HB2' ' A' ' 7' ' ' CYS . 3.7 m-20 -75.75 -25.06 56.19 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.714 -0.476 . . . . 1.1499999999999999 109.714 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.514 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -94.25 25.15 3.96 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.583 -0.735 . . . . 0.070000000000000007 110.337 178.515 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -50.22 -30.61 7.16 Favored 'Isoleucine or valine' 0 C--N 1.345 0.397 0 N-CA-C 111.689 0.255 . . . . 0.16 111.689 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 61.6 mtt -57.27 -29.01 63.48 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.62 -0.264 . . . . 2.1400000000000001 110.83 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.567 ' HB2' HG11 ' A' ' 5' ' ' VAL . 2.0 t -83.44 -47.57 11.25 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.396 -0.365 . . . . 0.23999999999999999 110.616 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.815 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -168.08 -169.49 31.62 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 120.738 -0.744 . . . . 0.17999999999999999 113.145 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 17.8 mt -92.02 81.21 5.1 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.143 0.497 . . . . 1.6799999999999999 111.019 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.636 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 99.15 82.17 1.65 Allowed Glycine 0 N--CA 1.455 -0.064 0 CA-C-N 115.523 -0.762 . . . . 0.12 111.489 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.815 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.1 mm -109.18 133.17 55.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 112.376 0.51 . . . . 0.23000000000000001 112.376 -178.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 57.1 m -67.35 127.06 31.28 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 108.88 -0.785 . . . . 0.73999999999999999 108.88 177.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.432 ' SG ' ' C ' ' A' ' 7' ' ' CYS . 4.4 t -96.98 126.64 42.26 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.11 0.481 . . . . 0.11 112.093 -178.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.601 ' HB3' ' HG3' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -94.62 -158.35 0.63 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.427 -0.806 . . . . 2.8999999999999999 109.007 178.689 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -56.42 65.72 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.343 0.657 . . . . 1.72 111.892 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.574 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 79.1 20.18 70.64 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.169 -0.923 . . . . 0.12 113.031 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.614 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 45.0 m-85 -145.33 -175.16 4.6 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.86 0.689 . . . . 1.22 112.86 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.734 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -92.44 138.92 31.1 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.611 -0.722 . . . . 0.13 111.826 -178.864 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.601 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 5.7 mt-30 -91.44 -51.82 5.09 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.829 -0.623 . . . . 0.48999999999999999 111.09 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.484 ' HA2' ' HG3' ' A' ' 2' ' ' PRO . . . 179.9 100.09 0.13 Allowed Glycine 0 C--N 1.337 0.59 0 CA-C-N 116.06 -0.518 . . . . 0.45000000000000001 111.923 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.631 ' CB ' HD12 ' A' ' 20' ' ' ILE . 15.6 p -78.98 -128.79 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 111.446 0.165 . . . . 1.04 111.446 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 46.1 p . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.497 -0.763 . . . . 1.71 111.191 -179.537 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 120.484 0.183 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.672 ' HA ' HG23 ' A' ' 5' ' ' VAL . 87.7 Cg_endo -81.39 43.73 1.59 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.909 2.406 . . . . 0.0 113.17 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.555 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.2 OUTLIER -96.49 -59.65 0.17 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.795 178.797 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.555 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 63.4 Cg_endo -93.84 10.37 2.03 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.997 2.465 . . . . 0.0 113.219 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.672 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -96.04 100.02 10.17 Favored 'Isoleucine or valine' 0 C--N 1.342 0.24 0 CA-C-O 120.986 0.422 . . . . 0.0 110.616 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.557 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 26.3 p30 -90.27 166.71 13.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.986 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.401 ' HB2' ' HB3' ' A' ' 12' ' ' ASP . 7.1 p -179.73 174.22 0.96 Allowed 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.385 0.612 . . . . 0.0 112.188 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -120.71 -46.2 2.37 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.344 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.5 p -113.42 -176.89 3.0 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.404 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.82 -63.22 1.38 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.49 4.2 2.52 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.401 ' HB3' ' HB2' ' A' ' 7' ' ' CYS . 3.5 m-20 -76.86 -29.35 55.81 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.535 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -92.2 23.03 4.04 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.139 178.209 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.1 p -51.21 -27.39 6.16 Favored 'Isoleucine or valine' 0 C--N 1.345 0.378 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.481 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -56.48 -25.8 52.18 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.445 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.56 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.5 t -84.08 -44.42 14.08 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.676 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.82 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -172.09 -169.2 34.57 Favored Glycine 0 C--N 1.337 0.608 0 C-N-CA 120.497 -0.858 . . . . 0.0 113.273 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.9 mt -91.09 82.39 5.56 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.194 0.521 . . . . 0.0 111.007 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.7 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 101.29 82.43 1.66 Allowed Glycine 0 C--N 1.324 -0.118 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.721 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.82 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -111.66 142.37 24.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -177.863 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 1.9 p -83.49 130.36 35.01 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.1 t -98.56 127.16 44.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.005 0.431 . . . . 0.0 111.891 -178.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.598 ' O ' ' N ' ' A' ' 25' ' ' GLY . 1.3 pttt -95.11 -155.73 0.48 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -53.64 64.08 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 O-C-N 123.956 0.785 . . . . 0.0 112.343 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 79.32 16.11 78.86 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.541 -0.754 . . . . 0.0 113.195 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 50.7 m-85 -143.64 -177.6 5.49 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 117.574 0.687 . . . . 0.0 112.403 -179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.672 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -83.66 140.1 32.38 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.543 -179.323 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.424 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 14.5 mt-30 -90.55 -46.61 8.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.453 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 167.48 104.52 0.18 Allowed Glycine 0 C--N 1.335 0.495 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.557 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.716 ' CB ' HD12 ' A' ' 20' ' ' ILE . 14.9 p -80.71 -128.2 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 111.415 0.154 . . . . 0.0 111.415 -179.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.9 p . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.167 -0.92 . . . . 0.0 111.353 -179.575 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 120.539 0.209 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.629 ' HA ' HG23 ' A' ' 5' ' ' VAL . 97.9 Cg_endo -82.62 42.27 1.27 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.938 2.426 . . . . 0.0 113.027 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.788 ' HB2' ' HD3' ' A' ' 4' ' ' PRO . 34.6 m-85 -96.03 -57.47 0.2 Allowed Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.896 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.788 ' HD3' ' HB2' ' A' ' 3' ' ' TYR . 63.7 Cg_endo -96.95 13.21 0.96 Allowed 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.021 2.481 . . . . 0.0 113.091 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.629 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.1 OUTLIER -95.15 103.3 14.54 Favored 'Isoleucine or valine' 0 C--N 1.34 0.171 0 CA-C-O 121.066 0.46 . . . . 0.0 110.674 -179.849 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.579 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 1.6 p-10 -90.14 163.51 14.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.949 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.4 p -178.5 172.78 1.42 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.37 0.605 . . . . 0.0 112.201 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.0 mttm -118.39 -46.88 2.57 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.237 178.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 p -112.27 -177.73 3.24 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.33 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -61.39 -58.23 9.05 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.5 mmt85 -72.78 2.45 6.66 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.2 -27.64 53.61 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.507 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.94 23.73 3.56 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.141 178.123 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.3 p -50.8 -28.77 6.47 Favored 'Isoleucine or valine' 0 C--N 1.346 0.446 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.363 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -55.35 -26.59 41.94 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.733 0.302 . . . . 0.0 110.592 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.457 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.2 t -84.07 -44.64 13.88 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.696 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.826 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -173.33 -170.01 36.4 Favored Glycine 0 C--N 1.337 0.619 0 C-N-CA 120.453 -0.879 . . . . 0.0 113.419 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.3 mt -91.13 81.49 5.57 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.162 0.506 . . . . 0.0 110.878 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.69 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 103.76 82.26 1.6 Allowed Glycine 0 N--CA 1.457 0.07 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.361 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.826 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.2 mm -111.26 147.1 15.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -177.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 28.7 m -87.58 129.41 35.11 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.9 t -98.46 129.47 45.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.065 0.46 . . . . 0.0 111.89 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.577 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.1 OUTLIER -94.9 -156.92 0.53 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.024 178.385 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.5 t30 -57.01 66.02 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.402 0.62 . . . . 0.0 111.678 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 79.83 18.53 72.54 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 115.322 -0.854 . . . . 0.0 113.066 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.579 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 54.0 m-85 -145.2 -175.28 4.64 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 117.516 0.658 . . . . 0.0 112.705 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.707 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -88.39 137.54 32.23 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.021 -179.008 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.448 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 9.8 mt-30 -90.17 -45.38 9.14 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.689 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.409 ' HA2' ' HG3' ' A' ' 2' ' ' PRO . . . 167.13 105.22 0.18 Allowed Glycine 0 C--N 1.336 0.537 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.749 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.791 ' CB ' HD12 ' A' ' 20' ' ' ILE . 10.1 p -79.63 -126.45 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.4 p . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.213 -0.898 . . . . 0.0 111.224 -179.57 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 12.2 t . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 120.425 0.155 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.803 ' HA ' HG23 ' A' ' 5' ' ' VAL . 85.1 Cg_endo -81.4 41.62 1.18 Allowed 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.967 2.445 . . . . 0.0 113.372 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.535 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.9 OUTLIER -95.71 -59.23 0.19 Allowed Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.876 178.851 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.535 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 69.7 Cg_endo -92.44 8.08 2.91 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.908 2.405 . . . . 0.0 113.255 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.803 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -99.58 96.56 5.04 Favored 'Isoleucine or valine' 0 C--N 1.342 0.259 0 CA-C-O 121.082 0.467 . . . . 0.0 110.382 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.627 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 8.0 p-10 -90.32 166.77 13.12 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.339 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.6 p -176.19 166.2 2.87 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.246 0.546 . . . . 0.0 112.27 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -109.71 -40.23 4.88 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.241 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.7 p -123.02 -177.39 3.66 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.037 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -60.76 -59.46 5.36 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -0.25 7.11 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -76.77 -30.1 56.37 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.617 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -89.63 21.85 3.29 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.972 178.042 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.2 p -49.48 -25.14 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.462 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.553 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 20.9 mmt -52.46 -28.64 20.99 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.58 ' SG ' HG21 ' A' ' 5' ' ' VAL . 0.7 OUTLIER -83.83 -45.05 13.7 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.974 179.337 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.8 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -173.12 -166.2 31.19 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.383 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.7 mt -91.48 81.24 5.39 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.078 0.466 . . . . 0.0 110.969 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.648 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 105.26 81.35 1.46 Allowed Glycine 0 N--CA 1.457 0.082 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.613 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.8 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -112.13 122.9 67.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.0 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 45.8 m -61.24 134.8 57.37 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.9 t -103.32 126.44 50.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.925 0.393 . . . . 0.0 111.559 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.583 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.1 OUTLIER -95.38 -157.5 0.58 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.225 178.735 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -55.08 64.87 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.404 0.682 . . . . 0.0 112.121 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 78.48 18.68 75.4 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.816 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.627 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 38.0 m-85 -144.14 179.62 7.1 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 117.354 0.577 . . . . 0.0 112.5 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.606 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -78.44 144.85 35.44 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.194 -179.729 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.462 ' HB2' ' O ' ' A' ' 21' ' ' SER . 10.7 mt-30 -90.34 -40.14 12.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.378 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -170.27 96.72 0.12 Allowed Glycine 0 C--N 1.337 0.606 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.949 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -40.24 90.31 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 123.809 0.844 . . . . 0.0 111.889 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.725 HG22 HD12 ' A' ' 20' ' ' ILE . 2.6 t . . . . . 0 C--O 1.25 1.089 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.129 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.43 ' HB ' ' HD3' ' A' ' 2' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.77 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.633 ' HA ' HG23 ' A' ' 5' ' ' VAL . 96.5 Cg_endo -82.83 43.33 1.46 Allowed 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 122.66 2.24 . . . . 0.0 113.166 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.562 ' HB2' ' HD3' ' A' ' 4' ' ' PRO . 2.1 m-85 -96.31 -59.38 0.17 Allowed Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.84 178.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.562 ' HD3' ' HB2' ' A' ' 3' ' ' TYR . 58.0 Cg_endo -94.36 11.06 1.78 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.062 2.508 . . . . 0.0 113.314 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.633 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.1 OUTLIER -94.9 101.99 13.1 Favored 'Isoleucine or valine' 0 C--N 1.341 0.223 0 CA-C-O 121.078 0.466 . . . . 0.0 110.579 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.542 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 6.4 p30 -90.15 165.15 14.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.837 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.9 p -176.73 175.64 1.63 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.306 0.574 . . . . 0.0 112.261 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.7 mttm -121.26 -49.11 2.18 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.448 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.502 HG22 ' H ' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -111.88 -176.69 2.99 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.269 178.632 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.502 ' H ' HG22 ' A' ' 9' ' ' THR . 0.5 OUTLIER -58.88 -64.26 1.0 Allowed 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.359 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.25 5.37 1.73 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.31 -31.28 58.09 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.552 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.38 22.02 4.16 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.376 178.622 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.7 p -51.61 -27.12 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.434 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 65.5 mtm -57.56 -25.04 59.37 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.646 0.26 . . . . 0.0 110.38 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.503 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.4 t -84.09 -44.05 14.44 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.523 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.828 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -171.04 -168.38 32.68 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.431 -0.89 . . . . 0.0 113.402 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.02 82.39 5.59 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.186 0.517 . . . . 0.0 111.029 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.677 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 99.05 82.79 1.69 Allowed Glycine 0 N--CA 1.457 0.061 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.843 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.828 HD11 ' C ' ' A' ' 17' ' ' GLY . 0.9 OUTLIER -111.13 139.11 36.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -177.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.4 m -82.32 128.65 34.42 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.9 t -94.91 128.3 41.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.938 0.399 . . . . 0.0 111.325 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.617 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -99.46 -154.71 0.48 Allowed 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.319 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -50.14 63.83 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.096 0.959 . . . . 0.0 113.031 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.617 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 76.63 14.4 82.52 Favored Glycine 0 CA--C 1.522 0.508 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.387 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 47.0 m-85 -142.71 -177.34 5.26 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 117.533 0.667 . . . . 0.0 112.645 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.667 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -82.85 141.05 32.56 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.467 -179.401 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.443 ' CG ' ' HB3' ' A' ' 23' ' ' LYS . 34.7 mt-30 -90.63 -51.24 5.49 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.569 179.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.449 ' HA2' ' HG3' ' A' ' 2' ' ' PRO . . . 173.48 102.41 0.16 Allowed Glycine 0 C--N 1.335 0.489 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.784 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.643 ' CB ' HD12 ' A' ' 20' ' ' ILE . 15.5 p -80.93 -127.66 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 111.402 0.149 . . . . 0.0 111.402 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 16.1 p . . . . . 0 C--O 1.253 1.254 0 CA-C-O 118.548 -0.739 . . . . 0.0 110.994 -179.56 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 120.564 0.221 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.632 ' HA ' HG23 ' A' ' 5' ' ' VAL . 94.7 Cg_endo -83.1 42.48 1.29 Allowed 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.922 2.415 . . . . 0.0 113.359 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.537 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.2 OUTLIER -96.66 -59.37 0.17 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.761 178.775 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.537 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 62.0 Cg_endo -93.48 10.67 2.09 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.975 2.45 . . . . 0.0 113.233 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.632 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.1 OUTLIER -94.76 102.06 13.19 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 CA-C-O 121.125 0.488 . . . . 0.0 110.508 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.551 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 4.3 p-10 -90.1 164.08 14.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.055 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.2 p -176.83 174.45 1.77 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.391 0.615 . . . . 0.0 112.127 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -119.71 -46.56 2.45 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.213 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.0 p -114.26 -177.16 3.06 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.243 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.94 -61.0 2.94 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.83 1.73 5.12 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -76.74 -28.45 55.77 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.513 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -92.62 22.92 4.34 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.153 178.104 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.1 p -51.14 -28.68 7.32 Favored 'Isoleucine or valine' 0 C--N 1.345 0.401 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.377 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 23.0 mtt -55.29 -25.98 37.46 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.489 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.492 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.5 t -84.1 -45.09 13.38 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.452 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.83 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -171.35 -169.7 34.58 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.402 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.7 mp -91.28 82.26 5.46 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.219 0.533 . . . . 0.0 110.835 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.689 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 101.61 82.41 1.65 Allowed Glycine 0 C--N 1.324 -0.097 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.514 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.83 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -111.23 146.63 15.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -177.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 67.0 m -87.8 129.63 35.12 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.5 t -96.53 127.71 42.77 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.074 0.464 . . . . 0.0 111.886 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.594 ' O ' ' N ' ' A' ' 25' ' ' GLY . 1.0 OUTLIER -95.05 -155.73 0.48 Allowed 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.364 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -54.97 65.21 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.375 0.67 . . . . 0.0 112.045 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 77.8 17.2 79.04 Favored Glycine 0 CA--C 1.521 0.444 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.95 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 41.1 m-85 -142.99 -176.67 5.0 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 117.392 0.596 . . . . 0.0 112.517 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.663 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -86.02 138.74 31.74 Favored 'General case' 0 N--CA 1.461 0.089 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.738 -179.284 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.458 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 16.2 mt-30 -89.94 -46.65 8.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.694 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 167.97 104.44 0.18 Allowed Glycine 0 C--N 1.336 0.543 0 N-CA-C 111.566 -0.614 . . . . 0.0 111.566 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.736 ' CB ' HD12 ' A' ' 20' ' ' ILE . 13.9 p -81.15 -127.96 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 121.971 0.108 . . . . 0.0 111.252 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.567 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 120.543 0.211 . . . . 0.0 111.283 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.683 ' HA ' HG23 ' A' ' 5' ' ' VAL . 96.7 Cg_endo -82.65 41.12 1.05 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.008 2.472 . . . . 0.0 113.36 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.555 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.2 OUTLIER -93.73 -59.72 0.2 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.854 178.811 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.555 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 64.9 Cg_endo -94.69 12.05 1.59 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.057 2.504 . . . . 0.0 113.319 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.683 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -97.13 100.91 11.55 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 CA-C-O 120.994 0.426 . . . . 0.0 110.735 -179.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.567 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 1.0 OUTLIER -90.37 165.25 13.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.789 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.402 ' HB2' ' CB ' ' A' ' 12' ' ' ASP . 7.9 p -178.79 173.86 1.2 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.363 0.602 . . . . 0.0 112.222 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.73 -48.59 2.37 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 114.966 -1.015 . . . . 0.0 109.152 178.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.543 HG22 ' H ' ' A' ' 10' ' ' ASP . 0.5 OUTLIER -112.62 -178.36 3.38 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.899 178.344 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.543 ' H ' HG22 ' A' ' 9' ' ' THR . 42.9 m-20 -58.92 -60.88 3.16 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.3 0.57 4.79 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.402 ' CB ' ' HB2' ' A' ' 7' ' ' CYS . 0.5 OUTLIER -75.38 -30.52 60.18 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.056 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.493 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.21 23.29 3.38 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.536 178.563 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.6 p -51.3 -27.63 6.79 Favored 'Isoleucine or valine' 0 C--N 1.345 0.384 0 CA-C-N 116.68 -0.237 . . . . 0.0 111.384 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 10.3 mmt -56.06 -25.73 46.36 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.404 178.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.567 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.4 t -84.09 -44.91 13.58 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.624 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.827 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -172.73 -169.12 34.96 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.434 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 mt -91.23 82.98 5.47 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.192 0.52 . . . . 0.0 110.84 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.689 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 101.27 82.68 1.68 Allowed Glycine 0 C--N 1.325 -0.061 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.41 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.827 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.1 mm -111.18 148.0 14.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -177.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 18.3 m -89.61 129.93 35.99 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.8 t -97.33 129.75 44.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.076 0.465 . . . . 0.0 111.987 -178.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.575 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -95.18 -157.41 0.57 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.34 -0.846 . . . . 0.0 108.994 178.352 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -56.69 65.62 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.233 0.613 . . . . 0.0 111.83 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 80.99 16.73 74.11 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-N 115.325 -0.852 . . . . 0.0 113.123 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 62.5 m-85 -144.99 -174.1 4.27 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 117.487 0.644 . . . . 0.0 112.57 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.694 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -86.86 139.05 31.05 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.79 -179.178 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.457 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 8.6 mt-30 -90.56 -44.15 9.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.479 178.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 164.99 105.61 0.19 Allowed Glycine 0 C--N 1.336 0.581 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.565 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.758 ' CB ' HD12 ' A' ' 20' ' ' ILE . 13.3 p -81.46 -127.82 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 111.42 0.155 . . . . 0.0 111.42 -179.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.3 p . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.479 -179.564 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 11.5 t . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 120.482 0.182 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.682 ' HA ' HG23 ' A' ' 5' ' ' VAL . 97.1 Cg_endo -83.14 40.52 0.96 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.017 2.478 . . . . 0.0 113.275 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.54 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.5 OUTLIER -95.07 -59.4 0.19 Allowed Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.926 178.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.54 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 67.3 Cg_endo -92.87 9.2 2.53 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.892 2.395 . . . . 0.0 113.249 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.682 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -95.24 101.24 12.24 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 CA-C-O 120.964 0.411 . . . . 0.0 110.482 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.545 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 27.5 p-10 -90.1 165.66 13.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.13 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.403 ' HB2' ' HB3' ' A' ' 12' ' ' ASP . 7.4 p -177.53 174.61 1.52 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.382 0.61 . . . . 0.0 112.324 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.04 -48.28 2.35 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.367 178.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.6 p -113.47 -175.66 2.72 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.176 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.27 -62.43 1.88 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.14 4.57 2.65 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.403 ' HB3' ' HB2' ' A' ' 7' ' ' CYS . 0.7 OUTLIER -77.02 -29.61 55.43 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.581 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.511 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.41 22.91 3.66 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.102 178.305 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.0 p -51.64 -26.52 6.75 Favored 'Isoleucine or valine' 0 C--N 1.345 0.391 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.313 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -25.93 60.48 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.777 0.322 . . . . 0.0 110.277 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.519 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.5 t -84.18 -44.91 13.49 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.557 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.824 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -170.58 -169.69 33.96 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.182 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 35.1 mt -91.02 81.89 5.61 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.111 0.482 . . . . 0.0 110.976 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.676 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 101.24 82.11 1.64 Allowed Glycine 0 N--CA 1.458 0.12 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.655 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.824 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -110.71 145.93 16.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -178.126 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.417 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 19.9 m -87.06 129.07 35.06 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.8 t -95.32 127.76 41.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.072 0.463 . . . . 0.0 111.99 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.62 ' O ' ' N ' ' A' ' 25' ' ' GLY . 2.6 ptmt -95.1 -155.42 0.47 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -54.28 65.02 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.286 0.634 . . . . 0.0 111.928 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.62 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 76.88 18.24 79.03 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.842 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 54.1 m-85 -143.93 -176.58 5.05 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 117.277 0.538 . . . . 0.0 112.357 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.665 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -85.11 140.34 31.03 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.74 -179.272 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.425 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 15.7 mt-30 -90.53 -47.9 7.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.489 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 168.72 104.07 0.17 Allowed Glycine 0 C--N 1.335 0.523 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.417 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.703 ' CB ' HD12 ' A' ' 20' ' ' ILE . 15.6 p -80.77 -128.43 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 111.428 0.158 . . . . 0.0 111.428 -178.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.186 -0.912 . . . . 0.0 110.767 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 120.294 0.093 . . . . 0.0 110.924 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.697 ' HA ' HG23 ' A' ' 5' ' ' VAL . 96.0 Cg_endo -82.6 40.47 0.97 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.9 2.4 . . . . 0.0 113.352 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.533 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -94.24 -58.35 0.21 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.961 178.763 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.533 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 69.3 Cg_endo -94.38 10.87 1.8 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.035 2.49 . . . . 0.0 113.231 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.697 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -97.97 98.74 7.67 Favored 'Isoleucine or valine' 0 C--N 1.34 0.163 0 CA-C-O 121.057 0.456 . . . . 0.0 110.667 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.535 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 12.0 p-10 -90.33 165.31 13.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.691 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.2 p -177.48 174.58 1.54 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.432 0.634 . . . . 0.0 112.559 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.7 mtpm? -119.71 -47.86 2.4 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.257 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.75 -177.53 3.15 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.01 178.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.84 -58.15 9.65 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.83 0.52 7.02 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.13 -32.35 59.09 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.537 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -90.92 20.35 4.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.384 178.397 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.3 p -51.3 -27.69 6.83 Favored 'Isoleucine or valine' 0 C--N 1.344 0.356 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.101 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.06 -25.79 33.19 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.317 178.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.59 ' HB2' HG11 ' A' ' 5' ' ' VAL . 5.1 t -83.99 -43.75 14.86 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.57 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.838 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -171.24 -169.88 34.72 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.552 -0.832 . . . . 0.0 113.212 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.415 ' N ' HD22 ' A' ' 18' ' ' LEU . 3.8 mm? -91.13 82.26 5.54 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.121 0.486 . . . . 0.0 110.658 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.701 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 101.76 82.12 1.63 Allowed Glycine 0 C--N 1.323 -0.178 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.554 -179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.838 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -110.83 146.54 15.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.075 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.1 m -88.6 129.45 35.49 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.3 t -97.45 126.93 43.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.916 0.389 . . . . 0.0 111.589 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.624 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -99.15 -154.49 0.47 Allowed 'General case' 0 C--O 1.225 -0.209 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.434 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -50.82 64.27 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.729 0.812 . . . . 0.0 112.776 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 76.64 15.15 81.8 Favored Glycine 0 CA--C 1.522 0.511 0 CA-C-N 115.714 -0.675 . . . . 0.0 113.397 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 54.8 m-85 -142.97 -176.18 4.8 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 117.486 0.643 . . . . 0.0 112.403 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.656 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -83.64 140.55 32.12 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.639 -179.35 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.482 ' CG ' ' HB3' ' A' ' 23' ' ' LYS . 16.3 mt-30 -90.81 -44.73 9.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.456 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 164.61 105.46 0.19 Allowed Glycine 0 C--N 1.336 0.528 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.522 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.722 ' CB ' HD12 ' A' ' 20' ' ' ILE . 16.9 p -81.75 -128.78 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 111.464 0.172 . . . . 0.0 111.464 -178.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 8.1 p . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.143 -0.932 . . . . 0.0 111.385 -179.533 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 120.472 0.177 . . . . 0.0 111.126 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.605 ' HA ' HG23 ' A' ' 5' ' ' VAL . 97.4 Cg_endo -82.19 43.71 1.56 Allowed 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.837 2.358 . . . . 0.0 113.168 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.608 ' HB2' ' HD3' ' A' ' 4' ' ' PRO . 3.0 m-85 -96.56 -59.44 0.17 Allowed Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.771 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.608 ' HD3' ' HB2' ' A' ' 3' ' ' TYR . 57.5 Cg_endo -95.05 12.64 1.44 Allowed 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.94 2.427 . . . . 0.0 113.13 179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.605 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.1 OUTLIER -94.88 102.84 14.03 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 CA-C-O 121.12 0.486 . . . . 0.0 110.548 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.578 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 7.6 p30 -90.17 164.77 14.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.012 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.0 p -178.07 174.69 1.34 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.467 0.651 . . . . 0.0 112.156 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -120.75 -44.73 2.42 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.669 178.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.499 HG22 ' H ' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -116.17 -177.65 3.22 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.026 178.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.499 ' H ' HG22 ' A' ' 9' ' ' THR . 0.9 OUTLIER -58.59 -63.94 1.1 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -179.453 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.1 1.96 3.15 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.12 -29.54 60.59 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.533 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -92.17 23.71 3.68 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.397 178.636 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.7 p -50.87 -27.44 5.19 Favored 'Isoleucine or valine' 0 C--N 1.343 0.323 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.552 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.51 -25.81 52.62 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.393 178.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.515 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.6 t -84.26 -43.88 14.42 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.726 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.84 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -173.25 -169.3 35.54 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.324 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.12 81.78 5.56 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.221 0.534 . . . . 0.0 110.934 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.725 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 102.69 82.87 1.68 Allowed Glycine 0 N--CA 1.458 0.161 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.43 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.84 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -112.47 141.88 26.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -177.793 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 0.9 OUTLIER -83.47 131.79 34.99 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 177.908 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.0 t -99.08 129.37 45.34 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.163 0.506 . . . . 0.0 112.021 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.608 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -94.94 -156.05 0.49 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.189 178.484 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -55.41 65.23 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 O-C-N 123.674 0.609 . . . . 0.0 111.807 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.608 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 78.76 18.24 75.72 Favored Glycine 0 CA--C 1.52 0.363 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.984 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.578 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 57.9 m-85 -144.74 -175.53 4.7 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 117.383 0.591 . . . . 0.0 112.43 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.688 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -85.72 138.32 32.2 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.755 -179.164 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.438 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 10.3 mt-30 -90.27 -45.48 9.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.536 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.409 ' HA2' ' HG3' ' A' ' 2' ' ' PRO . . . 166.56 104.65 0.18 Allowed Glycine 0 C--N 1.335 0.484 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.544 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.747 ' CB ' HD12 ' A' ' 20' ' ' ILE . 13.6 p -80.28 -127.53 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 111.469 0.174 . . . . 0.0 111.469 -179.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.4 p . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.456 -0.783 . . . . 0.0 111.044 -179.455 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 17.5 p . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 120.335 0.112 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.686 ' HA ' HG23 ' A' ' 5' ' ' VAL . 92.2 Cg_endo -82.2 36.57 0.63 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.924 2.416 . . . . 0.0 113.363 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.772 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 16.1 t80 -91.35 -55.99 0.26 Allowed Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.177 178.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.772 ' HD3' ' HB3' ' A' ' 3' ' ' TYR . 86.5 Cg_endo -96.24 12.2 1.22 Allowed 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 123.002 2.468 . . . . 0.0 113.165 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.686 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -98.7 101.36 12.03 Favored 'Isoleucine or valine' 0 C--N 1.34 0.152 0 CA-C-O 121.049 0.452 . . . . 0.0 110.724 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.541 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 5.3 p30 -90.55 164.51 14.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.008 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.9 p -176.89 164.31 2.33 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.389 0.614 . . . . 0.0 112.233 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -111.33 -31.27 7.11 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.572 178.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.466 ' H ' ' HB2' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -131.66 -179.17 5.22 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.349 178.532 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.95 -62.03 2.19 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.8 -1.46 7.18 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.878 0.696 . . . . 0.0 112.878 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.466 ' HB2' ' H ' ' A' ' 9' ' ' THR . 2.4 m-20 -74.99 -31.7 61.49 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.101 0.477 . . . . 0.0 109.849 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.506 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -88.09 23.46 2.1 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.379 178.306 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.3 p -51.31 -28.0 7.24 Favored 'Isoleucine or valine' 0 C--N 1.345 0.397 0 CA-C-N 116.752 -0.204 . . . . 0.0 111.292 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 27.2 mmm -55.23 -26.01 36.88 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.714 0.293 . . . . 0.0 110.311 178.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.575 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.4 t -83.95 -45.14 13.48 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.642 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.837 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -172.86 -169.15 35.09 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.436 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.7 mt -91.12 83.36 5.56 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.059 0.457 . . . . 0.0 110.816 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.682 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 101.19 82.62 1.68 Allowed Glycine 0 C--N 1.322 -0.202 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.365 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.837 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.2 mm -110.96 148.13 14.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -177.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.25 133.24 34.09 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.0 t -103.34 127.68 50.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.036 0.445 . . . . 0.0 112.045 -178.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.587 ' O ' ' N ' ' A' ' 25' ' ' GLY . 8.4 pttt -94.81 -156.07 0.49 Allowed 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.56 64.71 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.299 0.64 . . . . 0.0 112.259 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 80.2 17.43 74.18 Favored Glycine 0 CA--C 1.522 0.49 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.951 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 50.0 m-85 -143.74 -176.9 5.16 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 117.39 0.595 . . . . 0.0 112.476 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.718 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -85.03 138.37 32.49 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.69 -179.286 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.456 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 8.7 mt-30 -90.65 -40.21 12.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.528 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 161.07 107.1 0.22 Allowed Glycine 0 C--N 1.335 0.523 0 N-CA-C 111.562 -0.615 . . . . 0.0 111.562 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.785 ' CB ' HD12 ' A' ' 20' ' ' ILE . 12.0 p -82.51 -127.39 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 111.566 0.21 . . . . 0.0 111.566 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 12.0 p . . . . . 0 C--O 1.251 1.166 0 CA-C-O 118.584 -0.722 . . . . 0.0 111.397 -179.554 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.735 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.632 ' HA ' HG23 ' A' ' 5' ' ' VAL . 98.3 Cg_endo -83.14 42.74 1.33 Allowed 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.739 2.293 . . . . 0.0 113.248 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.551 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.8 OUTLIER -95.91 -59.29 0.18 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.778 178.857 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.551 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 61.6 Cg_endo -94.11 11.18 1.84 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.124 2.549 . . . . 0.0 113.296 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.632 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.1 OUTLIER -94.9 102.76 13.94 Favored 'Isoleucine or valine' 0 C--N 1.34 0.193 0 CA-C-O 121.052 0.453 . . . . 0.0 110.529 -179.89 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 26.6 p30 -90.01 164.99 14.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.076 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.46 ' HB2' ' HB3' ' A' ' 12' ' ' ASP . 7.3 p -178.02 174.59 1.37 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.333 0.587 . . . . 0.0 111.927 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.4 mmtt -118.95 -48.64 2.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.217 178.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.0 p -112.68 -175.87 2.78 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.217 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.05 -61.94 2.24 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.5 mtt85 -71.48 3.73 3.61 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -179.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.46 ' HB3' ' HB2' ' A' ' 7' ' ' CYS . 0.6 OUTLIER -76.46 -29.37 56.89 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.6 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.491 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.19 23.15 3.42 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.332 178.475 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 p -50.91 -27.62 5.46 Favored 'Isoleucine or valine' 0 C--N 1.344 0.335 0 CA-C-N 116.737 -0.211 . . . . 0.0 111.209 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 41.2 mtt -56.72 -25.52 54.67 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.755 0.312 . . . . 0.0 110.483 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.535 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.6 t -84.08 -44.66 13.85 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.481 179.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.825 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -171.39 -169.3 34.15 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.415 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.13 82.08 5.55 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.246 0.546 . . . . 0.0 110.999 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.688 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 101.03 82.29 1.65 Allowed Glycine 0 C--O 1.23 -0.095 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.627 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.825 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -110.68 149.53 13.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -178.066 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 42.0 m -90.7 129.86 36.76 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.9 t -97.31 128.61 44.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.091 0.472 . . . . 0.0 112.156 -178.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.594 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -94.93 -155.48 0.47 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.484 -0.78 . . . . 0.0 108.963 178.374 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -55.3 65.13 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.243 0.617 . . . . 0.0 111.913 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 78.18 18.51 76.31 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.932 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 58.9 m-85 -144.37 -175.93 4.83 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 117.382 0.591 . . . . 0.0 112.427 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.66 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -86.14 139.3 31.22 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.76 -179.191 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.443 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 11.0 mt-30 -90.58 -45.58 8.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.538 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.411 ' HA2' ' HG3' ' A' ' 2' ' ' PRO . . . 166.98 104.79 0.18 Allowed Glycine 0 C--N 1.336 0.549 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.611 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.723 ' CB ' HD12 ' A' ' 20' ' ' ILE . 15.9 p -81.95 -128.51 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 111.452 0.167 . . . . 0.0 111.452 -179.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.487 -0.768 . . . . 0.0 110.917 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 120.474 0.178 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.684 ' HA ' HG23 ' A' ' 5' ' ' VAL . 82.1 Cg_endo -84.82 42.55 1.15 Allowed 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.711 2.274 . . . . 0.0 113.204 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.535 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -97.28 -59.19 0.16 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.816 178.837 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.535 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 66.2 Cg_endo -92.99 9.43 2.45 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.911 2.407 . . . . 0.0 113.338 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.684 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -95.54 101.76 12.79 Favored 'Isoleucine or valine' 0 C--N 1.342 0.271 0 CA-C-O 120.99 0.424 . . . . 0.0 110.526 179.876 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.567 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 18.8 p30 -90.0 165.14 14.22 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.161 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.4 p -178.28 170.65 1.73 Allowed 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.298 0.57 . . . . 0.0 112.193 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -115.85 -42.88 3.04 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.386 178.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.06 -178.18 3.44 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.163 178.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.7 -58.59 7.82 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.07 0.01 6.86 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -77.09 -30.35 55.33 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.524 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -89.79 21.21 3.66 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.246 178.079 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.9 p -51.56 -28.42 8.65 Favored 'Isoleucine or valine' 0 C--N 1.346 0.456 0 CA-C-N 116.758 -0.201 . . . . 0.0 111.247 179.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.6 mtp -56.96 -25.4 57.91 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.406 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.531 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.5 t -84.0 -44.8 13.79 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.587 179.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.841 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -169.46 -169.31 32.6 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.583 -0.818 . . . . 0.0 113.37 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 12.5 mt -91.27 82.06 5.48 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.105 0.478 . . . . 0.0 110.867 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.667 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 98.9 82.43 1.66 Allowed Glycine 0 CA--C 1.515 0.051 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.656 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.841 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -109.82 145.45 16.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -177.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 14.9 m -85.53 129.14 34.89 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.0 t -95.74 128.96 43.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.049 0.452 . . . . 0.0 111.931 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.588 ' O ' ' N ' ' A' ' 25' ' ' GLY . 3.9 ptmt -95.29 -157.01 0.54 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.471 -0.786 . . . . 0.0 108.98 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.0 65.76 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 O-C-N 123.696 0.623 . . . . 0.0 111.785 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 78.74 18.12 75.99 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.313 -0.858 . . . . 0.0 113.016 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 51.2 m-85 -144.52 -176.26 4.97 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 117.451 0.625 . . . . 0.0 112.667 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.631 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -86.74 140.94 29.26 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.784 -179.173 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.436 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 14.5 mt-30 -90.5 -50.15 6.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.537 179.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 171.78 103.17 0.16 Allowed Glycine 0 C--N 1.335 0.489 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.694 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.637 ' CB ' HD12 ' A' ' 20' ' ' ILE . 19.9 p -81.86 -128.7 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 111.396 0.147 . . . . 0.0 111.396 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.7 p . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.253 -0.879 . . . . 0.0 111.374 -179.608 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 60.3 p . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 120.318 0.104 . . . . 0.0 111.048 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.697 ' HB3' ' HB3' ' A' ' 27' ' ' CYS . 15.3 Cg_exo -69.17 62.02 1.43 Allowed 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.122 2.548 . . . . 0.0 112.797 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.57 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.8 OUTLIER -116.13 -60.83 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.052 178.552 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.57 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 79.4 Cg_endo -95.08 8.1 1.99 Allowed 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.975 2.45 . . . . 0.0 112.998 179.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.678 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -94.64 98.02 7.57 Favored 'Isoleucine or valine' 0 C--N 1.345 0.37 0 CA-C-O 120.931 0.396 . . . . 0.0 110.348 179.911 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.573 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 5.0 p30 -90.19 164.37 14.45 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.296 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.0 p -176.72 174.72 1.78 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.261 0.553 . . . . 0.0 111.896 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -119.97 -47.04 2.41 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.377 178.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.73 -177.72 3.21 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.138 178.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -60.63 -61.06 2.87 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.67 4.77 2.91 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -77.69 -28.29 50.97 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.503 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.9 22.24 4.38 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.041 178.092 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.6 p -51.12 -29.31 8.05 Favored 'Isoleucine or valine' 0 C--N 1.347 0.474 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.328 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 19.0 mtm -55.98 -25.88 45.92 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.721 0.296 . . . . 0.0 110.471 178.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.0 t -83.87 -45.35 13.33 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.541 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.831 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -170.23 -170.23 34.33 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 120.616 -0.802 . . . . 0.0 113.303 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.7 mp -91.11 82.17 5.55 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.234 0.54 . . . . 0.0 110.924 179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.66 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 100.58 82.22 1.65 Allowed Glycine 0 C--N 1.325 -0.08 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.645 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.831 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -110.75 145.12 17.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.27 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.418 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 70.4 m -86.33 129.38 34.87 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.9 t -96.73 126.68 42.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.063 0.459 . . . . 0.0 112.035 -178.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.597 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.1 OUTLIER -94.7 -154.91 0.44 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.329 -0.85 . . . . 0.0 108.768 178.285 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -54.95 65.17 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.453 0.701 . . . . 0.0 112.095 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 75.8 19.89 78.53 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.574 -179.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 39.5 m-85 -143.77 179.79 6.94 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -179.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.697 ' HB3' ' HB3' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -84.34 143.36 29.54 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.813 -179.131 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' A' ' 21' ' ' SER . 16.6 mt-30 -90.87 -56.0 3.34 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.752 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 176.99 100.73 0.14 Allowed Glycine 0 C--N 1.334 0.45 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.207 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.651 ' CB ' HD12 ' A' ' 20' ' ' ILE . 15.5 p -79.58 -127.21 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 111.526 0.195 . . . . 0.0 111.526 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.1 p . . . . . 0 C--O 1.251 1.182 0 CA-C-O 118.612 -0.709 . . . . 0.0 111.393 -179.528 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 72.1 m . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 120.378 0.132 . . . . 0.0 110.984 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.683 ' HA ' HG23 ' A' ' 5' ' ' VAL . 87.8 Cg_endo -80.83 44.52 1.77 Allowed 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.938 2.425 . . . . 0.0 112.97 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.523 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -97.52 -59.15 0.16 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.86 178.78 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.523 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 67.7 Cg_endo -93.21 9.81 2.32 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.969 2.446 . . . . 0.0 113.052 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.683 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -96.74 99.0 8.22 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 CA-C-O 121.074 0.464 . . . . 0.0 110.446 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.565 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 1.0 OUTLIER -90.21 166.35 13.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.95 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.5 p -177.85 174.41 1.45 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.275 0.559 . . . . 0.0 112.092 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.7 mmtm -119.99 -47.14 2.4 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.197 178.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.9 p -113.11 -176.89 3.0 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.253 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.14 -62.64 1.72 Allowed 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.92 4.26 2.73 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -179.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -77.26 -28.89 53.67 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 178.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.53 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.48 23.25 3.54 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.088 178.053 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.9 p -51.62 -28.2 8.62 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.417 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -26.09 45.17 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.743 0.306 . . . . 0.0 110.453 178.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.518 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.3 t -84.03 -45.25 13.28 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.663 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.831 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -170.77 -169.62 34.04 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.333 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.0 mt -91.16 82.72 5.51 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.167 0.508 . . . . 0.0 110.903 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.655 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 100.45 82.27 1.65 Allowed Glycine 0 C--N 1.324 -0.116 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.634 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.831 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -111.25 141.97 25.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -178.175 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.417 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 11.4 m -83.77 129.01 34.94 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.0 t -95.13 127.43 41.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.128 0.49 . . . . 0.0 112.09 -178.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.596 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -95.48 -156.74 0.53 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.039 178.37 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -54.07 64.69 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 O-C-N 123.916 0.76 . . . . 0.0 112.336 -179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 78.39 15.55 80.77 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.549 -0.751 . . . . 0.0 112.922 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 44.7 m-85 -143.16 -177.99 5.63 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.687 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -84.17 142.9 29.99 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.905 -179.236 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.417 ' HB2' ' O ' ' A' ' 21' ' ' SER . 6.3 mt-30 -90.86 -52.91 4.63 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.445 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 173.07 102.91 0.16 Allowed Glycine 0 C--N 1.335 0.494 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.216 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.69 ' CB ' HD12 ' A' ' 20' ' ' ILE . 13.7 p -79.0 -127.33 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -178.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.4 p . . . . . 0 C--O 1.252 1.225 0 CA-C-O 118.614 -0.708 . . . . 0.0 111.16 -179.59 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 120.427 0.156 . . . . 0.0 111.182 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.707 ' HA ' HG23 ' A' ' 5' ' ' VAL . 87.2 Cg_endo -81.45 42.58 1.36 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.954 2.436 . . . . 0.0 113.23 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.535 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.2 OUTLIER -96.09 -58.66 0.19 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.858 178.799 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.535 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 68.8 Cg_endo -95.91 11.75 1.34 Allowed 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.049 2.5 . . . . 0.0 113.192 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.707 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -99.0 98.35 7.01 Favored 'Isoleucine or valine' 0 C--N 1.341 0.232 0 CA-C-O 121.026 0.441 . . . . 0.0 110.665 -179.87 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 5.0 p30 -90.45 166.21 13.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.691 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.5 p -176.36 174.28 1.98 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.436 0.636 . . . . 0.0 112.397 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -120.65 -45.6 2.4 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.339 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.444 HG22 ' H ' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -114.61 -177.82 3.22 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.977 178.895 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.444 ' H ' HG22 ' A' ' 9' ' ' THR . 2.0 p-10 -62.46 -58.18 8.54 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.8 3.9 3.76 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.9 -30.18 56.07 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.507 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.33 21.52 4.42 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.332 178.416 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.1 p -51.44 -28.27 8.01 Favored 'Isoleucine or valine' 0 C--N 1.345 0.392 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.388 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.78 -25.18 60.17 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.718 0.294 . . . . 0.0 110.356 178.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.501 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.2 t -84.05 -45.48 13.03 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.558 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.826 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -169.07 -169.3 32.27 Favored Glycine 0 C--N 1.335 0.524 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.298 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.8 mp -91.17 81.75 5.54 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.121 0.486 . . . . 0.0 111.002 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.65 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 99.28 81.77 1.62 Allowed Glycine 0 C--N 1.323 -0.16 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.862 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.826 HD11 ' C ' ' A' ' 17' ' ' GLY . 0.9 OUTLIER -109.51 144.99 16.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 112.143 0.424 . . . . 0.0 112.143 -178.17 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -86.46 129.91 34.69 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.6 t -95.0 126.35 40.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.196 0.522 . . . . 0.0 111.851 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.614 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -96.58 -155.49 0.49 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.964 178.422 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -52.77 65.43 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.647 0.779 . . . . 0.0 112.16 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.614 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 74.49 16.28 80.09 Favored Glycine 0 CA--C 1.519 0.326 0 CA-C-N 115.386 -0.825 . . . . 0.0 113.073 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 44.7 m-85 -143.34 179.47 7.07 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 117.346 0.573 . . . . 0.0 112.317 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.645 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -80.55 143.42 33.25 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.799 -179.327 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -90.83 -55.06 3.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.402 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 175.88 101.78 0.15 Allowed Glycine 0 C--N 1.333 0.373 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.286 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.601 ' CB ' HD12 ' A' ' 20' ' ' ILE . 17.1 p -80.86 -128.24 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 111.462 0.171 . . . . 0.0 111.462 -178.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 11.0 p . . . . . 0 C--O 1.252 1.19 0 CA-C-O 118.523 -0.751 . . . . 0.0 111.271 -179.526 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 120.432 0.158 . . . . 0.0 111.142 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.668 ' HA ' HG23 ' A' ' 5' ' ' VAL . 97.2 Cg_endo -82.54 40.85 1.02 Allowed 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.042 2.494 . . . . 0.0 113.302 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.57 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 0.2 OUTLIER -95.37 -57.48 0.21 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.888 178.852 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.57 ' HD3' ' HB3' ' A' ' 3' ' ' TYR . 86.5 Cg_endo -96.11 12.09 1.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.045 2.497 . . . . 0.0 113.038 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.668 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -96.95 102.42 13.46 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-O 121.189 0.518 . . . . 0.0 110.683 -179.888 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -89.8 162.66 15.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.564 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.3 p -177.99 174.45 1.4 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.399 0.619 . . . . 0.0 112.342 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.2 -47.29 2.15 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.295 178.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.9 p -112.12 -176.81 3.01 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.219 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.09 -62.76 1.63 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.7 mtt85 -71.09 4.13 2.95 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -76.91 -27.38 54.91 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.479 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -92.84 23.75 4.0 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.256 178.272 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.3 p -50.88 -27.81 5.62 Favored 'Isoleucine or valine' 0 C--N 1.346 0.456 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.433 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 5.8 mtt -57.05 -25.72 59.12 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.672 0.273 . . . . 0.0 110.487 178.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.587 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.6 t -84.06 -45.19 13.32 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.564 179.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.83 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -171.26 -168.89 33.55 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 120.485 -0.864 . . . . 0.0 113.588 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.12 82.25 5.55 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.212 0.529 . . . . 0.0 111.075 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.671 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 100.03 82.22 1.65 Allowed Glycine 0 C--N 1.325 -0.073 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.514 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.83 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.1 mm -109.93 150.12 12.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -178.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.419 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 0.9 OUTLIER -91.81 129.77 37.71 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.057 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.6 t -96.92 127.65 43.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.996 0.426 . . . . 0.0 111.772 -178.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.6 ' O ' ' N ' ' A' ' 25' ' ' GLY . 38.1 pttt -95.04 -155.5 0.47 Allowed 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -54.05 64.95 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 O-C-N 123.915 0.759 . . . . 0.0 112.216 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.6 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 79.1 14.67 81.58 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.31 -0.859 . . . . 0.0 113.149 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -142.37 -176.52 4.87 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 117.607 0.704 . . . . 0.0 112.568 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.657 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -83.51 139.42 32.92 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.707 -179.362 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.435 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 12.8 mt-30 -90.36 -47.5 7.71 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.54 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 168.03 104.2 0.17 Allowed Glycine 0 C--N 1.336 0.533 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.667 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.716 ' CB ' HD12 ' A' ' 20' ' ' ILE . 14.7 p -80.76 -128.32 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 122.061 0.145 . . . . 0.0 111.224 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.455 -0.783 . . . . 0.0 110.56 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.802 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.71 ' HA ' HG23 ' A' ' 5' ' ' VAL . 93.3 Cg_endo -82.61 41.04 1.04 Allowed 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.598 2.199 . . . . 0.0 113.368 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.716 ' HB3' ' HD3' ' A' ' 4' ' ' PRO . 4.5 t80 -94.51 -56.39 0.22 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.013 178.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.716 ' HD3' ' HB3' ' A' ' 3' ' ' TYR . 94.4 Cg_endo -95.53 11.48 1.46 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.011 2.474 . . . . 0.0 113.085 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.71 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -100.06 98.7 7.3 Favored 'Isoleucine or valine' 0 C--N 1.34 0.17 0 CA-C-O 121.092 0.472 . . . . 0.0 110.823 -179.853 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.541 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 2.3 p-10 -90.37 166.91 13.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.654 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.415 ' HB2' ' HB3' ' A' ' 12' ' ' ASP . 7.8 p -179.1 173.17 1.18 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.445 0.641 . . . . 0.0 112.443 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.52 -47.68 2.53 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.035 178.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.9 p -113.08 -177.16 3.07 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.191 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -61.63 -56.97 14.05 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.63 -0.22 10.25 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 7' ' ' CYS . 0.8 OUTLIER -75.56 -28.71 59.12 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.045 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.484 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.7 23.61 3.5 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.414 178.546 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.6 p -51.62 -28.24 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.282 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -57.11 -26.04 59.8 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.397 178.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.624 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.5 t -83.85 -46.17 12.45 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.621 179.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.819 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -170.93 -169.09 33.56 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.454 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.3 82.56 5.44 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.276 0.56 . . . . 0.0 110.874 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.681 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 100.43 82.36 1.66 Allowed Glycine 0 N--CA 1.458 0.134 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.618 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.819 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -110.16 150.12 12.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -178.167 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.404 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 6.0 m -91.74 129.15 37.76 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 3.0 t -96.5 125.86 41.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.961 0.41 . . . . 0.0 111.558 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.62 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -96.32 -152.66 0.38 Allowed 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.166 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -51.97 64.62 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.46 0.704 . . . . 0.0 112.721 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.62 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 74.48 19.62 79.81 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.8 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 89.1 m-85 -145.36 -175.44 4.71 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.678 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -84.15 140.31 31.84 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.803 -179.135 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.413 ' HG3' ' HB3' ' A' ' 23' ' ' LYS . 13.0 mt-30 -90.85 -45.66 8.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.285 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.39 105.34 0.19 Allowed Glycine 0 C--N 1.336 0.577 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.25 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.73 ' CB ' HD12 ' A' ' 20' ' ' ILE . 12.8 p -80.83 -128.42 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 111.437 0.162 . . . . 0.0 111.437 -178.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.45 -0.786 . . . . 0.0 110.65 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 11.2 p . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.725 0.297 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.79 ' HA ' HG23 ' A' ' 5' ' ' VAL . 95.5 Cg_endo -79.11 49.44 3.16 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.806 2.338 . . . . 0.0 113.211 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.544 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.2 OUTLIER -100.64 -59.42 0.11 Allowed Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.633 178.562 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.544 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 68.1 Cg_endo -93.53 9.34 2.3 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.856 2.371 . . . . 0.0 113.308 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.79 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.1 OUTLIER -99.82 95.87 4.49 Favored 'Isoleucine or valine' 0 C--N 1.343 0.295 0 CA-C-O 120.966 0.413 . . . . 0.0 110.097 179.675 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.548 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 0.9 OUTLIER -90.19 165.14 14.13 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.144 -179.099 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.8 p -179.06 169.7 1.51 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.282 0.563 . . . . 0.0 112.151 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.0 mmtt -114.25 -45.06 3.07 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.059 177.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.6 p -115.92 -177.65 3.21 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.683 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -58.37 -62.46 1.83 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -69.47 -0.28 6.29 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -75.59 -28.42 58.91 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.0 110.258 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.632 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -90.8 24.49 2.71 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.069 178.28 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.4 p -49.46 -26.2 2.17 Favored 'Isoleucine or valine' 0 C--N 1.345 0.398 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.589 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 9.8 mtm -52.46 -29.16 23.27 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.606 0.241 . . . . 0.0 110.444 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.602 ' SG ' HG11 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -83.86 -46.96 11.58 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.914 179.377 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.793 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -172.76 -166.03 30.67 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.458 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.29 81.45 5.49 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.244 0.545 . . . . 0.0 111.136 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.649 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 105.34 81.53 1.47 Allowed Glycine 0 N--CA 1.457 0.056 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.713 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.793 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -113.07 123.27 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -178.12 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 0.2 OUTLIER -61.44 138.19 58.26 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 178.088 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.6 t -109.77 130.06 55.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.989 0.423 . . . . 0.0 111.946 -178.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.571 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.1 OUTLIER -95.1 -156.72 0.53 Allowed 'General case' 0 C--N 1.334 -0.085 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.31 178.596 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 -56.67 65.9 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.753 0.658 . . . . 0.0 111.733 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.571 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 79.1 21.02 68.71 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.954 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 58.4 m-85 -145.33 179.14 7.59 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 117.445 0.622 . . . . 0.0 112.429 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.622 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -78.81 143.6 35.88 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.192 -179.74 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.447 ' HB2' ' O ' ' A' ' 21' ' ' SER . 7.3 mt-30 -90.51 -40.61 11.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.028 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -166.17 94.48 0.11 Allowed Glycine 0 C--N 1.339 0.695 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.268 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -40.91 90.55 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.85 0.86 . . . . 0.0 111.858 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.762 HG22 HD12 ' A' ' 20' ' ' ILE . 2.0 t . . . . . 0 C--O 1.249 1.046 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.07 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 38.5 m . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 120.358 0.123 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.682 ' HA ' HG23 ' A' ' 5' ' ' VAL . 92.5 Cg_endo -82.9 42.0 1.21 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.943 2.428 . . . . 0.0 113.271 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.519 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -97.4 -58.79 0.16 Allowed Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.813 178.828 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.519 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 67.4 Cg_endo -92.28 9.36 2.68 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.865 2.377 . . . . 0.0 113.27 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.682 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -95.88 102.11 13.16 Favored 'Isoleucine or valine' 0 C--N 1.342 0.254 0 CA-C-O 121.013 0.435 . . . . 0.0 110.265 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.565 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 26.1 p30 -88.9 164.94 14.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.303 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.9 p -177.19 167.86 2.37 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.29 0.567 . . . . 0.0 112.041 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.77 -46.92 3.09 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.898 178.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.6 p -114.89 -176.73 2.96 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.193 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -60.26 -61.77 2.36 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -71.4 3.86 3.44 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -178.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.96 -28.6 55.24 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.5 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -90.21 22.66 3.2 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.229 178.274 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.6 p -50.79 -28.17 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.307 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 10.8 mtt -55.76 -26.31 45.18 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.418 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.448 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.5 t -84.04 -44.89 13.66 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.538 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.836 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -170.69 -170.04 34.47 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.276 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.7 mp -91.1 81.52 5.59 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.129 0.49 . . . . 0.0 110.903 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.676 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 101.54 81.84 1.61 Allowed Glycine 0 C--N 1.325 -0.075 0 CA-C-N 115.597 -0.728 . . . . 0.0 111.598 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.836 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -110.49 147.74 14.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -178.053 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.2 m -86.49 136.93 32.9 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.2 t -104.97 130.85 53.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.272 0.558 . . . . 0.0 112.479 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.581 ' O ' ' N ' ' A' ' 25' ' ' GLY . 1.4 mtpp -94.03 -159.25 0.68 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.197 -0.911 . . . . 0.0 108.718 178.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -58.01 66.67 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.41 0.624 . . . . 0.0 111.025 179.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 80.53 19.27 68.98 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.969 -179.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 44.7 m-85 -143.45 -177.8 5.57 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 117.541 0.67 . . . . 0.0 112.601 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.674 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -86.62 142.52 28.19 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.2 -178.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.452 ' HG2' ' HD2' ' A' ' 23' ' ' LYS . 7.1 mt-30 -90.89 -50.19 6.02 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.499 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 169.46 104.21 0.17 Allowed Glycine 0 C--N 1.336 0.535 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.534 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.715 ' CB ' HD12 ' A' ' 20' ' ' ILE . 15.0 p -80.15 -128.11 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 111.517 0.191 . . . . 0.0 111.517 -178.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.628 -179.636 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 120.555 0.217 . . . . 0.0 111.422 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.764 ' HA ' HG23 ' A' ' 5' ' ' VAL . 73.8 Cg_endo -73.65 53.68 2.78 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.964 2.443 . . . . 0.0 113.406 -179.832 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.574 ' CB ' ' HD3' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -100.19 -59.95 0.11 Allowed Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.462 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.574 ' HD3' ' CB ' ' A' ' 3' ' ' TYR . 61.8 Cg_endo -96.16 12.08 1.25 Allowed 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 123.193 2.595 . . . . 0.0 113.144 179.425 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.764 HG23 ' HA ' ' A' ' 2' ' ' PRO . 0.1 OUTLIER -104.83 92.28 2.1 Favored 'Isoleucine or valine' 0 C--N 1.344 0.344 0 CA-C-O 121.201 0.524 . . . . 0.0 110.512 -179.965 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.508 ' HA ' ' HA ' ' A' ' 26' ' ' TYR . 1.0 OUTLIER -90.58 164.91 14.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.621 -179.695 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.416 ' HB2' ' HB3' ' A' ' 12' ' ' ASP . 10.3 p -179.25 175.28 0.95 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.353 0.597 . . . . 0.0 112.387 179.439 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -122.12 -46.67 2.18 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.28 178.264 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.91 -177.95 3.26 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.323 178.74 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -58.39 -64.32 0.96 Allowed 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.526 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.27 3.18 2.35 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -179.102 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.416 ' HB3' ' HB2' ' A' ' 7' ' ' CYS . 4.2 m-20 -76.59 -30.0 56.8 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.496 ' HB3' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -91.54 22.02 4.27 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.243 178.138 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.6 p -50.4 -29.55 6.47 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 CA-C-O 120.592 0.234 . . . . 0.0 111.195 179.724 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.516 ' HG3' HG12 ' A' ' 5' ' ' VAL . 7.1 ptp -54.71 -25.46 27.54 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.61 178.373 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.673 ' HB2' HG11 ' A' ' 5' ' ' VAL . 4.7 t -83.98 -43.97 14.66 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.646 179.396 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.839 ' C ' HD11 ' A' ' 20' ' ' ILE . . . -171.11 -169.67 34.37 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.37 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.518 ' N ' HD22 ' A' ' 18' ' ' LEU . 2.9 mm? -91.18 82.19 5.52 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.161 0.505 . . . . 0.0 110.776 179.744 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.686 ' C ' HD13 ' A' ' 20' ' ' ILE . . . 100.66 82.15 1.64 Allowed Glycine 0 N--CA 1.457 0.062 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.523 -179.354 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.839 HD11 ' C ' ' A' ' 17' ' ' GLY . 1.0 OUTLIER -110.73 150.31 13.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -177.939 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 2.1 p -91.18 138.46 31.57 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 177.7 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.401 ' SG ' ' C ' ' A' ' 7' ' ' CYS . 3.6 t -103.92 129.51 51.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.102 0.477 . . . . 0.0 111.957 -178.659 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.57 ' O ' ' N ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -95.3 -157.35 0.57 Allowed 'General case' 0 C--O 1.227 -0.131 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.018 178.327 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -56.12 65.54 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.254 0.622 . . . . 0.0 112.024 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 81.21 15.25 77.27 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-N 115.398 -0.819 . . . . 0.0 113.16 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 6' ' ' ASN . 65.5 m-85 -143.51 -174.87 4.35 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 117.455 0.627 . . . . 0.0 112.412 -179.55 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.658 ' SG ' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -81.61 140.0 34.68 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.687 -179.469 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' A' ' 21' ' ' SER . 5.8 mt-30 -90.67 -36.22 14.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.467 178.647 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 156.02 107.6 0.27 Allowed Glycine 0 C--N 1.338 0.646 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.635 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.706 ' CB ' HD12 ' A' ' 20' ' ' ILE . 19.8 p -86.01 -130.63 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.575 0.188 . . . . 0.0 111.489 -178.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 6.9 p . . . . . 0 C--O 1.253 1.266 0 CA-C-O 118.512 -0.756 . . . . 0.0 111.01 -179.629 . . . . . . . . 0 0 . 1 stop_ save_